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Elemental metabolic labelling using 15N stable isotopes is a technique used in peptide-
centric proteomics that allows samples to be mixed before preparation and analysis 
(minimising technical variance) without introducing sample ambiguity to the results. 
Labelling with 15N induces a mass shift in labelled peptides that, when analysed by mass 
spectrometry (MS), allows the signal associated with differently labelled samples to be 
differentiated. 
When compared to similar labelling techniques such as Stable Isotope Labelling by Amino 
acids in Cell culture (SILAC), 15N poses unique challenges for analysis because the level 
of label incorporation affects not only the relative intensity of signals in MS analysis, but 
also how that signal is distributed. A computational signal extraction algorithm is not 
easily generalised to all peptides, especially if there are differences in the level of 
incorporation. Analysis of 15N data has been neglected by the general pace of software 
development in proteomic MS. Furthermore, the current 15N analysis options have 
relatively complex installation procedures and are limited to a command-line interface. 
I describe the development of a cross-platform 15N quantification software package 
(HeavyMetL) which runs inside a web browser, requiring no installation procedure and 
providing a graphical interface for both the analysis of data and visual interrogation of 
results (in addition to a more typical text-format table output). The optimisation (using 
experimental data) of a core part of the algorithm to determine the level of 15N 
incorporation is described in detail. Finally, the performance of HeavyMetL is 
benchmarked against published 15N labelled data from Arabidopsis seedlings quantified by 
a previously published algorithm, showing that HeavyMetL produces quantification of 
equivalent or better quality.
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Chapter 1: Introduction 
1.1 Proteomic Mass Spectrometry 
1.1.1 Background 
The last three decades have seen the rise of the ‘-omics’; large scale multivariate analysis 
of biological systems. From the birth of genomics in 1977 with the sequencing of 
bacteriophage ΦX174 (1) the field of systems biology has expanded from DNA through 
mRNA, proteins and metabolites to new levels of complexity. Proteomics is the study of 
the proteome (2); the overall state of an organism’s temporal protein makeup. 
Biological systems are dynamic and involve interactions between and within complexity 
levels (genome, transcriptome, proteome, metabolome and so on) (3). The state of the 
transcriptome cannot be predicted based purely on the genome, and the state of the 
proteome is governed not just by the current state of the transcriptome. 
The biological state of the proteome is, at any point in time, encoded not just in relative 
protein abundance (a dynamic consequence of both protein production and degradation 
rates (4)), but also in their potential for activity, which depends on their current post-
translational modification state ; their folded structures (5); their localisation relative to 
cellular spatial organisation (6) and the local availability of interaction partner molecules 
(7) and substrates. This last point introduces a recursive problem for metabolite substrates, 
since prediction of the metabolome is itself dependent on the proteome, albeit not 
exclusively, depending not only on (local) protein activity but also local reactant 
availability (8, 9). 
While lagging behind the meteoric rise of genomics as a tool for scientific understanding, 
the more nuanced view of proteomics has demonstrated that a ‘genome-centric view’ of 
biological pathways reveals only a part of the subtle network of interactions that govern 
the processes of life. The complexity revealed has, as in many avenues of scientific 
research, resulted in increasingly specialised analyses that focus on tissues or even sub-
cellular levels of organisation rather than the relative heterogeneity of whole organisms. 
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Small-scale proteomic analysis using classical targeted approaches such as western 
blotting (10), and even larger experiments based on two-hybrid models (11) have been 
employed for several decades, but the area of systems biology that might be thought of as 
modern proteomics has coalesced around two approaches that have exploited 
technological developments in Mass Spectrometry (MS) - the analysis of intact proteins 
(‘top-down’ proteomics), and the analysis of peptides (‘bottom-up’ proteomics) discussed 
in Section 1.1.2.2 below. 
1.1.2 Mass Spectrometry as a Proteomic Analysis Tool 
1.1.2.1 Analytical Constraints 
As a measurement of physical phenomena, mass spectrometry is subject to three principles 
which apply broadly across most observational techniques. 
I. More abundant entities are easier to detect, and to measure accurately, having higher 
signal-to-noise. 
II. It is easier to analyse samples of lower complexity. Both the number of entities and 
the range of entity abundances contribute to complexity. 
III. Difficulties stemming from points I and II require additional effort to address. For 
this reason, there is always a trade-off between sensitivity, robustness and time for 
analyses with any given instrument. 
As a simple example of such principles, consider an observer counting pixels in a small 
image (Figure 1-I-A). There are 950 black pixels, 20 dark grey, 20 light grey, and 10 
white. It is easy for the observer to conclude, just at a first glance, that there are a lot of 
black pixels. The observer can easily conclude that of the 1000 pixels, almost all are 
black; a quick estimate that all 1000 pixels are black will have relatively high accuracy. 
Counting the white and grey pixels is more difficult, as an over-count or under-count by 
one will cause a significant relative change in the count (Principle I). The 20 dark grey 
pixels may be easily mistaken for black (especially on a low resolution computer screen), 
so separating the pixels by colour before counting will make the counting of the non-black 
pixels much easier (Figure 1-I-B). In contrast, if the 1000 pixels were scattered at random 
through a large image of 10,000 pixels in another shade of dark grey, accurate evaluation 
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of the (previously simple) black pixel abundance would itself become challenging 
(Principle II) (Figure 1-I-C,D). If observation time is limited to a few seconds, then the 
observer can conclude quickly if a specific colour of pixel is present or not, but will not 
necessarily be able to evaluate the actual proportion of pixel colours, except to say that 
there are many more black (small image) or dark grey (large image) pixels. If, however, 
the observer is given more time to analyse the image, it is reasonable to assume they will 
be able to giver a better evaluation of relative pixel proportions (Principle III). To extend 
the analogy, an observer with better eyesight or faster tallying method may be able to 
make a more accurate assessment of the image in the same time frame, or alternatively 
they could apply the same standard of assessment as the original observer to multiple 
images in the same time frame. In the context of a mass spectrometry based proteomic 
experiment, this might correspond to using an instrument with a more sensitive detector or 
a faster scan speed. 
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Figure 1-I. Principles of Observation. A & B: These images each contain 1000 pixels in 
the ratio 950:20:20:10 for black:medium grey:light grey:white respectively. Estimation of 
the number of black pixels is relatively straightforward as they are the majority of the 
data, even an estimate that all 1000 pixels are black will be relatively accurate. 
Assessment of the other colours cannot be performed as easily with a similar level of 
relative error, but the task can be rendered easier if the pixels are sorted by colour first 
(B). C & D: These images contain the same 1000 pixels as A and B, and an additional 
9,000 dark grey pixels. Now, even counting the black pixels becomes challenging (C), and 
while the image may again be sorted to separate the colours (D), an at-a-glance estimate 
of anything but the number of the dominant dark grey pixels is more difficult. 
Samples analysed in proteomics are typically a protein mixture obtained from a cell or 
tissue preparation (12), although analyses of exogenous proteins and peptides in fluids 
(e.g. urine (13), blood (14, 15)) or extracellular matrices (e.g. plaques (16), biofilms (17)) 
are also widespread. A simple preparative protocol might, for example, involve lysis of 
tissue sample cells in a buffered detergent, followed by precipitation of the protein content 
and re-suspension of the pellet in a low pH buffer. Biochemical techniques for the general 
extraction of the protein mixture are not a focus of this thesis, but the same considerations 
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absolute and relative amount of protein high (Principle I), minimisation of sample 
complexity, such that the proteome or proteome components of interest are not swamped 
by other biomolecules (Principle II), and minimisation of technical variance so that 
accuracy of measurement is as high as possible within a feasible number of replicates 
(Principle III). 
Even with optimised preparation of the protein mixture, proteomic samples are generally 
relatively complex, so ‘modern’ proteomic mass spectrometry routinely involves some 
strategy to reduce sample complexity before mass spectral analysis, to maximise the 
resolution and depth of obtained spectra. Descriptions of exemplary experimental designs 
can be found as early as 1993 when Henzel and colleagues described a strategy of 
separation of proteins by two dimensional electrophoresis, tryptic digestion and MS 
analysis of excised spots, and identification of proteins by comparison against in silico 
digestion of a database of possible candidates (18). 
1.1.2.2 Methodologies 
There are two broad methodological approaches to the analysis of proteins by MS, which 
distinguish between the MS analysis of intact proteins, or alternatively the MS of 
constituent peptides (predominantly generated by protease digestion). Respectively, these 
are commonly referred to as ‘top-down’ (19) and ‘bottom-up’ (20). Initially, this 
distinction in analytical method referred to the point of separation, so the methodology of 
Henzel et al. would be considered to be top-down as the separation step (by 2D 
electrophoresis) is performed on intact proteins. The definition has shifted over time to 
refer to ‘the composition of the sample at the point of introduction to the MS’ (21). Since 
in Henzel et al. the samples are digested before MS analysis, the analyte is a mixture of 
peptides, so their methodology would now be considered bottom-up. 
Preserving protein compositional integrity in top-down proteomics facilitates 
discrimination between isoforms and modification states and is often preferred when such 
distinctions are key to understanding results. However, the heterogeneous proteomic 
composition of many biological samples presents many challenges for intact analysis. The 
diverse array of physiochemical characteristics can frustrate attempts to find an acceptable 
set of analytical conditions, or to achieve sufficient separation such that the acquired mass 
spectra can be de-convoluted and interpreted. 
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Conversion of the protein mixture to a population of derived peptides effectively imposes 
soft limits on the length of the polypeptide chains present in the sample, which narrows 
the distribution of the physiochemical characteristics in the population. In effect, 
population physiochemical complexity is reduced at the expense of population sequence 
complexity, as each protein is converted into a mixture of peptides. Peptides with a 
particular amino acid sequence may be generated by digestion of several different protein 
species, resulting in a loss of information that can frustrate the inference of protein-level 
results based on the peptide data. This so-called Protein Inference Problem (22) is 
discussed further in Section 1.1.2.10.2. Nevertheless, the reduction in molecular weight 
and physiochemical complexity broadens the range of applicable sample separation 
techniques (in particular, the use of liquid chromatography) and allows MS to be 
optimised for a ‘general case’ peptide sample scenario. 
Both top-down and bottom-up strategies have been employed in various incarnations for 
studies of the proteome; however, the bottom-up approach is the sole methodology 
applicable to all the experiments described in this thesis. Further discussion of proteomic 
mass spectrometry and the associated workflow will be confined to this area. 
1.1.2.3 Sample Preparation 
As discussed in the pixel analogy, better results are obtained when analyte complexity is 
as low as possible. Techniques to separate intact proteins (i.e. prior to digestion), while 
playing an important role in top-down proteomics, have been somewhat overshadowed in 
bottom-up analyses due to the ascendancy of in-line liquid chromatography peptide 
separations. Nevertheless, such techniques continue to play an important role in bottom-up 
strategies, as they allow discrimination between protein isoforms that would otherwise be 
impossible to distinguish post-digestion due to very high sequence overlap resulting in 
many, if not all detectable peptide products being shared. Separation by polyacrylamide 
gel chromatography is generally employed on intact proteins, since they have a much 
greater spread of masses than a peptide mixture. By the same token, the relatively narrow 
distribution of peptide lengths which makes them so amenable to liquid chromatographic 
separation (see below) places high requirements on gel chromatography in terms of mass 
resolution and reproducibility. 
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Protein (and peptide) separation techniques may also be employed on relatively simple 
samples for ‘clean up’ purposes in order to make them more amenable to MS analysis. 
Many contaminants do not have a significant interaction with common separation 
mechanics, remaining in the loading buffer or eluting before the first protein/peptide 
fraction is collected. This section will discuss key bottom-up workflow steps in preparing 
a sample for MS analysis starting from a point of a relatively pure protein mixture, as the 
preceding steps relating to cell lysis/extracellular protein collection and depletion of non-
protein biological components are specific to experimental design and biological context. 
1.1.2.3.1 Protein Separation 
Protein separation by mass using Polyacrylamide Gel Electrophoresis (PAGE) is a 
venerable (23) and adaptable technique employed widely in proteomics (24). In the most 
widely used incarnation, protein samples are prepared for PAGE separation by boiling in 
Sodium Dodecyl Sulphate (SDS). The combination of the anionic surfactant SDS and the 
disruption due to heat results in general denaturation of the protein mixture; this popular 
pairing of techniques is referred to as SDS-PAGE. Denatured proteins are loaded onto a 
polyacrylamide gel and a constant electric field is applied across the gel, causing proteins 
to migrate through the gel towards the anode. In their denatured state, lower mass proteins 
travel more rapidly through the gel matrix, thus the population becomes spread over the 
length of the gel according to mass. In cases where the use of SDS results in poorly 
resolved bands (for example, glycoprotein samples), alternative denaturing reagents such 
as the cationic surfactant hexadecyl-trimethyl-ammonium bromide (cetrimonium bromide, 
CTAB) may be used instead. After separation, proteins may be visualised generally on the 
gel by Coomassie or Silver Stain, or specifically by techniques that use antibody detection 
(such as western blotting). Sections of a gel lane may also be excised, and the proteins 
then extracted for further investigation. For analysis by MS, the proteins may be digested 
in-gel to peptides, which are able to diffuse out of the gel matrix. 
In principle, the ability to visualise the mass distribution of proteins prior to MS analysis 
yields information regarding the relative abundance of different protein 
isoform/modification states which is frequently intractable to ‘bottom-up’ analysis. 
However, a single dimension of separation by mass alone provides insufficient resolution 
for analysis of all components in a protein mixture, even for relatively low complexity 
examples. For this reason, the pre‑eminent approach to proteomics in the late 1990s/early 
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2000s involved two dimensions of separation wherein proteins were first separated by 
isoelectric point (pI) on an immobilized pH gradient gel (termed isoelectric focussing, 
IEF) and then subsequently by mass on an SDS-PAGE gel, termed two-dimensional gel 
analysis (2DGE). This approach has retained some popularity, particularly for isoform and 
modification state visualisation, but for general proteomic analysis has been found to have 
a number of disadvantageous qualities (25). In particular, the technique yields very poor 
coverage of membrane proteins, which frequently resist solubilisation in IEF-compatible 
zwitterionic detergents such as 3-[N,N-dimethyl(3-
myristoylaminopropyl)ammonio]propanesulfonate (amidosulfobetaine-14, ASB-14) or 3-
[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) due to 
hydrophobic transmembrane domains. Furthermore, the resolution in both 2DGE 
dimensions is insufficient to separate proteoforms with similar pI and mass, thus a single 
2DGE spot may contain more than one protein, frustrating quantitative comparisons. The 
reproducibility of separation is further degraded by even small inconsistencies in gel 
casting, an effect which increases with gel size (larger gels are otherwise desirable for 
better resolution). There are also experimental practicality limits on the size of the gel 
apparatus and the feasibility of performing a large cohort study. These factors have driven 
2DGE to be largely supplanted by liquid chromatography peptide separation (Section 
1.1.2.4) as the predominant proteomic separation approach. 
1.1.2.3.2 Digestion 
Peptides must contain enough information to be distinctive whilst being short enough to 
limit their physiochemical characteristics to an acceptable range. In general, modern 
bottom-up proteomic MS analysis techniques are optimised for peptides containing 
between 6 and 20 residues (26). The most widely used method of generating peptides from 
parent proteins is by digestion by proteolytic enzymes. The enzyme trypsin is frequently 
employed as it has a well characterised, highly specific cleavage pattern (C-terminal to 
lysine or arginine residues not followed by a proline) that tends to generate a large number 
of peptides favourable to MS analysis. The distribution of arginine and lysine in the 
proteome sequence of most organisms is typically such that peptides of desirable length 
are generated from most proteins, whilst ensuring every peptide has at least one proton 
accepting group at each peptide terminus (favouring a minimum charge state of 2+ after 
positive ionisation). Trypsin is generally utilised in a commercially available modified 
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form whereby reductive methylation of lysine residues reduces the autolytic properties of 
the protease. 
While trypsin is overwhelmingly popular due to agreeable cleavage properties, efficient 
kinetics (close to 100% digestion may be achieved within an hour or less (27)), and 
amenability to a broad range of buffer conditions, other proteases may also be used in 
conjunction with or instead of trypsin, particularly when the distribution of lysine and 
arginine in the proteins of interest lead to a suboptimal distribution of peptide lengths (and 
thus achievable coverage). Historically, this would typically be an avenue explored if 
initial tests with trypsin indicated poor coverage of proteins of interest. However, very 
recent advances in the ability to predict the amenability to MS identification of particular 
peptide sequences may ultimately lead to more frequent selection of trypsin alternatives 
(28). The extent to which a proteome is covered by observable peptides resulting from 
tryptic digestion varies substantially from species to species. In humans, the average 
tryptic peptide length is 14 amino acids (29), but in yeast, the average length is only 8.4, 
with 56% of tryptic peptides generated having a length of 6 amino acids or less (30), 
yielding a high proportion of non-observable peptides. Common alternative proteases 
include LysC, LysN, AspN, GluC and chymotrypsin. The properties of popular proteases 
are listed in Table 1-I. Proteases with varying degrees of non-specificity (i.e. a propensity 
to cleave at random or loosely defined residue motifs) including elastase and pepsin may 
also be used; these present an additional challenge for data interpretation as the partially 
random cleavage means the range of possibly generated peptides is much larger and the 
resulting peptide mixture less comparable between experiments. Increasing interest has 
also been paid to the analysis of peptides generated by in vivo protein cleavage, 
particularly in the context of immunology, for example, the endogenous peptides 
displayed on major histocompatibility complexes (class I and II) (31, 32). 
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Table 1-I. Site-specific Proteases Popular in Proteomics. Adapted from Giansanti, P. et 
al., 2016 (33). 
1.1.2.4 Peptide Separation 
While proteolytic digestion of a typical proteome is effective for reducing the range of 
physiochemical properties by limiting maximum polypeptide length, this still results in a 
highly complex sample. For example, tryptic digestion of the human proteome 
(approximately 20000 genes) results in millions of peptides with abundances ranging 
across seven orders of magnitude (34), and thousands of these peptides share very similar 
m/z ratios. Consequently, it is widespread practice to include one or more stages of peptide 
separation before MS analysis in order to reduce complexity (as per Principle 2 in the 
pixel analogy) and increase the resolving power of the analysis. Improved resolving power 
decreases the number of peptide species competing for ionisation at the same time and 
thus reduces the possibility of failing to observe low abundance (or poorly competitive) 
ion species whose signal would otherwise be suppressed below detection limit (35). 
The most widely used separation technique in bottom-up proteomics is Liquid 
Chromatography (LC). Peptides are soluble in a wide range of solvents and LC separation 
may be combined in-line with Electrospray Ionisation (see below) to feed eluting peptides 
directly into the mass spectrometer. 
LC separates a sample between a column-immobilised matrix (the stationary phase), and a 
solvent passed through the column (the mobile phase). Analytes exhibit a range of 
Protease Type Specificity
ArgC Cysteine Protease C-terminal to R (high efficiency)
C-terminal to K (lower efficiency)
AspN Metalloprotease N-terminal to D (high efficiency)
N-terminal to E, in presence of detergent (low efficiency)
Chymotrypsin Serine Protease C-terminal to FLMWY (varying efficency, many missed cleavages)
GluC Serine Protease C-terminal to E
C-terminal to D (at pH 8)
LysargiNase Metalloprotease N-terminal to KR
LysC Serine Protease C-terminal to K
LysN Metalloprotease N-terminal to K
Pepsin Aspartic Protease C-terminal to FWY
pH-dependent broader specificity 
Trypsin Serine Protease C-terminal to K when not followed by P (lower efficiency)
C-terminal to R when not followed by P higher efficiency)
In addition, negatively charged residues e.g. DE & phospho-ST adjacent or 
proximal to cleavage site reduce efficiency.
WaLP and MaLP Serine Protease C-terminal to aliphatic residues
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affinities for the stationary phase relative to the mobile phase and thus can be eluted over 
time during which the composition of the mobile phase can be changed (the ‘gradient’). In 
proteomics, the column is usually prepared by ‘packing’ with the stationary phase in the 
form of silica beads that have the desired surface chemistry. LC is a powerful tool for 
proteomic separation as it can be highly optimised for the separation of a particular 
mixture. As well as stationary phase chemistry, separation resolution is also affected by 
flow rate, column diameter and length, stationary phase bead size and the design of the 
solvent gradient. Two LC techniques are widely used in proteomics: Reversed-Phase and 
Strong Cation Exchange, both of which are straightforwardly compatible with 
Electrospray Ionisation, either directly in-line (Reversed-Phase) or with minimal further 
processing (Strong Cation Exchange). 
1.1.2.4.1 Reversed-Phase Chromatography 
Reversed-Phase (RP) chromatography separates analytes by their hydrophobicity. Peptides 
generally contain a high proportion of hydrophobic or uncharged amino acids and thus are 
particularly suited to this form of separation. Analytes are partitioned between a 
hydrophobic stationary phase and a polar hydrophilic mobile phase. The mixture is loaded 
onto the stationary phase under low-organic solvent conditions and analytes selectively 
return to the mobile phase as the organic component of the mobile phase is increased 
(either as a continuous gradient or in a series of steps). The order of elution relates to the 
strength of the hydrophobic interactions of each peptide with the stationary phase. The 
stationary phase typically consists of a C18 resin, i.e. silica beads derivatised to present 
alkane chains of 18 carbons. The mobile phase is usually based on a mixture of water and 
acetonitrile (as the organic component). One drawback of silica-based matrices is the 
interaction of residual silanol groups with the positive charges of peptides. This effect can 
be minimized by lowering the pH below 4, as silanol groups then become protonated. The 
column surface can also be treated to ‘end-cap’ the polar surface silanol groups with a 
non-polar trimethylsilyl group. 
The use of a low pH aqueous/acetonitrile mobile phase is ideal for electrospray ionisation 
(see below), so low pH RP-LC is a very popular technique for in-line separation 
immediately prior to introduction into the mass spectrometer. It has become increasingly 
popular to precede this with an initial high-pH RP-LC separation step for greater 
resolution (see Section 1.1.2.4.3) 
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Advances in LC technology have enabled the development of systems which operate at 
high pressures, allowing smaller bead sizes in the column (increasing the relative surface 
area for hydrophobic interactions) and lower flow rates (improving MS ionisation 
efficiency and reducing the amount of sample required for sensitive analysis). High-
Pressure/High-Performance and, more recently, Ultra-High-Performance LC systems have 
been rapidly adopted in proteomics. 
1.1.2.4.2 Strong Cation Exchange Chromatography 
Strong Cation eXchange (SCX) chromatography separates molecules by the number of 
positively charged residues they contain. Just as free amino acids are zwitterionic, so are 
peptides, thus they have predominantly net positive charge when the pH is lower than the 
pKa values of both the N-terminal amino group conjugate acid (such that it is protonated) 
and the C-terminal carboxylic acid group (such that it is neutral). This threshold is 
determined by the lower of the two pKa values which is that of the carboxylic acid, 
approximately 3.1 (36). At this threshold, arginine, lysine and histidine will also carry a 
second positive charge due to protonation of their guanidino (pKa 12.5), lysyl (pKa 10), 
and imadazole (pKa 6) side chains respectively (36). Under typical SCX buffer conditions 
(pH 2.5 to 3), tryptic peptides (containing one arginine or lysine) will (on average) carry a 
net charge of +2, further increased by one for each histidine residue or missed cleavage 
(additional arginine or lysine). The peptides are loaded onto a stationary phase consisting 
of exposed negatively charged groups, which interact with the positively charged peptides. 
Peptides may then be eluted by increasing the concentration of salt ions in the mobile 
phase such that the peptides are outcompeted for electrostatic interaction with the 
stationary phase. 
Relative to RP methodology, SCX does not offer as fine a control over the elution process. 
The quantised nature of charge means a large number of peptides tend to elute closely 
together, particularly groups of doubly and triply charged peptides that contain zero or one 
histidine or missed cleavage. An additional problem is that samples must be desalted after 
separation, which can be a relatively high variance step. This prevents salt ions from 
competing for charge as the sample is introduced into the mass spectrometer, causing ion 
suppression. 
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1.1.2.4.3 Multidimensional Separation 
Resolution in chromatographic separation may be improved by increasing the number of 
fractions into which the sample is divided. Many peptides have properties that are 
sufficiently similar that they co-elute under particular LC conditions, imposing a practical 
limit to peptide separation. One solution to this problem is to further separate each sample 
fraction using an orthogonal fractionation method, producing a series of fractions-of-
fractions with reduced complexity. Separation efficiency is measured in peak capacity, 
defined as the number of peaks which may be separated without overlap, assuming peaks 
to extend four standard deviations from the apex (37). The maximum achievable 
separation efficiency will be the product of the peak capacity of each separation step. This 
can enable a much higher resolution of peptides to be achieved if separation steps are 
sufficiently orthogonal, either by separating differently according to the same 
physiochemical properties, or by separating on different physiochemical properties. 
Assuming that the final stage of separation is in-line low pH RP chromatography, then 
options for prior dimensions include alternative aqueous/organic partitioning-based 
methods (such as high pH RP or Hydrophilic Interaction Chromatography(38)), or charge 
based methods such as SCX. 
Two-dimensional chromatographic separation of peptides has for many years been 
restricted to SCX followed by low pH RP. SCX-low pH RP is not ideal as the 
orthogonality of SCX to RP (and thus the peak capacity) can be limited when there is a 
relatively small range of peptide charges (which is the case when employing tryptic 
digestion). Recently, the use of high pH RP instead of SCX as a first dimension of 
separation has been gaining traction as a strategy. At high pH, the set of amino acids 
contributing to RP chromatographic behaviour is different to the set contributing at low 
pH. At low pH, positively charged residues are surrounded by counterions from the buffer 
which strongly affect peptide retention. Due to the different protonation and deprotonation 
pKa values for the various side chains, a large change in pH substantially alters the charge 
distribution within the peptide, which in turn affects ion pairing and thus retention (39), 
resulting in different separation profiles. Studies of separation at pH 10 have shown high 
pH RP to be orthogonal in terms of separation to the more usual low pH approach (39, 
40), with high-pH RP–low pH RP approaches demonstrating a greater peak capacity than 
SCX-low pH RP. Two dimensional RP is now frequently employed in modern studies 
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where high protein coverage is desirable and the additional MS time required to analyse 
the separate fractions can be justified (41). 
1.1.2.5 Mass Spectrometer Architecture 
Mass spectrometry evaluates the ionic composition of a gas phase analyte, reporting the 
mass-to-charge (m/z) ratios of constituents, and their relative intensity. Only charged 
species can be observed. The primary functions of MS analysis are therefore (i) 
conversion of the analyte to gas phase, with the molecules of interest within the mixture 
carrying charge, (ii) manipulation of the population of ionised species to maximise 
sensitivity of the detection method, and (iii) detection of each ion species. The 
components of a mass spectrometer fulfilling these functions are described respectively as 
(i) Ion Sources, (ii) Mass Analysers and (iii) Detectors. Mass analysis and detection may 
be combined within the same device and are discussed together here. Technological 
developments in instruments and the associated prior (sample preparation) and posterior 
(data analysis) workflows have largely been driven by the principles of observation 
described at the start of this chapter. 
1.1.2.5.1 Ion Sources 
To be analysed by the mass spectrometer, the analyte must be both charged and in the gas 
phase so that it can be easily manipulated by electromagnetic fields inside the instrument. 
The optimum method of ionisation depends on the starting phase of the analyte and the 
stability of the target molecules. An early technique developed for ionisation was brute 
force electron bombardment of samples already in the gas phase (Electron Ionisation - EI). 
EI is an example of a ‘hard’ ionisation technique, in that it imparts a large amount of 
energy to the ionised molecules, frequently resulting in the fragmentation of the molecule 
to a series of smaller ions. In relatively low complexity samples (such as small molecules) 
this may be desirable, as fragmentation can yield additional information about the 
molecular structure. However, for complex samples such as peptide mixtures, the resulting 
mixture of fragments cannot be readily deciphered, or even analysed in a robust fashion. 
For the analysis of peptides, it is desirable that the analytes survive ionisation intact. In 
proteomics, there are two popular so-called ‘soft ionisation’ techniques that can achieve 
this result: Electrospray Ionisation (ESI) and Matrix Assisted Laser Desorption (MALDI). 
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1.1.2.5.1.1 Electrospray Ionisation 
In Electrospray Ionisation (ESI) a strong electric field (typically 2-3 kV in modern 
nanolitre flow range LC) is applied under atmospheric pressure to a liquid passing through 
a capillary tube with low flow rate. Charge accumulates at the liquid surface located at the 
end of the capillary (the ‘emitter’). The liquid at the tip of the emitter forms a Taylor cone 
(42) and a jet of liquid is ejected from the centre. This jet rapidly disintegrates into small 
droplets, which are dispersed radially by Coulomb repulsion, and the droplet plume is 
sampled into the first vacuum stage of the mass spectrometer, where the droplets 
evaporate leaving charged analyte ions (Figure 1-II). Evaporation may be assisted by use 
of an inert nebulising gas such as nitrogen. 
 
Figure 1-II. Electrospray Ionisation of Peptides from Nano-Flow HPLC Column. Adapted 
from Steen, H., and Mann, M., 2004 (43). 
ESI was originally described by Fenn et al. (44) for the analysis of intact proteins, as the 
charge states achieved allow high mass analytes (such as proteins) to be brought within an 
m/z range amenable to MS analysis. ESI has remained a popular technique in proteomics 






Nanolitre flow (50-500 nl/min)
Spray needle tip (∼8 μm)
Plume
Droplets
HPLC Column (∼75 μm diameter)
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in-line with LC, allowing protein and peptide mixtures to be separated (to reduce mixture 
complexity) and then charged and introduced into the MS in a single unified workflow. 
ESI in-line with an LC system is the most popular and widely used method of sample 
introduction in proteomic mass spectrometry. Ionisation efficiency is improved by 
reducing the initial size of the droplets formed, yielding greater sensitivity for a smaller 
amount of sample. This also reduces competition and suppression effects where the total 
available charge is insufficient to ionise all eluting species and due to preferential 
ionisation of the most kinetically amenable species, may result in low abundance less 
amenable species being masked. The drive towards smaller droplet sizes and lower flow 
rate lead to the development of micro- and nano-electrospray (45) techniques. Modern 
nano-ESI is usually operated at flow rate of 50 to 500 nL/min and the use of a nebulising 
gas to maximise droplet evaporation is no longer necessary. 
The exact mechanism by which solvated ions are transferred to gas phase is not 
completely understood, and there are two competing theories that explain it. Under the 
vacuum conditions, solvent evaporates from the droplets until they reach their Rayleigh 
limit (46). At the point of instability, the droplet deforms and undergoes Coulomb fission, 
emitting charged jets of liquid. According to the Ion Evaporation Model (IEM), the 
surface area of the droplet eventually becomes small enough to support field desorption of 
ions from the droplet surface (47). According to the Charge Residue Model (CRM), 
fission of the droplets continues until they contain an average of only one analyte 
molecule, at which point evaporation of the remaining solvent molecules leaves the 
analyte molecule in the gas phase with the remaining charge carried by the droplet (48). 
When investigations of the mechanism have examined large macromolecules like proteins, 
the results have generally supported CRM (49) (50), whilst investigations examining small 
inorganic and organic ions have indicated support for the IEM (51). Although the pre-
eminence of a single model has been asserted for both theories (52, 53), there is now some 
consensus that the process is a combination of multiple mechanisms, with low molecular 
weight analytes following the IEM, while the CRM dominates for larger species (54, 55). 
A third proposition, the Chain Ejection Model (CEM), has been suggested to apply when 
changes in species conformation result in the exposure of nonpolar, hydrophobic moieties 
previously buried within a folded structure, for example in protein unfolding. While the 
folded protein would follow the CRM, unfolding forces the now non-polar version to 
Chapter 1: Introduction 17 
migrate to the surface of the droplet, where it is ejected stepwise in a manner more similar 
to IEM (55). 
1.1.2.5.1.2 Matrix Assisted Laser Desorption/Ionization 
In Matrix Assisted Laser Desorption/Ionization (MALDI), a matrix containing the analyte 
mixture is bombarded with laser pulses. The energy is absorbed by the matrix causing the 
top layer to be ablated as a microplasma plume of matrix and analyte molecules which is 
sampled into the mass spectrometer. The laser pulses thus result in both vaporization and 
ionization of the sample. While laser desorption from a variety of surfaces is possible, the 
mass spectral data that can be obtained depend on the specific physiochemical proprieties 
of the analyte, particularly photoabsorption and volatility. The key advance for widespread 
adoption of this technique was to present the analyte inside a matrix which had excellent 
photoabsoption and proton-donation properties to increase the efficiency of energy 
absorption from the laser and encourage ionisation. This approach was pioneered 
primarily by Karas and Hillenkamp in early 1985 (56, 57). 
The analyte is prepared in a mixture of water and organic solvent to encourage both 
hydrophobic and hydrophilic molecules to dissolve, then mixed with a suitable matrix 
molecule solution. For biomolecules such as peptides, this is usually 3,5-dimethoxy-4-
hydroxycinnamic (sinapinic) acid (SA), α-cyano-4-hydroxycinnamic acid (CCA) or 2,5-
dihydroxybenzoic (gentisic) acid (DHB). The choice of matrix determines the amount of 
internal energy transferred to the analyte during desorption and ionisation. SA is a ‘softer’ 
matrix than CCA and DHB as less energy is transferred resulting in reduced ion 
fragmentation during laser ablation (termed post-source decay) and is generally the matrix 
of choice for intact protein analysis. CCA and DHB are more commonly used for analysis 
of peptides where fragmentation due to post-source decay may be more easily 
deconvoluted to gain further sequence information. DHB is particularly used for the 
preparation of glycopeptides (58, 59). The analyte-matrix molecule mixture is precipitated 
onto the target surface so that the analytes are presented within the crystallised matrix 
molecules. The target is then bombarded with nanosecond laser pulses, typically in the 
ultraviolet frequency range. The precise mechanisms of the microplasma plume generation 
and analyte ionisation are not fully understood. It is known that irradiation by the laser 
imparts localised excitation of the matrix molecules, resulting in rapid heating and 
sublimation of the matrix crystals, ablation of a portion of the crystal surface and 
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expansion of the matrix into the gas phase. This plume contains intact analyte along with 
protonated, deprotonated and neutral matrix molecules. Within the plume, protons are 
transferred to the analyte molecules, resulting in a quasi-molecular charged analyte which 
is sampled into the mass spectrometer (Figure 1-III). 
 
Figure 1-III. MALDI Ionisation of Peptides from a Photoabsorbant Matrix. Adapted from 
de Hoffmann, E., and Stroobant, V., 2007 (60). 
MALDI is more resilient to higher concentrations of detergents and salts than electrospray 
with the added benefit that, after precipitation onto the matrix, the sample is preserved in 
the crystal structure of the matrix and can be re-probed for future analyses. The sampling 
of ions into the instrument is more efficient than ESI. However, MALDI is less suited for 
some experiments. The nature of the matrix deposition means that the analyte is not 
homogenously deposited throughout the matrix, so the total amount of analyte sampled 
may vary between probings (laser discharges). The presence of matrix ions in the sampled 
plume can also mask low molecular weight signals due to noise and ion suppression, and 
the fact that ESI generates multiply charged ions increases the total range of biomolecules 
that can be sampled. 
1.1.2.5.2 Mass Analysers 
Once gas-phase ions have been produced, it is necessary to separate them according to 
their masses so that the mass values (and relative abundance) can be determined. Mass 
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analysers measure the m/z of ions. Several types of mass analysers have been developed 
based on a number of principles, although in general they involve the manipulation and 
separation of ions by a combination of electromagnetic fields (generated either by electric 
induction or by actual magnets). The primary differences between the various types of 
mass analyser are the methods by which these fields are used to achieve separation, each 
with advantages and limitations. These methods typically fall into two broad categories. 
‘Scanning’ analysers separate ions of different m/z values successively over time by 
limiting transmission of ions to a restricted window which ‘scans’ over time through the 
m/z range of detection. ‘Simultaneous’ analysers allow co-transmission of ions of any m/z, 
which are then resolved according to differential behaviour (e.g. flight time or angular 
frequency) within the analyser. Analysers may also be grouped on the basis of other 
properties, for example analysis of a continuous ion beam versus a discrete ion packet, or 
by the typical kinetic energy of the ions during the analysis (Table 1-II). 
 
Table 1-II. Summary of Mass Analysers Typically used in Proteomics. Adapted from de 
Hoffmann, E., and Stroobant, V., 2007 (60). 
Simultaneous analysers that trap the ions being detected can manipulate the trapped ions 
to induce a current differential which carries information about the m/z values of the 
trapped ion population in the waveform. Detection of ions transiting or ejected from 
scanning analysers, and in simultaneous analysers where the ions are not trapped (e.g. 
Time-of-Flight devices), is generally performed by Electron Multiplier Tubes/Plates 
(EMTs). Ions colliding with the plate induce an electric current, proportional to the 
number of ions striking the plate. The signal is amplified by secondary emission, in that 
ions striking the detector surface release further electrons towards detector surface deeper 
into the tube. This causes a cascade effect which propagates through the tube, resulting in 
a detectable electric current. By ‘scanning’ a population of ions separated by m/z over time 
into an EMT, the signal observed over time yields the intensity across the corresponding 
m/z range. It is possible to saturate EMTs with abundant ions, as they have a small 
recovery period after transduction of a signal, the result of which is under-sampling of the 
Mass Analyser Short Form Principle of Separation
Quadrupole Q / Quad Trajectory stability
Linear Ion Trap (Linear Trapping Quadrupole) LTQ Resonance frequency and trajectory stability
Time-of-Flight ToF Velocity
Fourier Transform Ion Cyclotron Resonance FT-ICR Resonance frequency
Fourier Transform Orbitrap Orbitrap Resonance frequency
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ion current and thus underreporting of the true ion intensity. Multiple small EMTs around 
10 microns in diameter may be combined in an array to form multichannel plates (61) 
offering greater sensitivity and a higher saturation threshold. 
Mass analysers may be compared on the basis of five primary characteristics: mass range, 
scan speed, sensitivity, mass accuracy and resolution. Mass range is the range of m/z 
values over which the MS can record ion intensity as a spectrum, and scan speed is the 
time taken to produce a spectrum over a given mass range (assumed to be the full range of 
the instrument unless otherwise stated). Sensitivity is generally given in terms of the 
transmission ratio between the number of ions entering the mass analyser and the number 
reaching the detector; a higher transmission ratio results in more ions reaching the detector 
which facilitates detection of lower abundance species. Mass accuracy indicates the 
difference that is observed between the theoretical m/z values of ion species and the m/z 
values measured in the mass analyser. It is usually expressed in parts per million (ppm). 
Finally, resolution (in mass spectrometry terms) is the ability of a mass analyser to yield 
distinct signals for two ions with a small m/z difference. The technical definition of 
resolution, according to the International Union of Pure and Applied Chemistry (62), is the 
ratio of the mass of a mass spectral peak to the resolving power (or ‘peak separation’) at 
that mass. The resolving power may be defined in terms of either the minimum 
distinguishable mass difference between two peaks, or the width of a peak at that mass. In 
the former case (‘valley definition’), the minimum distinguishable mass difference is the 
mass difference at which the signal intensity between two peaks of equal height is no more 
than 10% of the maximum height of either peak. In the latter case (‘peak width 
definition'), the peak width is taken as the width at a specified fraction of the maximum 
intensity, either 50%, 5% or 0.5%.  In the case of the width at 50%, this value is typically 
referred to as the ‘Full-Width at Half Maximum’ (FWHM) (Figure 1-IV). 
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Figure 1-IV. The Full-Width at Half Maximum Property of a Spectral Peak. 
1.1.2.5.2.1 Quadrupoles 
A quadrupole mass analyser consists of four electrode rods arranged in an equidistant 
diamond configuration around a central channel (Figure 1-V). Each rod is electrically 
connected to its counterpart on the opposite side of the channel, creating two pairs at 90° 
to each other. The rods may be cylindrical or have a hyperbolic cross-section (compare 
Figure 1-V-A and Figure 1-VI-B); the latter design yields a more optimal distribution of 
electric field but is harder to fabricate. Ions are streamed through the device via the central 
channel. Ions whose trajectory intersects the edge of the channel will discharge on the rods 
or the surrounding surfaces and will not pass through the quadrupole. 
An alternating current (AC) in the radiofrequency range is applied across each electrode 
pair, with the potentials of each pair exactly out-of-phase with the other (in this case, 
inverted). A constant direct current (DC) is also applied between the two electrode pairs. 
Because both AC and DC voltages are applied orthogonal to the channel axis, the ion 
velocities along the channel axis are unaffected. Ions are attracted to the electrode pair 
with opposite charge and repelled from the electrode pair with the same charge. The 
oscillation of the AC component deflects the ions alternately in the two dimensions 
orthogonal to the direction of travel, such that they describe a helical path through the 
quadrupole, with a radius which stabilises over the course of the path towards a constant 
value r (Figure 1-V-B). In a typical quadrupole analyser, the AC component may vary 
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Ions are affected by electric fields in proportion to their m/z ratio. This property is 
exploited to differentially affect their path though the quadrupole, by varying the AC 
frequency and holding AC and DC voltages constant, or by varying AC and DC voltages 
(while preserving the relative ratio) fixed for a constant AC frequency. The trajectory of 
low m/z ions is affected substantially by the AC component of the field, while as m/z 
increases (relative to the AC and DC voltages), the destabilising effect of the DC 
component dominates. 
 
Figure 1-V. Schematic of Ion Motion along a Quadrupole Mass Analyser. A: A 
Quadrupole consists of four electrodes, paired in left-right (x) and top-bottom (y) 
dimensions through which ions travel orthogonally to both electrode pairings (z). B: An 
electrical current comprising an AC component and a DC component is applied across 
the electrodes. The AC component inversions (shown in blue/red) cause ions to adopt a 
corkscrew motion. C: Ion trajectory through the analyser is only stable for a narrow 
range of m/z; the boundaries of this range change as a function of the AC and DC 
voltages (or the AC frequency). Ion motion traces adapted from Steel, C., and Henchman, 
M., 1998 (63). 
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The cross-sectional radius of the helical path is dependent on ion m/z, with lower mass 
ions describing a larger radius, closer to the radius of the channel itself. Ions with very low 
m/z cannot stabilise at a path where r is less than the radius of the channel (the stability 
threshold is lower than the physical channel radius, as the strength of the field increases 
with proximity to the electrode). For these ions, their trajectory will move ever closer to 
the electrodes and eventually intersect the edge of the channel (row (i), Figure 1-V-C). 
This applies a lower bound on the m/z of ions able to traverse the quadrupole. 
For higher m/z ions, the AC component has a stabilising effect of ‘nudging’ their 
trajectory into a path with r less than the radius of the channel (row (ii), Figure 1-V-C). As 
m/z increases further, this effect is reduced and the ion trajectories become dominated by 
the constant DC component, deviating from the central channel and eventually intersecting 
the edge (row (i), Figure 1-V-C). This applies an upper bound on the m/z of ions able to 
traverse the quadrupole. 
By altering the parameters (AC/DC voltages or AC frequency) of the composite field the 
quadrupole may be ‘tuned’ to act as a filter for ions in a particular range of m/z. The width 
of this range may be varied by changing the parameters, but is also constrained by the 
fabrication tolerances of the quadrupole, including the symmetry of field potentials, the 
range of voltages and AC frequencies that can be applied, and the range of initial 
velocities and angular momenta of ions entering the channel. 
Varying the parameters over time to ‘scan’ the region of stable traversal through an m/z 
range allows a beam of ions to be effectively separated by m/z in a time dependent 
manner. When coupled to a method of detecting the abundance of the filtered ion sub-
population exiting the quadrupole this can be used to generate a mass spectrum. 
Quadrupoles may also act as a simple ‘ion guide’ by setting the voltage of the DC 
component to zero; in this mode, all ions with m/z high enough to be stabilised by the AC 
component will be transmitted. Other ‘multipole’ devices with three or four pairs of 
electrode rods (hexapoles and octupoles) are often used in this role. The additional electric 
fields provide a shallower gradient of field strength across the central channel (with a 
much steeper gradient close to the electrodes). This allows wider mass ranges of ions to be 
efficiently contained (and thus transmitted with reduced loss of signal). The trade-off for 
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this is that selected transmission of a narrow mass range of ions (i.e. filtering) is much less 
efficient, so these devices are generally only used as ion guides (60). 
1.1.2.5.2.2 Ion Traps 
An ion trap is a device that uses a combination of electric and magnetic fields to contain a 
population of ions. Electric field-based ion traps are historically classified into two types: 
the 3D ion trap or the 2D ion trap (Figure 1-VI). The first ion traps used as mass analysers 
were 3D quadrupole ion traps or ‘Paul traps’ (64), made up of a circular electrode, with 
two ellipsoid caps on the top and the bottom to create a 3D quadrupolar field. A 
conceptually simpler design which was developed later is the 2D ion trap, which may be 
thought of as a quadrupole mass analyser with the ends capped by lenses that reflect ions 
forwards and backwards within the quadrupole, such that they are contained radially by 
the quadrupolar field (by the mechanism described above), and axially by electric fields 
generated from end caps. Modern terminology generally refers to this design as the Linear 
Ion Trap (LIT) or Linear Trapping Quadrupole (LTQ). The linear ion trap design lends 
itself to a larger trapping volume than the Paul trap, which reduces undesirable 
interactions/collisions between trapped particles. Introduction (injection) of ions into the 
trap and ejection of ions from a linear trap is via slots in one pair of quadrupoles. The 
presence of the slots causes a perturbation of the RF field which reduces containment 
precision compared to a quadrupole of the same length. This can be somewhat mitigated 
by slightly stretching the quadrupole, increasing the distance between the cut rods. 
 
Figure 1-VI. Ion Trap Layouts. A: Three-dimensional (Ring) Ion Trap. B: Two-
dimensional (Linear) Ion Trap with hyperbolic electrodes (modern designs are typically 
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In quadrupole instruments, the potentials are adjusted so that a constant flow of ions is 
serially filtered to allow only ions with a selected m/z to pass through. In ion traps, a 
discrete population of ions with various masses is initially contained together within the 
trap. A spectrum is generated by expelling ions according to their m/z. In both cases the 
intensity recorded from the transiting (quadrupole) or expelled (ion trap) ions is correlated 
with the filter or expulsion settings to generate the spectrum. 
1.1.2.5.2.3 Orbitraps 
The Orbitrap (Figure 1-VII) is an alternative design of ion trap mass analyser proposed by 
Makarov (65), albeit based on a much older design for ion containment by Kingdon (66). 
The Orbitrap design consists of a central spindle with opposite charge to the ion 
population, inside a larger shell at ground potential with a split halfway along the long axis 
of the device (Figure 1-VII). Neither magnetic nor radiofrequency fields are applied, 
instead a static quadrupole field is applied in combination with a logarithmic field. Ions 
are first ‘cooled’ to low kinetic energy before injections, so that the spread of the 
distribution of individual ion energies is narrow and they can be injected into the Orbitrap 
as a tight packet. Once injected, ions oscillate in spirals around the central spindle. The 
frequency of axial oscillation is proportional to the square root of the m/z ratio (60) and is 
independent of their kinetic energy (radial oscillation and rotation are not independent). 
The population of oscillating ions induce a differential current between the two halves of 
the outer shell, which when amplified yields an ‘image current’ (composite waveform) 
that may be de-convoluted by Fourier transform into a spectrum of frequencies and thence 
scaled to yield a m/z-intensity spectrum. The Orbitrap offers ‘high’ performance in terms 
of resolution (>1 million FWHM) and mass accuracy (<2 ppm with internal calibrants) 
and has garnered substantial popularity in the field since its introduction. 
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Figure 1-VII. Orbitrap Layout. Ions are ‘cooled’ to low kinetic energy in the C-trap, then 
injected as a single packet into the Orbitrap. There, contained by the quadrupolar and 
logarithmic fields, ions oscillate back-and-forth along the central spindle in a spiral 
motion. The frequency of the axial component of this motion is proportional to the square 
root of their m/z; the induced current waveform generated between halves of the outer 
shell is a composite of the frequencies generated by ions of different m/z and may be de-
convoluted to a spectrum by Fourier transform. Injection of ions as a single initial packet 
minimises the time over which the current waveform must be observed in order to de-
convolute with precision, maximising achievable resolution. 
1.1.2.5.2.4 Ion Cyclotron Resonance Devices 
The ion cyclotron (or ‘Penning trap’) is an ion trap where the ions are contained axially in 
a quadrupolar field but radially by a homogenous and static magnetic field (60, 67). Ions 
travel in a circular trajectory within the magnetic field. Under resonant excitation, by an 
electromagnetic wave of specific frequency, ions of particular m/z are excited, and their 
kinetic energy is increased, which results in an increase in velocity and thus a larger 
diameter of circular motion. The ‘image current’ that is induced by the ions circulating in 
the analyser wall perpendicular to the trajectory of the ions can be measured by the 
difference in induced current between two opposing detection plates and converted to a 




C-Trap Ion Packet Injection
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Fourier-Transform Ion Cyclotron Resonance (FT-ICR) resolution depends on the strength 
of the magnetic field and the quality of the cell. For low mass ions, the maximal 
achievable resolution is higher than current-generation Orbitraps. However, while the 
resolution of FT-ICR is inversely proportional to m/z, the resolution of the Orbitrap is 
inversely proportional to the square root of m/z. Orbitraps are therefore able to offer high 
resolution across a wider mass range. 
1.1.2.5.2.5 Time-of-Flight Mass Analysers 
The Time-of Flight (ToF) mass analyser is essentially a long vacuum drift tube along 
which a packet of ions is fired (Figure 1-VIII). The packet is collected at the start of the 
tube and kinetic energy is imparted by an electric field of known strength. Each ion 
acquires the same kinetic energy and is propelled down the tube with velocity inversely 
proportional to the square root of their m/z (60). In combination with a detector at the far 
end of the tube to record the ion signal over time following the initial dispatch of the ion 
packet, the time taken for an ion to traverse a drift tube of a given length can thus be 
converted to m/z. The longer the tube, the further the ions of different m/z will be 
separated over their journey, increasing the resolution. 
ToF performance can be substantially improved by the addition of an ion reflecting device 
(‘reflectron’) at the far end of the tube, which helps correct for starting differences in 
kinetic energy between ions of the same species. More energetic ions will penetrate further 
into the reflectron, which slightly increases their journey length and helps to normalise 
their flight time against less energetic particles of the same m/z which are reflected at a 
shallower depth. Additionally, by reflecting the flight path back in a V-shape to the 
starting end of the tube, the total journey length is doubled, which reduces the amount of 
physical space the ToF analyser must occupy in order to reach a certain level of resolution 
(additional reflectrons may also be used to further increase path length) (68). 
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ToF analysers offer superior resolution and mass accuracy to the quadrupole scanning 
technique. Ion-scanning based methods generally have a small speed advantage when 
generating spectra for small m/z ranges but are slower than ToF devices in generating a 
full-range spectrum. ToF-based mass spectrometers were essentially unchallenged for 
high-resolution work in proteomics until the advent of Orbitrap based designs which are 
able to offer greater resolution and mass range (and, due to the absence of the drift tube. a 
smaller physical footprint). 
 
Figure 1-VIII. Time-of-Flight Drift Tube. Ions are collected at the start of the drift tube 
and ‘pulsed in’ as a packet by an electric field. They travel down the tube with velocity 
inversely proportional to the square root of m/z. The ion path may be reflected back and 
forth several times by reflectrons to maximise path length and thus the separation of ions 
by m/z, improving resolution. Ions arriving at the end of the tube are detected by a 
microchannel plate; the change in signal over time since the ion packet was pulsed in 
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1.1.2.6 Fragmentation 
Determining peptide mass alone is insufficient to derive complete peptide or protein 
sequence information. Notwithstanding knowledge of the exact mass of a species, it is 
impossible to differentiate residue sequence variants or other configurations resulting in 
molecular isomers. Various combinations of residues may result in the same net elemental 
contribution to the peptide total; cysteine + valine and alanine + methionine both 
contribute C8H14N2O2S1 to the total elemental composition of a peptide, so two peptides 
which differ only in having one or other cysteine + valine / alanine + methionine pair will 
be indistinguishable by mass. Many other combinations of amino acids produce elemental 
contributions which are so close in mass as to be effectively indistinguishable within 
feasible reasonable mass precision tolerances. In addition, complicating factors such as 
mutations and post-translational modifications exponentially inflate the number of 
potential matches to an observed mass value. Using the LC Retention Time (RT) of the 
species to estimate hydrophobicity of the species, and limiting the search space by 
assuming a set of possible peptides (based on prior knowledge of the sample), one can 
reduce the number of possible peptide matches. However, even in cases when the list is 
much smaller than a typical biological sample (for instance, a digest of a purified protein, 
or a mixture of synthetic peptides) it may not always be possible to differentiate between 
peptides from the list on the basis of mass alone. 
1.1.2.6.1 MS/MS Analysis 
One method to generate such information is to deliberately induce ion fragmentation. The 
fragments generated will depend on the fragmented peptide sequence, its modifications 
and charge state (a Peptide-Modification-Charge entity; PMC) and thus the pattern of 
fragment ions observed may be used (in conjunction with the precursor ion m/z) to deduce 
or infer sequence information. Fragmentation in proteomics is usually performed as part of 
a multistage mass analysis pathway whereby fragment ion spectra (or whole or selected 
parts of the mass range) are collected interspersed with spectra of the non-fragmented ion 
population. The most ubiquitous example of such a strategy is to identify, isolate and then 
fragment a single ion mass from the eluting population (referred to as the ‘precursor’). In 
practice, ‘isolation’ of a mass means imposing a narrow m/z filter centred on the desired 
value – the shape and minimum width of this window are dependent on the mass analyser 
used for selection. Any other masses sufficiently close to the target mass to fall within the 
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selection window will also be co-selected, so an assumption that the selection window 
isolates a single ion species will not always be correct. The isolated ions are fragmented, 
and a mass spectrum of the resulting fragments is collected. This process thus involves the 
collection of two spectra, first the non-fragmented eluting population (denoted as ‘MS1’), 
followed by the fragments from a single selected ion species from that population 
(denoted as ‘MS2’). This two-stage method is generally referred to as ‘MS/MS’ analysis 
(or ‘Tandem MS’ analysis). The archetypical bottom-up proteomic instrument setup 
involving a liquid chromatography system connected in-line with an MS configured for 
two-stage analysis is frequently summarised as ‘LC-MS/MS’. 
For certain tasks, particularly the identification of post-translational modifications and in 
cases where complete fragmentation of the precursor ion is desirable, ions produced after 
fragmentation may themselves be isolated and subjected to further fragmentation 
(‘MS/MS/MS’ analysis, producing an MS3 spectrum). This approach is particularly useful 
when a single round of fragmentation is not expected to yield sufficient information about 
the analyte to make a firm identification (for example, if one round of fragmentation 
merely results in the loss of simple neutral molecules such as water or phosphate), or if the 
MS2 spectrum is too complicated (for example, if the analyte can fragment by multiple 
pathways). This process of selection and fragmentation may be repeated for multiple 
additional rounds, referred to as multistage mass spectrometry (denoted by MSn). 
Interpretation of peptide ion MS2 data in the context of proteomics is discussed further in 
Section 1.1.2.10, below. 
1.1.2.6.2 Collision-Induced Dissociation 
The most commonly employed technique for fragmentation is Collision-Induced 
Dissociation (CID). Analyte ions are accelerated into collisions with atoms of a neutral gas 
(e.g. nitrogen). Depending on the instrument configuration, ions may be accelerated by 
electric potential (e.g. in a quadrupole), or by resonant excitation (e.g. in an ion trap) (69). 
The kinetic energy of the impact is transferred to internal vibrations within the analyte, 
which lead to fragmentation of the peptide molecule along the backbone. In CID, this 
fragmentation predominantly occurs at peptide amide bonds; for each possible cleavage 
site, the two fragments that may be produced are sub-sequences of the original amino acid 
sequence from the N and C terminals to the point of cleavage. Under the nomenclature of 
fragment ions (Figure 1-IX) originally proposed by Roepstorff and Fohlman (70), the most 
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frequently observed species in CID are b- and y-ions (corresponding to the fragments 
containing the original N-terminal and C-terminal respectively). Each cleavage event will 
typically produce only one charged (and therefore observable fragment). 
 
Figure 1-IX. Notation of Peptide Fragmentation using the Roepstorff-Fohlman Scheme. 
In CID cleavage of tryptic peptides, y-ion fragments are typically observed at a higher 
intensity, being more stable due to the presence of the guaranteed basic residue (arginine 
or lysine) and are thus more easily defined in the fragment spectrum (71). However, the 
relative intensities of individual fragment ions are difficult to predict. The current 
framework of understanding is the mobile proton theory (72), which assumes that for 
protonated peptides formed by soft ionization methods such as ESI, the positive charges 
(ionising protons) are initially localized to the most basic sites, i.e. the N-terminus and the 
side chains of basic residues (arginine, lysine or histidine), and further that most 
fragmentation of protonated peptides is charge-directed, i.e. requires the involvement of a 
proton at the cleavage site. Given these assumptions, the theory postulates that when the 
peptide ion becomes energised during fragmentation (e.g. by collision in CID), the 
ionising protons are ‘mobilised’ and move from the basic sites to other locations in the 
peptide that would not normally be energetically favourable. Some possible relocations 
may provide a mechanistic route to cleavage of the (normally non-labile) backbone that 
yields a charged backbone fragment as the final product after decomposition. The 
locations where the mobilised proton is likely to move to, the possible cleavage 
mechanisms these enable and the likelihood of producing a charged background fragment, 
as well as the energy required to initially mobilise the ionising protons, are all 
characteristics specific to a particular PMC. The fragmentation pattern of a particular 
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PMC is thus the synthesis of many competing mechanistic effects (72). Furthermore, the 
dominance of particular mechanisms may change with fragmentation conditions (the 
kinetic energy of the analyte ions, neutral gas composition and pressure), as well as 
instrument-specific factors such as the method by which the ion population is subjected to 
fragmentation and the duration of the process (especially with regard to the potential for 
an ion to undergo multiple fragmentation events), as well as the mass range of the 
spectrum that is acquired from the final fragment population (73). Deterministic prediction 
of the relative intensities of the ion signals resulting from fragmentation of a particular 
sequence is thus extremely complex, but the same PMC analysed under similar conditions 
will generally give the same result. Within the context of the mobile proton theory it is, 
however, possible to form generalisations (for example, particularly abundant y-ions tend 
to be observed N-terminal to proline residues), and the problem is particularly well suited 
to the application of machine-learning prediction tools (74-77). 
1.1.2.6.3 Alternative Dissociation Methods 
The most popular alternative to CID involves addition of electrons to analyte to generate 
analyte-radical ions that fragment. The initial approach, Electron Capture Dissociation 
(78) required an FT-ICR instrument, but was later refined to a more generally applicable 
technique, Electron Transfer Dissociation (ETD) (79). ETD has some limits in peptide 
fragmentation, as it does not work well for 2+ charged species (80), but at higher charge 
states (z >2) it is very efficient, so is most commonly used for protein fragmentation or 
fragmentation of peptides carrying additional charges due to post-translational 
modifications. ETD results in a complementary fragmentation pattern to CID (c- and z-
ions rather than y- and b-; Figure 1-IX); the results may also be combined for higher 
confidence identification.  
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1.1.2.7 Hybrid Instrument Designs 
Most modern mass spectrometers are hybrid designs, wherein multiple mass analysers are 
coupled together to leverage their various advantages and thus allow parallelised analysis 
strategies, particularly those involving fragmentation. Ion fragmentation is usually 
performed in a quadrupole or linear ion trap-type analyser, while the analysis of non-
fragmented analytes is optimally performed in a mass analyser with higher resolution. 
1.1.2.7.1 Triple Quadrupole 
The simplest design in regular use in proteomics, the ‘Triple-Quadrupole’ design (Figure 
1-X) involves three multipole mass analysers, generally referred to as Q1,  q2 and Q3 for 
purposes of describing their configuration, followed by an EMT detector. Q1 and Q3 are 
generally quadrupole devices whereas q2 may also be a hexapole or octupole analyser, 
especially when primarily used as a collision cell for fragmentation. The instrument 
configuration is often abbreviated as ‘QqQ’ to denote the different role of q2. The QqQ 
operates on a beam of ions from the source at all times. To collect an unfragmented 
spectrum (MS1 mode), the mass range is scanned through in Q1, and q2 and Q3 operate as 
ion guides to transmit selected ions through to the detector. To collect a fragmented 
spectrum from a selected precursor (MS2 mode), Q1 is used to select the precursor ion of 
interest, which is then fragmented in q2 and the fragment ion masses scanned through Q3 
to generate the fragment ion spectrum. 
 
Figure 1-X. Triple Quadrupole Schematic. In MS2 mode, ions are selected in Q1 (fixed 
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1.1.2.7.2 Quadrupole-ToF 
Before the advent of the Orbitrap, ToF mass analysers were the pre-eminent option for 
collecting high resolution mass spectra. Most commonly, a ToF analyser replaces what 
would be Q3 in a Triple Quad configuration, typically performing the role of spectrum 
collection in both MS1 and MS2 modes. The preceding quadrupoles are used for precursor 
selection and fragmentation in MS2 mode. A modern example of a quadrupole-ToF hybrid 
system is the ‘TripleTOF’ line of instruments produced by ABSciex (Figure 1-XI). 
 
Figure 1-XI. ABSciex TripleTOF 5600 Quadrupole-ToF Schematic. Based on ABSciex 
product literature. 
1.1.2.7.3 Orbitrap Hybrids 
Hybrid instruments which combine quadrupole and linear ion trap mass analysers with an 
Orbitrap are popular in proteomics research. The coupling of an Orbitrap to a linear ion 
trap was the first reported configuration for a commercially available Orbitrap instrument 
(81). In this configuration, a linear ion trap was placed in series with the Orbitrap, 
connected by an ion guide quadrupole. This allowed the speed and sensitivity of the ion 
trap for ion selection and fragmentation (and spectrum collection for MS2 spectra) to be 
combined with the resolution and mass accuracy of the Orbitrap for collection of MS1 
spectra. Various advances in Orbitrap and LTQ speed sensitivity have led to a line of 
successive instruments following this design with increased resolving power and 
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LTQ-Orbitrap XL (Figure 1-XII), the LTQ-Orbitrap Velos (with an improved dual-
pressure ion trap and collision cell) and most recently the LTQ-Orbitrap Elite, LTQ 
Orbitrap Fusion and LTQ-Orbitrap Fusion Lumos, with second-generation high field 
Orbitrap analysers and a new signal processing method, which together approximately 
quadruple the resolving power. 
Advances in the scan speed of Orbitraps have led to a second design in which the Orbitrap 
and an associated collision cell effectively replaces q2/Q3 in a triple quad setup, in which 
the Orbitrap is used to collect both MS1 spectra (with Q1 transmitting all ions directly to 
the Orbitrap) and MS2 spectra (with Q1 selecting a precursor, passing it to the collision 
cell for fragmentation which then passes to the Orbitrap for spectra collection). This 
instrument line consists of (in release order) the Q-Exactive (Figure 1-XIII), the Q-
Exactive Plus (with an improved, segmented quadrupole), the Q-Exactive HF (with the 
second-generation Orbitrap and signal processing advances described above) and most 
recently the Q-Exactive HF-X (with improved ion optics). 
The two instrument schematics shown on the next page are the instruments used to collect 
the datasets discussed in Chapters 3 and 4, respectively.  
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Figure 1-XII. Thermo Fisher LTQ-Orbitrap XL Schematic. Adapted from Thermo Fisher 
product literature. 
 
Figure 1-XIII. Thermo Fisher Q-Exactive Schematic. Adapted from Thermo Fisher 
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1.1.2.8 Data-Dependent Acquisition 
The most common experimental paradigm in bottom-up proteomics is Data-Dependent 
Acquisition (DDA). Peptides are eluted from an on-line RP-LC system into a mass 
spectrometer which repeatedly samples the eluting peptides to collect full-range MS1 
spectra. In real time, the most recent MS1 spectrum is analysed to identify potential 
peptide signals of sufficient intensity to warrant further analysis, excluding background 
noise signals and likely non-peptide contaminant species. If species of potential interest 
are identified, they are ranked in order of descending interest and the top candidate on the 
list is analysed further. Ions of this m/z value are selectively isolated, fragmented and an 
MS2 spectrum is then collected. Additional candidates may then be selected in turn, 
moving down the list, until a predefined limit (typically 5-50) is reached, at which point 
the instrument returns to MS1 mode, collecting a new spectrum from which new 
candidates may be selected for MS2. Selected candidates are generally excluded from 
subsequent rounds of selection for a period of time in order to prevent repeated selection 
of the highest abundance species. This concept is referred to as Data-Dependent Analysis, 
since the m/z values selected for fragmentation and MS2 spectrum collection are dependent 
on the ion intensities observed in MS1 (Figure 1-XIV). 
In most MS instruments, operation in MS1 and MS2 modes is mutually exclusive due 
either to configuration (e.g. in a Triple-Quad, the first quadrupole may either scan through 
m/z values to produce an MS1 scan or select a single m/z for fragmentation) or control 
logic (firmware) limitations. Recently, a degree of parallelisation has been implemented in 
some instruments, such as the later models of the LTQ-Orbitrap series, which allow 
simultaneous use of the ion trap detector for MS2 scans whilst high resolution MS1 scans 
are acquired in the Orbitrap, with a potential for more involved schedules to minimise the 
idle time of both detectors (41). 
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Figure 1-XIV.  Data-Dependent Acquisition Process Flow. 
As depicted in Figure 1-XIV, the resulting data from a typical DDA experiment will be a 
series of MS1 spectra showing the intensities of ions eluting from the LC gradient over a 
time course. Interspersed among these scans will be the MS2 scans that have been acquired 
based on the preceding MS1 spectra, each of which show the result of fragmentation of a 
selected precursor ion. The number of MS2 events in between each MS1 spectrum may lie 
anywhere between zero and the predefined limit, as the maximum selectable number of 
candidates that are both intense enough and not currently excluded from consideration 
may not be found in every MS1 scan. The times between the collection points of sequential 
MS1 scans are thus irregular, although certain examples of newer instruments such as the 
LTQ-Orbitrap Fusion Lumos do have the ability to enforce MS1 spectra collection at fixed 
intervals. The elution profiles of m/z ions are thus sampled in a non-uniform manner, 
which has ramifications for quantification approaches using MS1 data (as discussed in 
detail under Section 1.1.2.11.1). Furthermore, there is no guarantee that a particular PMC 
(Peptide-Modification-Charge entity; see Section 1.1.2.6.1) will be selected for MS. If, 
following each MS1 scan during the elution period of a particular PMC, the PMC signal is 
Chapter 1: Introduction 39 
never ranked high enough in the list of potential candidates to be selected (generally 
because the signal or signal-to-noise value at the time of each MS1 is low) then no MS2 
will be collected for that particular PMC during that MS run. On mass spectrometers with 
a slow overall cycle time this can result in variable visibility of PMCs with very short, 
sharp elution peaks (even if their intensity, if measured at peak apex, would be high) if 
they elute between MS1 scans. With modern instruments, this consideration is relatively 
minor due to the speed of acquisition although it is relevant when designing a method with 
a large number of allowed MS2 events between each MS1. More common is the problem 
of low abundance (but still detectable) PMCs, or higher abundance PMCs with poor 
chromatographic resolution, resulting in broad elution peaks where the signal is spread 
over a relatively long period of elution time (e.g. several minutes) where even though the 
integral of the signal may be high, the maximum intensity is not. In both cases, in a series 
of MS analyses of similar samples (or even technical repeats of the same sample), all 
detectable PMCs may not be found in every analysis. This stochastic sampling of the 
detectable PMC space, with a bias against low abundance PMCs, poses challenges for 
statistical analysis as inconsistent visibility leads to missing values. Various methods have 
been developed to allow identifications to be inferred between runs of similar samples for 
PMCs which are visible in MS1 but not necessarily identified in a particular sample run. 
Typically, this is done by matching MS1 retention-time dependent peak clusters across 
runs, either on an individual feature basis, or more often for all features. Such strategies 
are particularly important for Label-Free Quantification (see Section 1.1.2.11.3), a 
prominent example being the Match-Between-Runs feature in MaxQuant (82). 
1.1.2.9 Data-Independent Acquisition 
While DDA is the typical paradigm for bottom-up proteomic mass spectrometry, several 
Data-Independent Acquisition (DIA) approaches have recently been described. Rather 
than selecting a single m/z value for fragmentation, a conceptually similar non-dependent 
approach is to perform fragmentation on either the full mass range, termed MSE (83), or 
on a series of consecutive intervals (e.g. 25 Da windows) across the full m/z range. This 
latter concept is commonly referred to as SWATH (Sequential Window Acquisition of all 
THeoretical spectra) (84) or SWATH-like, although such strategies pre-date this term 
(85). These approaches rely on computational algorithms to de-convolute the resulting 
data based on matching elution profiles of fragment ion spectra with ions in the MS1 scan. 
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A more targeted approach that may be used if the peptides of interest are known in 
advance is to predefine the monitoring of both a required precursor and a particular 
fragment from that precursor, rather than collecting the whole MS2 spectrum. Since certain 
combinations of a selected MS1 precursor and an observed MS2 fragment ‘daughter’ 
(known as a ‘transition’) ion are unique to a particular analyte, this method, known in 
various incarnations as Selected Reaction Monitoring (SRM) or Multiple Reaction 
Monitoring (MRM), can allow for rapid targeted identification and quantification of pre-
selected peptides (86). SRM is particularly suited to Triple-Quadrupole design mass 
spectrometers as it maximises a strength (the three consequent quadrupoles can be used 
for selection of a precursor, fragmentation, and selection of a fragment ion) while avoiding 
a weakness (quadrupole mass analyser-based detection is slower to collect a spectrum 
across an m/z range). In Orbitrap hybrid designs, the Orbitrap mass analyser cannot be set 
to detect only a single MS2 fragment as it measures all fragments simultaneously. A 
complementary technique to SRM on such machines involves selecting a particular MS1 
precursor (pre-defined rather than based on a preceding spectrum), fragmenting the 
precursor but then analysing all fragments simultaneously. This technique is termed 
Parallel Reaction Monitoring (PRM) (87).  
1.1.2.10 Interpretation of MS2 Spectra in Proteomics  
MS2 spectra collected in proteomics may be the result of fragmenting a single precursor 
mass (with the caveat that multiple masses may be co-selected, see 1.1.2.6.1), which 
applies to both DDA-style experiments and DIA experiments with a fixed isolation mass 
lists (e.g. PRM). In the case of DIA experiments that isolate larger mass window ranges 
(as opposed to a single target mass) interpretation of the fragmentation spectra is 
considerably more complex. Discussion in this section will be limited to the former case 
(single precursor isolation) as being most relevant to this work. 
In the case of bottom-up proteomics, where the precursors are peptides, a ‘perfect’ MS2 
spectrum would be one in which all possible fragment ions from at least one side of the 
fragmentation location are observed (a complete ‘ion series’, see Figure 1-IX). This would 
be sufficient to identify the amino acid sequence of any non-post-translationally modified 
precursor, and to presume with high confidence the sequence of any precursor with typical 
post-translational modifications. The assignment of peptide sequence, modification state 
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and charge to an MS2 spectrum is referred to as a Peptide-Spectrum Match (PSM), 
although technically ‘PMC-Spectrum Match’ would be a more accurate definition of the 
acronym. 
Fragment spectra may be interpreted by manual assignation of the fragment ions. In the 
case of peptides, one can assume that each fragment peak observed will be from the 
proportion of the total precursor species population undergoing fragmentation at a 
particular point on the backbone or side chains. The likely fragmentation locations may be 
predicted from the method of fragmentation. CID, for example, is expected to result 
primarily in cleavages at amide bonds in the amino acid chain. For most experiments, the 
number of spectra collected render manual assignation ion-by-ion to be impractical, and 
computational strategies are employed for bulk analysis of acquired spectra. 
1.1.2.10.1 Automated Peptide Identification 
It is possible to predict some or all of the amino acid sequence based solely on the 
observed data in the same manner as manual sequence assignation, commonly referred to 
as ‘de novo’ sequencing. However, it can be challenging to distinguish the two 
complementary ion series (e.g. b- and y-ions) from each other, and from background noise 
or contaminating co-selected species due to non-specificity in the precursor selection 
window. Alternatively, a putative identity may be produced by comparing the observed 
spectrum to either theoretically generated fragmentation patterns, or a spectral library 
generated from previous analyses.  
Theoretical fragmentation patterns are generated by applying the expected fragmentation 
behaviour to peptides generated by in silico digestion of a proteome reference (generally 
derived from genomic data) according to the known cleavage specificity of the protease 
used. In order to reduce the complexity of the problem and thus the number of 
comparisons to be made, a number of constraints are typically employed. The m/z of the 
precursor ion selected prior to fragmentation is used to limit the number of theoretical 
peptides considered to only those with a corresponding mass. Possible modifications are 
pre-specified as either fixed (assumed to be present on all corresponding possible sites) or 
variable (theoretical peptides will be considered with and without the modification on each 
possible site); the number of variable modifications is generally limited to avoid 
exponential increases in the number of theoretical peptides considered. Error tolerances 
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for precursor and fragment ion mass are generally set to account for the expected 
resolution and mass accuracy of the mass analyser used for spectrum collection. 
Commonly used commercial and open-source search tools implementing this approach 
include Mascot (88), SEQUEST/Crux (89, 90), X!Tandem (91), OMSSA (92) and 
Andromeda (93). A generalised workflow for such tools is illustrated in Figure 1-XV. 
 
Figure 1-XV.  Peptide Identification by MS2 Spectrum Database Searching. Adapted from 
Nesvizhskii et al., 2007 (94). 
In silico fragmentation patterns are generally compared on the basis of expected m/z value 
only, rather than taking intensities into account. Prediction of relative fragment ion 
abundance is considerably more challenging than just predicting the m/z values of the ions 
generated. As an alternative to theoretical peptides, one may use a library of high 
confidence PSMs from previous analyses to identify new PSMs in the current experiment 
by similarity. This has the advantage of allowing fragment ion relative abundances to be 
included in the matching process, which improves selectivity and can reduce false 
positives. This approach is most useful in contexts where there is a large amount of 
existing data available. Error tolerances for precursor and fragment ion mass are used, as 
above, to limit the search space for each spectrum to be matched so that only plausible 
contenders are scored. Examples of open-source spectral library search tools include X! 


















Chapter 1: Introduction 43 
In both approaches, the observed spectrum is compared to fragment ion patterns of eligible 
theoretical/library peptides and the correspondence in each case is scored. Scoring models 
differ between search algorithms, and there is a wide variety of approaches. The general 
aim is two-fold, to identify the closest theoretical match (and thus assign an identity) and 
to somehow represent how close a match this was, for comparison with other 
identifications. Comparative methods always seek to return the ‘best’ match via theoretical 
spectra, spectra library or de novo analysis, even in the case of MS2 spectra for which 
there is no ‘correct’ answer (for example, the spectrum was overwhelmed by noise, or a 
non-peptide precursor was selected, or the peptide selected does not appear in the 
proteome sequence database or spectral library). Repeat analyses cannot be guaranteed to 
produce identical MS2 spectra due to, among other factors, LC variability and stochastic 
selection of potential peptide precursors (see Data-Dependent Acquisition, Section 
1.1.2.8) and variance in sample processing. It is therefore necessary to consider each PSM 
in the context of all PSMs produced within each analysis, to determine an appropriate 
score threshold in order to control the rate of incorrect PSM assignments (usually referred 
to, slightly misleadingly, as the False Discovery Rate (FDR) of the search). 
FDR methodologies rely on assessment of the comparison score distributions among all 
PSMs in an analysis (Figure 1-XVI). It is possible to differentiate the distribution of the 
scores of genuine PSMs from those of incorrect PSMs as the ‘correct’ median score may 
be assumed to be higher than incorrect PSMs (otherwise, the comparison metric would 
have no selective power at all). For proteome database searching (the most widely used 
identification method), two approaches to FDR control have predominated (94). The first 
approach is to model the correct and incorrect PSMs as a mixture of two distributions 
(Figure 1-XVI-A). This ‘mixture model’ approach works best when there are a very large 
number of PSMs within the analysis, so that the distribution function is well characterised. 
The alternative ‘target-decoy’ approach, which is reasonably robust even at a relatively 
low number of PSMs, is to include an approximately equal number of ‘decoy’ sequences 
within the proteome to be searched. Such sequences should be equivalent in amino acid 
relative composition and peptide length to the proteome sequences; the easiest way to 
achieve this is simply to reverse the sequences of the proteome. Spectra producing 
incorrect matches (i.e. that match effectively at random) may be assumed to match in 
approximately equal numbers (and with equal scoring distribution) to both proteome and 
decoy sequences. The number and scoring distribution of PSMs matching decoy 
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sequences is thus an estimate of half the underlying incorrect PSM distribution (Figure 
1-XVI-B). 
 
Figure 1-XVI. Statistical Assessment of PSM Scores. The red and blue distributions 
represent incorrectly and correctly assigned PSMs respectively. On the left side of the 
figure, these indicate the true distributions in both sets of PSMs while on the right side, the 
predicted distributions derived by the two approaches (that may be then used to infer FDR 
values). A: Mixture model approach on large set of PSMs. B: Target-decoy approach on 
smaller set of PSMs. The orange bars indicate the distribution of PSMs assigned to a 
decoy database sequence.  
If the genome or proteome of the organism being studied is poorly characterised, then the 
proteome database or spectral libraries available may be unacceptably incomplete. 
Furthermore, if the analysed peptide mixture contains a large number of PMCs with novel 
sequence, point mutations or unusual or highly complex post-translational modifications, 
these will be outside the space typically considered by a database search under standard 
parameters. In such cases it may be necessary to fall back on purely de novo analysis tools 
such as PepNovo (98). More recently, so-called ‘second generation’ search engines such 
as Peaks (99) and Byonic (100) combine de novo and database searches. In these engines, 
the identification of common PMCs by database search is supplemented with the 
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1.1.2.10.2 Protein Inference 
Bottom-up proteomics produces information regarding the identities (sequence and 
modification state) of peptides in a sample. This information may be collated to infer the 
identity of the protein compositions prior to digestion, but the direct connection between 
peptides and proteins is broken by the digestion of all proteins simultaneously. As 
discussed in the comparison with top-down proteomic methodology, it is usually 
impossible to derive the exclusive set of parent proteins from peptide-level results, as 
many proteins (particularly isoforms and splice variants) share considerable sequence 
homology and may therefore produce the same peptide upon digestion. This issue in 
bottom-up proteomics has been recognised in the field since inception (22, 101); even 
before the widespread adoption of LC-MS it was recognised that unresolved proteoform 
‘spots’ in 2DGE would not be differentiable by mass spectrometry of a peptide digest 
from the excised spot. The historical ‘rule of two’ solution, in which proteins with less 
than two uniquely assignable peptides were discounted has largely been supplanted by 
protein grouping solutions either built into search engines (e.g. Mascot, Andromeda) or 
stand-alone tools for re-analysis of identified PSM lists (e.g. ProteinProphet (102)). 
Protein grouping approaches attempt to find a minimal number of ‘groups’ containing one 
or more parent proteins which would explain the set of observed PSMs. Such approaches 
resolve problems where overwhelming evidence has been observed for a group of two or 
more proteoforms, but all relevant detected peptides map to more than one proteoform and 
thus none are strictly ‘unique’. Under the two-peptide rule, no evidence for any of the 
proteoforms is admissible; it is more representative of the observed data to say that the 
group of proteoforms was observed but cannot be further separated. 
Whilst protein grouping resolves many protein inference problems with regard to 
identification, basing protein quantification on peptide identifications has the additional 
challenge that it is unknown how much of the observed peptide intensity is potentially 
contributed by each potential parent protein in a protein group. Either quantification must 
be qualified as applying to the protein group as a whole, or it must be restricted to unique 
peptides, or assigned proportionately to group members based on a statistical model of the 
likelihood that they were actually observed. 
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1.1.2.11 Quantification Techniques 
In bottom-up proteomics, quantification of proteins is achieved by measuring ion current 
derived from surrogate peptides or their derived fragments. Comparisons of abundance 
may be made directly between MS runs, or between species with comparable ionisation 
kinetics such as the same peptide differentially labelled so as to have a resolvable mass 
shift. If the concentration on one side of the comparison is known, the concentration and 
thus absolute abundance of the other side may be deduced; i.e. quantification is absolute. 
This is generally only the case with internal standards that have been pre-quantified, either 
by amino acid analysis or by quantitative nuclear magnetic resonance (103-105), and 
requires the identity of the peptides to be quantified by MS to be known in advance. In 
most cases, quantification is relative and can only be expressed as fold-changes between 
samples. 
Labelling strategies are designed to allow separation of samples by mass in either MS1 or 
MS2 spectra, although there are examples of experimental designs in which a combination 
of MS1 and MS2 labelling strategies is used to address specific biological problems (106). 
This allows the simultaneous analysis of multiple samples, or of one sample and a shared 
standard against which samples acquired over a series of runs may be normalised (thus 
allowing sample quantification across multiple runs). Such an internal standard is 
generally constructed so as to be comparable against the most extreme samples. One way 
to achieve this is to generate a ‘pooled’ standard from equal aliquots of all samples. 
Protein and peptide mass labels may be introduced metabolically, i.e. by providing them to 
the organism or cell/tissue culture over a period of time in nutrient sources, such that they 
are taken up and incorporated naturally into biological components. Alternatively, labels 
may be introduced after protein extraction by means of a chemical reaction. 
Metabolic labelling allows samples to be combined and processed together as early as 
possible in the MS analysis workflow and facilitates analysis of metabolic processes 
governing the incorporation or depletion of a label over time. Metabolic labelling 
strategies include Stable Isotope Labelling by Amino acids in Cell culture (SILAC) and 
Elemental Metabolic Labelling (EML) such as 15N. 
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Chemical labelling strategies have fewer limitations in terms of biological impediments to 
labelling chemistry and may be applied in cases where metabolic labelling is not possible, 
for example tissue biopsies. Chemical labelling strategies are, however, exposed to more 
technical variability. 
Variation in labelling efficiency correlates with the technical variation introduced by all 
intermediate sample extraction and processing steps prior to labelling and combination of 
samples (107). Metabolic labelling allows combination after the fewest steps (Figure 
1-XVII). Since there are many potential targets for chemical labelling in the polypeptide 
chain, a large number of chemical labelling strategies have been reported (108). Many 
such strategies are limited in practicality due to incomplete or nonspecific labelling, which 
complicates interpretations. Chemical labelling strategies that have been widely employed 
include enzyme-catalysed 16O to 18O exchange, Isotope-Coded Affinity Tagging (ICAT), 
Dimethyl labelling, and Isobaric Tagging (Isobaric Tags for Relative and Absolute 
Quantification; iTRAQ™, and Tandem Mass Tags; TMT™); these are discussed in more 
detail in Section 1.1.2.11.1.3. 
 
Figure 1-XVII. Summary of Strategies for the Comparison of Proteomic Samples. Red 
and blue blocks indicate differentially labelled samples. Yellow blocks indicate a 
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indicate steps where technical variance may be introduced due to unaccounted differences 
in processing or measurement. Adapted from Bantscheff et al., 2012 (109). 
1.1.2.11.1 MS1-Based-Quantification 
Separation of samples by a mass shift at the peptide level allows multiple samples to be 
quantified simultaneously from MS1 spectra. Ideally the method for inducing this mass 
shift should not also affect the behaviour of the labelled peptides on LC gradients, so that 
differently labelled peptides still co-elute and are measured in the same context. A simple 
way to induce mass shifts without (substantially) changing LC characteristics is to use 
stable isotopes, such that differentially labelled peptides retain the same elemental 
composition but with some number of atoms having differential isotopic enrichment and 
thus overall different masses. Within the Born-Oppenheimer approximation, the increased 
mass of isotope labels will lead to a reduction in nuclear vibrational wave function 
amplitude and thus reduce the average volume and polarizability of bonds involving the 
labelled atom, potentially reducing the hydrophobicity of the molecule, depending on the 
intramolecular location of the label (110). The retention time effects of replacing 14N with 
15N and 12C with 13C are usually small enough to disregard, but the effect of hydrogen-
deuterium labelling, i.e. replacing 1H with 2H, is more substantial. Nevertheless, 
hydrogen-deuterium replacement still has applications, especially where the number of 
deuterium replacements is small (e.g. Dimethyl labelling - see Section 1.1.2.11.1.3). 
For each peptide, quantification is achieved by comparison of the differently labelled 
versions of that peptide within each of the MS1 scans across the joint elution window. 
Note that herein and henceforth I will use ‘signal’ to refer to the intensity corresponding to 
(or at least presumed to correspond to) a specific differently labelled version of a PMC in 
the MS. When multiple PMCs correspond to the same peptide, there are various methods 
for inferring a peptide-level value from PMC quantification results. For a peptide with a 
single PMC instance, it is generally assumed that the signal intensity is a proxy for peptide 
abundance, although the gradient of the linear correlation between the two is not 
consistent between PMCs, or between the same PMC measured in different sample 
contexts. 
Intensity signal-to-noise can be maximised by comparing the elution peak apex intensities, 
or the integral of intensities over RT. Whilst there is no guarantee that the apex of the 
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elution peak will be measured due to MS1 sampling intervals, modern instruments sample 
with sufficient rapidity that uncertainty in peak shape is minimal. For label-to-label 
comparisons within a single MS run, peak uncertainty will in any case be equivalent 
between labels so long as labelling does not introduce a substantial chromatographic shift. 
1.1.2.11.1.1 Stable Isotope Labelling of Amino Acids in Cell culture 
Stable Isotope Labelling of Amino Acids In Cell culture (SILAC) labelling (111) is 
achieved by metabolically introducing isotopically labelled amino acids with a fixed mass 
shift to proteins. When labelling by particular amino acids is paired with use of an 
appropriately specific protease (e.g. trypsin with arginine/lysine labelling) to guarantee at 
least one labelled amino acid per peptide, the resulting labelled peptides will have fixed 
mass shift that is a multiple (allowing for missed cleavage) of the labelled amino acid 
shift. This allows for straightforward quantification as the labelled signal in the MS will 
always be shifted by a predictable mass from the unlabelled signal. Widely used 
arginine/lysine labelling labels induce mass shifts of +6 Da (13C6 arginine and 13C6 lysine) 
or +10/+8 (13C6, 15N4 arginine and 13C6, 15N2 lysine). The property of quantitative interest 
is the ratio between the unlabelled and labelled signal intensities, which is a function of 
both the ratio between the unlabelled and labelled samples, and the incorporation level of 
the SILAC label in the samples (Figure 1-XVIII-A). 
SILAC has proved an extremely popular technique in the field for a number of reasons. 
The relatively simple nature of the quantitative data analysis and robust support for the 
technique by polished, relatively easy to operate quantification platforms such as 
MaxQuant (82), Mascot Distiller (112) (Matrix Science) and Proteome Discoverer 
(Thermo Fisher) have facilitated use of the technique without requiring heavy 
bioinformatic support. A high level of label incorporation is achievable. Indeed complete 
labelling of model organisms such as Drosophila melanogaster (113) and Mus musculus 
(114) has been described, and Geiger et al demonstrated the labelling of multiple human 
cell lines that could be combined to effectively approximate a generalised human tumour 
proteome for the purposes of an internal standard for quantification (115). 
Not all organisms are amenable to SILAC-style in vivo labelling, however. Ideally, 
organisms must be auxotrophic for the labelled amino acids (116). It is also recommended 
that they be unable to convert the labelled amino acids into other amino acids (causing 
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unintended secondary labelling), although there are strategies that can somewhat mitigate 
this second issue by experimental design (117-120) or bioinformatic post-processing (121-
123). While labelling in green algae has been successful (124), the ability of higher plants 
to easily convert between amino acids (particularly arginine to proline) makes SILAC 
labelling difficult (125), although successes have been reported in plant cell culture (126) 
and even seedlings (127). 
1.1.2.11.1.2 Elemental Metabolic Labelling 
An alternative approach, rather than labelling specific amino acids, is to label all atoms of 
a particular element. This is frequently referred to as metabolic labelling, although I refer 
here specifically to Elemental Metabolic Labelling (EML) to distinguish this strategy from 
SILAC-style (amino-acid centric) labelling techniques, as both introduce the label by 
metabolism. Isotopes of 18O, 2H, 13C and 15N have all been used for such studies (128-
132). The mass shift thus induced is proportional to the number of atoms of the labelled 
element, although the labelled signal will appear as a distribution of different masses in 
the mass spectrum if the incorporation level of the labelled element is less than 100%. 
Since EML leads to stable isotope labelling of both the proteome, metabolome and all 
other biological components, it has extensive history (133-137) and considerable ongoing 
interest (138-141) in proteomics and metabolomics as well as applicability to questions 
involving nucleic acids (142). There are two properties of quantitative interest, the ratio 
between the unlabelled and labelled signal intensities, and (when labelling is not 
performed to completion) the incorporation level of the labelled element observed in each 
labelled signal; unlike SILAC these may be measured independently (Figure 1-XVIII-B). 
The automated quantification of EML data is more complicated than that of SILAC. 
Whereas incomplete labelling in SILAC affects only the ratio between the intensity of the 
labelled and unlabelled signal, in EML, the proportion of incorporation also affects both 
the masses of the major isotopologues of the labelled signal, and their relative proportions. 
Realities of experimental design with regard to controlling all metabolic intake of a 
particular element, and the financial limitations on maximum reagent isotopic purity mean 
it is usually impractical to achieve complete incorporation of an elemental label (143). 
Procedures for quantitative EML data analysis are discussed below in further detail. 
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1.1.2.11.1.3 Chemical Labelling 
An early example of chemical labelling in order to introduce a mass shift in labelled 
peptides is the enzyme-catalysed exchange of two 16O for two 18O (supplied via H218O) 
during digestion. First described in 1981 (144), this technique was used for MS-based 
quantification of peptides as early as 1983 (145) and applied in various ways for 
quantitative proteomic studies from 2000 onwards (128, 146, 147). An alternative 
approach by Münchbach et al. (148), also published in 2000, proposed labelling peptide 
N-termini using H4 and 2H4 (four hydrogen versus four deuterium, with a mass shift of 
approximately +4 Da) versions of nicotinoyloxy succinimide esters. In this example, 
primary amines on lysine side chains were blocked via succinylation to ensure only N-
terminal amino groups were labelled. 
The first methodology used broadly in the field was Isotope-Coded Affinity Tagging 
(ICAT) (149). ICAT involves labelling peptides with reagent consisting of a cysteine-
directed reactive group, an isotopically coded linker (originally using 2H but more 
commonly now using 13C), and a biotin group for labelled species recovery. The labelled 
signal is separated from unlabelled signal in MS1 according to the total isotopic mass delta 
of the linker component, which thus allows simultaneous analysis of multiple samples. 
Samples are labelled at the protein level, allowing pooling prior to digestion and thus 
avoiding the introduction of sample bias at subsequent steps. Whilst considered a 
prototypical example of chemical labelling, ICAT is limited to cysteine-containing 
peptides by design. In recent years it has been mostly supplanted by strategies which 
target primary amine groups on lysine side chains and amino termini, and thus present at 
least one labelling site in all peptides with unblocked N-termini. A popular example of 
such a technique is Dimethyl labelling, which labels the primary amines of peptides with 
2H and 13C isotopically-labelled formaldehyde and cyanoborohydride (150). This approach 
has the advantages of low reagent costs and few experimental limitations, although 
analysis must be robust to potential RT shifts introduced by 2H isotope labels and, unlike 
ICAT, samples must be labelled post-digestion. For all chemical labelling strategies, the 
property of quantitative interest is the ratio between the unlabelled and labelled signal 
intensities (Figure 1-XVIII-C). Incorporation level in the labelled sample may generally be 
assumed to be close to 100%, unless the labelling chemistry is disrupted. 
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Figure 1-XVIII. Summary of MS1 Labelling Approaches. 
1.1.2.11.2 MS2-Based-Quantification by Chemical Labelling 
In MS2-based labelling, samples have the same mass prior to fragmentation, so that they 
may be selected as a single precursor mass. This is achieved by labelling with a two-
component reagent where the isotopic mass differences of individual ‘reporters’ (labels) 
are offset by corresponding balance groups. This strategy is employed by two related 
labelling systems - Isobaric Tags for Relative and Absolute Quantification (iTRAQ) (151) 
and Tandem Mass Tags (TMT) (152). 
In both approaches, an isobaric tag is attached to peptide primary amines via N-
succinimide ester chemistry. The tag (consisting of reporter and balance components) 
contributes an equal mass shift to the labelled signal regardless of label (this has the 
advantage of not increasing the complexity of the MS1 spectrum). All labels are co-
selected, and during fragmentation both the reporter and balance are cleaved from the 
peptide. The reporter group retains a charge and is observed in the MS2 spectrum. 
Separated from their balance groups, reporter ions corresponding to each label now have 
different masses and thus may be quantified individually yielding the relative proportion 
of each label in the selected peptide precursor (Figure 1-XIX). The reporter ions are 
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similar-mass ions derived from the peptide backbone fragmentation that might hinder 
quantification. By directly linking peptide identification with relative quantification across 
labels, a quantitative reading for each label is guaranteed for all identified peptides, even if 
the abundance of the peptide in some samples would otherwise be too low to allow 
consistent identification (i.e. sufficient intensity both to trigger selection of the precursor 
for MS2, and for the resulting fragment ion spectrum to yield a highly scored PSM) of that 
peptide in those samples. An issue arises with the co-selection of peptides that are below 
the background detection limit, whose fragment ions remain spread across the mass range 
at background levels, but whose reporter ions, being all of the same mass as the reporter 
ions of the selected peptide, contribute to quantitative error. This has led to refinements in 
isobaric tagging analysis whereby the unfragmented precursor from the MS2 scan is 
subject to a second round of fragmentation to yield a MS3 spectrum with the majority of 
co-selected background excluded (153, 154). Isobaric tagging approaches are available in 
2- to 11-plex formats, allowing for a wide range of experimental designs. However, as 
there is an upper limit on the number of ions that may be simultaneously selected and 
fragmented from a single precursor mass, high-multiplex formats risk spreading the 
available signal too ‘thinly’ resulting in higher variance of individual label measurements. 
 
Figure 1-XIX.  Isobaric Tagging. Example of isobaric-tag labelling using the iTRAQ 4-
plex labelling scheme. Adapted from Ross, P. L. et al., 2004 (151).  
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1.1.2.11.3 Label-Free Quantification 
The primary purpose of MS1 and MS2-based labelling is to allow all comparisons of peak 
intensity to be performed within a single run, comparing between runs only via an internal 
standard included as one of the labels. Historically, direct comparison of a peptide signal 
between runs without a labelled internal standard was frustrated by chromatographic 
variation, and label-free approaches were limited to semi-quantitative approaches such as 
spectral counting. 
Spectral counting is based on the observation that, in a typical DDA experiment, the less 
abundant the parent protein, the fewer peptides are expected to be detected, therefore the 
ratio of PSMs corresponding to a protein between two runs is an approximate indicator of 
relative abundance. This base metric may be refined by normalising for protein length to 
give the Normalised Spectral Abundance Factor (NSAF) value (155) and theoretical 
predictions of detectable peptide numbers to give the Exponentially Modified Protein 
Abundance Index (emPAI) value (156). A more recent refinement is to account for 
fragment intensity in the ‘counted’ spectra to give the Normalised Spectral Index 
Quantitation (SINQ) value (157). Nevertheless, these metrics are hamstrung by incomplete 
modelling of the relationship between protein abundance and spectral counts, and are 
generally only reliable for fold changes greater than an order of magnitude (158). 
More recent advances in peak-picking and retention-time alignment have enabled robust 
direct comparison of ion signals integrated from MS1 spectra in the same manner as MS1 
label-based quantification, generally referred to as Label-Free Quantification (LFQ). 
Software packages offering this functionality include Progenesis QIP (Nonlinear 
Dynamics), Census (121) and MaxQuant (82). 
The great advantage of LFQ strategies is the absence of a need for any labelling, which 
applies no constraints on sample compatibility and reduces per-sample preparation costs. 
Each sample must be analysed separately by MS, however, increasing the required MS 
instrument time, and chromatographic variation must be minimised, which requires 
samples to be processed in a single batch, and a robust front-end chromatography system 
with minimal run-to-run variation, especially for large sample cohorts where tens (or even 
hundreds) of samples are to be run sequentially. 
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1.2 MS1-Based-Quantification of 15N EML 
This thesis will concentrate on the quantitative analysis of MS1 data from EML 
experiments in which the labelling is achieved by increasing the 15N:14N ratio in labelled 
samples. Labelling with 15N is widely used in turnover studies (particularly in plants, 
where factors such as arginine-proline conversion would complicate SILAC approaches), 
and 15N salts are comparatively inexpensive and easily sourced (141). Labelling with 15N 
has also been used for proteomic studies in algae (159, 160) and yeast (85, 161-164), and, 
by employing near-completely labelled algae or yeast as food sources, higher eukaryote 
model organisms such as C. elegans, D. melanogaster (138), M. musculus (165) and A. 
thaliana (107, 141). 
1.2.1 The Analytical Challenge 
A typical DDA experiment generates what may be thought of as a three-dimensional 
dataset, with each signal in each MS1 spectrum corresponding to a point in the dimensions 
of RT (from in-line low pH RP-HPLC), mass-to-charge ratio and intensity (Figure 1-XX). 
 
Figure 1-XX. The Three Dimensions of Data Recorded in a DDA Experiment. Analyte 
signals recorded are defined in terms of A: m/z, B: Intensity and C: the RT of the MS1 














Chapter 1: Introduction 56 
Our ability to accurately characterise this dataset is limited by the capabilities of the 
instrument setup. The m/z axis is limited by the mass resolution and accuracy of the mass 
spectrometer, and the intensity axis by the minimum and maximum recordable signal of 
the detector, as well as detector-specific effects such as ion saturation and intensity-
dependent (heteroscedastic) variance. Comparing run-to-run, chromatographic differences 
will result in RT shifts and variance in the elution peak width of the same species. This 
dimension is also sampled at discrete intervals rather than as a continuum, and these 
intervals are not guaranteed to be consistent. 
Each PMC yields a separate signal in this data-space, eluting from the LC column over a 
particular RT window and consisting of distributions of ion species (each consisting of 
multiple m/z-intensity signals – see below) corresponding to the unlabelled and labelled 
forms of the PMC. The goal in EML quantification is twofold; to identify the 15N 
incorporation level in the labelled form of the PMC, and to quantify the total signal for 
both unlabelled and labelled forms so that peptide- level (and protein-level) labelled to 
unlabelled ratios can be calculated. 
1.2.1.1 Peptide Isotopologue Patterns 
Due to the existence of elemental isotopes, the signal produced by a PMC (in each 
labelling state) is further split into several discrete peaks with increasing m/z. At a 
superficial level (fine detail being obscured by limits of instrument resolution), this 
appears as a series of peaks in a mass spectrum with m/z differences at a consistent 
fraction of 1 that tail off (in terms of relative signal proportion) until they are no longer 
observable. These peaks correspond to the different isotopologues (peptides with the same 
elemental composition but different isotopic composition) found in the PMC population, 
with the fractional difference between each peak corresponding to the charge state of the 
PMC (since the x-axis in a MS is mass-to-charge rather than just mass). The first peak 
corresponds to the isotopologue where all atoms in the peptide are the lowest mass isotope 
of their element, and thus has a m/z value of the monoisotopic molecular mass (M) divided 
by peptide charge (zp). This peak may be referred to as the monoisotopologue. The next 
peak corresponds to the isotopologue where one atom (anywhere in the molecule) has an 
additional neutron, thus the total mass is greater than the monoisotopic mass by the 
approximate mass of one neutron, i.e. a mass increase of approximately +1 (due to binding 
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energy mass loss, the mass differences between isotopes of different elements are not 
exactly 1). This peak thus has an m/z value of (M+1)/zp. The next peak corresponds to the 
isotopologue where two atoms (anywhere in the molecule) have additional neutrons, thus 
a mass increase of +2 and an m/z value of (M+2)/zp and so on (Figure 1-XXI). 
 
Figure 1-XXI. Peptide Isotopologue Distribution. Peaks are observed at m/z values 
corresponding to the monoisotopic molecular mass (M) with zero, 1, 2… additional 
neutrons. The charge state (zp) of the PMC may be deduced from the m/z distance between 
peaks; a distance of 1/2 means a charge of 2, a distance of 1/3 means a charge of 3. 
The total signal for a PMC is distributed between the isotopologues according to the 
underlying probability distribution that a given molecule in the population of the PMC 
will have 0, 1, 2 and so on extra neutrons. The natural relative isotopic abundances for the 
five elements (C, H, N, O, S) comprising the standard 20 amino acids (i.e. disregarding Se 
in selenocysteine) are all disproportionately found in the lowest mass form (see Table 
1-III), so for short peptides the monoisotopologue peak is reliably the largest proportion of 
the total signal intensity for the PMC. As peptide length increases, the total number of 
atoms in the molecule increases along with the probability that at least one atom 
somewhere in a given molecule will not be a monoisotope. Thus, for longer peptides the 
second or third isotopologue peak may be the most probable scenario and will therefore be 
observed with the highest relative abundance. Peptides in the observed mass range in 
proteomics (typically 0 to 2 kDa), are generally not long enough that more than 6-7 
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Table 1-III. Elemental Isotopes in Standard Proteinogenic Amino Acids. The precise 
values listed are those used in Fan et al., 2016 (166). 
Since the mass shifts engendered by each isotope are not identical, then (for example) the 
m/z of a PMC with a single 15N or 2H isotope is not precisely the same as the m/z of a 
PMC with a single 13C isotope. The isotopologue peaks are not a single signal from ions of 
identical m/z but rather a composite signal of all ions with m/z values produced by 
combinations of isotopes that yield a certain net number of additional neutrons. The 
instrument resolution required to reliably separate these signals is considerably higher than 
typical operating parameters for proteomic analysis, and so for practical purposes these 
may be considered as a single peak. In an unlabelled signal, the probability distribution is 
overwhelmingly dominated by the effect of carbon due to a proportionately high 
percentage of the atomic composition and large relative abundance of the 13C isotope.  
It is relevant to consider, however, that the observed centroid m/z values of isotopologue 
peaks (particular those corresponding to a net neutron increase of more than 2) are 
comprised of contributions from many isotopic composition permutations. As well as 
engendering a difference in intensity, the centroid m/z of the +5 neutron isotopologue peak 
of an unlabelled signal will not be exactly the same as the centroid m/z of the +5 neutron 
peak of a 15N labelled signal. The m/z values of the components of the peak do not change, 
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against the previously dominant component corresponding to five 13C, and so a weighted 
centroid of all component m/z values will be different. 
1.2.1.1.1 Prediction of Peptide Isotopologue Patterns 
In SILAC and (ICAT/Dimethyl labelling), the isotopologues of both the unlabelled and 
labelled signals occur at predictable m/z and with effectively equivalent distributions. The 
addition of a few atoms in the SILAC label is not enough to substantially change the 
expected isotopologue proportions. The labelled distribution is always shifted in mass by a 
fixed amount multiplied by the number of labelled amino acids. It is not necessary to 
predict the expected isotopologue distribution of either unlabelled or labelled signal 
(although this can be used for noise assessment and quality control) since labelled signal 
intensity may be calculated by whatever method was used for the unlabelled signal 
intensity, with an appropriate mass-shift to account for the label. Furthermore, a label 
incorporation level of less than 100% merely alters the expected ratio of unlabelled to 
labelled signal intensity, as a single molecule may either have a label (and thus contribute 
to the labelled signal intensity) or not (and thus contribute to the unlabelled signal 
intensity). 
In EML only the isotopologue distribution of the unlabelled signal is predictable without 
knowledge of the label incorporation level. Labelling effectively increases the relative 
abundance of a particular non-monoisotope relative to the monoisotope (so, for example, 
labelling with 15N increases the 15N isotope abundance versus the 14N isotope abundance). 
This has the effect of increasing the mass of the labelled peptide and, for incorporation 
levels less than 100%, also changing the isotopologue distribution of the corresponding 
signal, as a single peptide molecule can have a variable number of heavier isotope atoms. 
The incorporation level (and thus relative abundance) of the labelled peptide must be 
determined by identifying the incorporation level at which optimum fitting of the observed 
spectrum of the labelled signal is achieved (Figure 1-XXII). 
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Figure 1-XXII.  Effect of Labelling on Peptide Isotopologues in 15N EML vs. SILAC. A & 
B: The mass shift induced by SILAC is proportional to the number of labelled amino acids 
whereas the shift induced by 15N EML is dependent on the number of labelled nitrogens. 
C: If labelling occurs prior to digestion (as in SILAC but not in ICAT/Dimethyl labelling) 
then any missed cleavages will mean the resultant peptide will have multiple SILAC-
labelled amino acids and thus the mass will be increased by a multiple of the base shift  – 
here, the dotted lines for SILAC indicate where the distribution would be located without 
this shift. D: The labelling methods are particularly distinguished in cases of incomplete 
labelling – here, the dotted lines for 15N indicate where the unlabelled (left) and fully 
labelled (right) distributions would be located. In 15N EML the distribution shape of the 
whole sample is altered, whereas in SILAC the signal is split into fully labelled and 
unlabelled populations. Unlabelled peptides from a SILAC labelled sample with 
incomplete incorporation produce a signal indistinguishable from peptides that have not 
been labelled at all. 
Isotopologue distributions may be predicted in silico from the chemical composition of the 
peptide. Distribution calculation algorithms described by Kubinyi (167) and Rockwood et 
al. (168-171) have been widely used for this purpose. Development of these algorithms 
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and these algorithms are optimised for speed. Distribution calculations for peptides are 
thus extremely fast on modern computers, allowing rapid computation of many 
possibilities. Peptide distributions may be found step-wise by repeated convolution of the 
isotopic probability distribution of each element (C, H, N, O, S) with itself to find the 
isotopic probability distributions for a molecule consisting only of a number of atoms of 
that element equal to that in the peptide composition (Figure 1-XXIII), then convoluting 
those elemental molecule probability distributions together to find the distribution for the 
complete molecule. 
 
Figure 1-XXIII. Stepwise Prediction of an Isotopologue Distribution. For simplicity, the 
molecule is assumed to consist only of three carbon atoms. 
The approach described by Kubinyi is an efficient shortcut to this process. Rather than 
convoluting each ‘running total’ elemental distribution with the atomic distribution n-1 
times (where n is the number of atoms of that element), this approach represents n as a 
binary number. The atomic distribution is convoluted with itself, then the resulting 
distribution with itself and so on, until it represents the distribution corresponding to the 
highest power of two in the addends of the binary representation of n. Finally, each 




mass 24 25 26
proportion 0.9801 0.0198 0.0001
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For example, to find the distribution for C50 the stepwise approach is to convolute C1 and 
C1 giving C2, then convolute C2 with C1 giving C3 etc. This involves 49 convolution 
operations to get to C50. Alternatively, by the Kubinyi method, the binary addends of 50 
are 32, 16 and 2; once these three stages are calculated, one can then can convolute C32 
with C16 (giving C48) then the result with C2 to get C50. This optimisation already 
reduces the number of operations required to 32 (to get to C32) + 2 = 34. But optimisation 
can be taken further since the binary addends, as powers of two, can be reached quickly by 
convoluting C1 with itself to get C2, then C2 with itself to get C4 and so on. The largest 
addend required is C32 i.e. 25, which requires only 5 operations in total counting the initial 
convolution of C1 with C1 to get C2, producing C16 along the way. Calculation of C50 
thus involves a total of only 5 (to get C2, C16 and C32) + 2 (to combine the addends at the 
end) = 7 convolution operations, many fewer than the step-wise method (Figure 1-XXIV). 
 
Figure 1-XXIV. Comparison of Isotopologue Distribution Prediction Algorithms. A: The 
step-by-step method for prediction of an n multi-atom isotopologue distribution (in this 
case, C50) involves iterative convolution of a single atom with the result of the previous 
operation n times. B: The Kubinyi method reduces the number of convolutions required by 
calculating only the binary addends of n. (i) These may be found quickly by convoluting of 
each result with itself (thus finding the distributions representing powers-of-two). (ii) 
Once the highest binary addend required has been found, the distribution representing n 
can be calculated with a minimal number of further operations. 
SILAC/ICAT/Dimethyl labelled distributions may be found by applying the mass shift of 
the label to the isotopologues of the unlabelled distribution. For EML labelling, due to the 
change in isotope proportions, the isotopologue distribution should ideally be fully re-
calculated. An alternative ‘short-cut’ method for EML distributions used by some existing 
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incremental multiples of the heavier isotope mass delta (e.g. for 15N-14N this is 
~0.9970348932) to the molecular weight of the monoisotopic isotopologue. The advantage 
of this approach is that it saves computation time by avoiding re-generation of the 
distribution from scratch for each increment of incorporation in the label incorporation 
range to be tested. This method, however, is vulnerable to cumulative error as it does not 
account for the changing relative contribution to each isotopologue centroid m/z by the 
EML isotope (see above). For example, in 15N EML, the proportionally weighted centroid 
mass of each isotopologue decreases as the contribution from 15N rises, because the shift 
due to 15N (0.997 Da heavier than 14N) is less than that due to 13C (1.003 Da heavier 
than 12C). At high incorporation, therefore, the ‘short-cut’ method is relatively accurate, 
but at low incorporation, when the isotopologue centroid is dominated by the 13C mass 
difference, the effect is to substantially underestimate the centroid m/z. While this 
inaccuracy appears to have little effect when viewed at a scale across the full mass range 
of the possible distributions (Figure 1-XXV-A), applying error windows appropriate for 
modern instruments to individual isotopologues is more revealing. The short-cut method 
results in substantial accumulated errors compared to the weighted isotopologue centroids 
from fully calculated theoretical distributions. Taking the peptide VVISAPSK as an 
example, this effect results in m/z errors of > 10 ppm (Figure 1-XXV-B). Mass accuracy in 
an MS1 scan on an Orbitrap instrument (~60-120k resolution) is typically below 5 ppm, so 
errors of more than 10 ppm are quite substantial. 
Since the labelled isotopologue distributions must be predicted, this also means any 
quantification is reliant on first identifying the PMCs present (in order for the prediction to 
be accurate). Identification of EML-labelled peptides presents additional difficulties as 
current peptide identification search engines generally do not adequately handle EML 
peptides of unknown incorporation (172). By allowing a range of incorporations, pre-
filtering of the search space by precursor masses would become much less selective, 
substantially increasing the number of potentially matching possible sequences and thus 
greatly increasing the complexity of the search. In contrast, SILAC/ICAT/Dimethyl 
labelling, by introducing a known mass shift, can be handled as a routine post-translational 
modification. The identification problem is commonly addressed by using reference 
analyses of fully unlabelled but compositionally identical samples run under the same 
chromatographic conditions, so that any peptides identified can be matched against the 
mixed-labelling dataset by RT.
 
 
Figure 1-XXV. Mass Errors Associated with the ‘Short-Cut’ Method. The ‘short-cut method’ estimates the labelled distribution by applying 
fixed mass shifts to the unlabelled distribution. A: At the isotopologue-window scale, the isotopologues of example peptide VVISAPSK appear to 
be calculated correctly. B: Closer examination reveals that at low incorporation, the higher-neutron number isotopologue centroid m/z values 
are underestimated by more than 10 ppm. Each box shows a ‘zoomed-in’ snapshot of an isotopologue mass from A on the same axes (showing 
m/z in a limited window, y-axis showing increasing 15N incorporation). Boxes left-to-right top-to-bottom correspond to isotopologues in 
increasing mass order. Vertical thresholds indicate 5 and 10 ppm error windows either side of the centroid m/z.
A B
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1.2.2 Analysis Methodologies 
The MSQuant framework first referenced in publications in 2003 (173, 174) was capable 
of quantifying 15N labelled signal given a fixed, pre-specified level of 15N incorporation. 
However, the framework was geared towards SILAC labelling and 15N support was 
somewhat awkward, requiring additional scripts to pre-patch search result input before 
quantification. In 2006, Andreev et al. (175) described a dedicated 15N quantification 
algorithm, again assuming a fixed level of incorporation. Although the algorithm 
theoretically supports any level of 15N incorporation, the authors only demonstrated 
performance in the case of complete labelling, where the analytical challenge is reduced 
since there is no need to account for differences in isotopologue distribution shape. 
Subsequently, Palmblad et al. (132) described a similar analytical pipeline for 
quantification of fully incorporated 15N labelling using Bruker instrument software 
(DataAnalysis and CompassXport) in combination with peak extraction tools in the Trans-
Proteomic Pipeline (176). Both methods demonstrated good performance on high 
incorporation biological samples, in the process indicating a degree of robustness to small 
deviations from ‘idealised’ complete labelling, which in reality is generally impractical to 
achieve (159). Another similar algorithm (Peakardt) was robustly validated by orthogonal 
quantification via 2DGE using the Difference-In-Gel Electrophoresis approach with 
fluorescent CyDyes (177). 
Two later software tools support 15N quantification (with pre-specified incorporation 
levels) as part of a broader MS1 quantification offering. Census (121, 178) is a free tool 
with ongoing support (179) in which peak extraction tolerances are highly customisable, 
allowing optimisation for both low and high resolution data. Mascot Distiller (Matrix 
Science) is a commercial quantification solution which integrates closely with the Mascot 
Server search engine from the same vendor. A complete pipeline for automated analysis 
using Mascot Distiller (Matrix Science) was described by Bindschedler et al. (112). 
Further optimisations to a Mascot Distiller-based approach via optimisation of 
chromatographic alignment and cross-run matching (by artificial insertion of PSM MS2 
spectra into aligned runs at matching RTs) were described by Russell and Lilley (107). 
The approaches described above require the 15N incorporation level to be pre-specified 
and assume the level to be the same for all peptide/proteins. This narrows the range of 
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feasible experimental designs (requiring incorporation to reach a stable level) and 
precludes use of 15N for pulse-chase experiments (particularly useful in the analysis of 
protein turnover), where the level of incorporation not only varies from peptide-to-peptide 
but is the metric of experimental interest (as opposed to the labelled/unlabelled ratio, 
indeed the sample may not even contain unlabelled peptide). Accounting for variable 
incorporation introduces considerable challenge, in particular controlling the potential for 
incorrect estimation of peptide incorporation (due to noise, or co-eluting species within the 
mass error window of integrated peaks) leading to mis-quantification. 
There have been two paradigms described for incorporation-agnostic quantification of 15N 
data, which may be classified as to whether or not 15N incorporation in the labelled signal 
is estimated in the course of determining the unlabelled to labelled ratio. In many 
experimental designs the relative amount of unlabelled to labelled (but unknown 
incorporation) peptide is of more interest than the incorporation level itself. In this ‘ratio-
only’ approach, 15N quantification is analogous to SILAC quantification and provides an 
alternative in vivo methodology when SILAC labelling is complicated by other factors. It 
is not necessary to determine an exact incorporation level to quantify the unlabelled to 
labelled ratio as the total intensities of the unlabelled and labelled signals across all their 
isotopologues can simply be compared. A downside to not estimating 15N incorporation is 
that co-eluting interference by species of coincident mass with certain isotopologues can 
only be detected by the effect on the calculated ratio, rather than during calculation of the 
respective unlabelled and labelled signal intensities (where it may be corrected). 
An early published example of this approach is the work by Zhang et al. (180) whose 
ProTurnyzer tool refines the broad approach described above to optimise for cases of very 
low incorporation where the unlabelled/labelled mass coincidence is substantial. 
Subsequently Lyon et al. (181) described a further refinement to the ‘ratio-only’ approach. 
Their Protover tool processes samples in order of expected decreasing 15N label 
incorporation level, for example by processing a time course of MS sample analyses in 
order of expected decreasing incorporation (so, for example, a time course of 
incorporation on labelled media would be analysed in reverse). For suitable experimental 
designs this allows the extraction of label masses at each time point to be refined based on 
the masses observed in previously processed data files (as the maximum isotopologue 
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mass found for a peptide in each file may be taken as an upper bound of the possible 
isotopologue masses for that peptide in subsequent files). 
The alternative paradigm for 15N quantification may be summarised as the ‘theoretical-
distribution-matching’ approach in which labelled distributions are characterised by 
comparing the intensity ratios of the isotopologues of each 15N labelled signal to a range 
of theoretical distributions using a scoring system, in order to find the best fit. Knowledge 
of the incorporation level may then be applied to optimise calculation of the unlabelled to 
labelled ratio by estimating the total area of the labelled signal based on the most intense 
isotopologues only (increasing the effective signal to noise). 
Over the course of two papers (131, 182), Snijders et al. described a manual 
implementation of this paradigm, in which ion intensities for the unlabelled and labelled 
distributions of each peptide were extracted using the peak integration capabilities in the 
instrument vendor software Analyst Qs (Applied Biosystems). For the labelled 
distribution, incorporation was then manually characterised by comparison to theoretical 
distributions generated using IsoPro (https://sites.google.com/site/isoproms/home) to 
generate theoretical spectra. 
Contemporaneously, MacCoss et al. (183) described an automated incorporation 
determination approach to theoretical distribution fitting, although this lacked the ability to 
track across the RT dimension to find the peak apex or integral, or match by RT between 
runs. 
The work by MacCoss et al. was later adapted by Huttlin et al. (184) into a quantification 
workflow which combines ion chromatogram extraction with automated incorporation 
determination to produce an incorporation-agnostic automated approach. In the Huttlin et 
al. paper, the approach was benchmarked at both near-complete labelling, and also at very 
low (<10%) partial incorporation. The MacCoss and Huttlin studies use Pearson 
correlation as their isotopologue distribution matching metric. 
A similar workflow was described by Price et al. (165), detailed methodology for which 
was later elaborated by Guan et al. (185). These methods use a non-negative least squares 
algorithm for distribution matching. These analytical workflows involved a series of 
scripts rather than a single integrated software tool, which may limit their uptake by the 
wider community. Later iterations of the ‘two-feature’ approach have presented 15N 
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quantification tools that are a single program or script, which make further refinements to 
the theoretical-distribution approach. Protein TurnStILE (160) allows the list of peptides 
for quantification to be generated separately from the quantification runs, so that peptide 
identifications can be obtained in separate dedicated runs using only unlabelled sample for 
optimum peptide-spectrum matching. The isotopologue distribution matching metric used 
by Protein TurnStILE is least-squares rather than Pearson correlation. 
The recent work by Fan et al. (166) describes a hybrid approach, ProteinTurnover. After 
ion extraction, an amalgam of the unlabelled and labelled distributions represented by a 
composite of two beta-binomial distributions is fitted to the data using maximum 
likelihood estimation. Theoretical 15N incorporation distributions are not matched directly 
to the data, but the composite distribution includes a shape parameter representing 15N 
incorporation in the labelled signal, so the parameters of best fit do include an estimate of 
incorporation level. This particular tool will be discussed in more detail in Chapter 4 in the 
context of a comparison with the work of this thesis. 
1.2.3 HeavyMetL 
Despite steady development of quantification approaches, no tool described thus far for 
EML (or specifically 15N) quantification has seen substantial adoption by the proteomics 
community for this purpose (although there are some widely used tools such as Mascot 
Distiller which support rudimentary 15N quantification among other features). This may be 
attributable to two factors. Firstly, usability; published approaches are typically scripts run 
in an environment such as R or Python, which are intimidating and inaccessible to many 
researchers. A hallmark of most tools widely used by the field is that they have at least a 
rudimentary graphical user interface (for local programs e.g. MaxQuant (82)) or a web 
interface for remotely hosted services such as UniProt (186) or Panther (187); this is not 
the case for existing options. Secondly, the tool must be sensitive and accurate for general 
use (not just for very high-quality data). For the tool to be useful on a large scale, it must 
produce robust results for a majority of PMCs identified. For reference data, results must 
be consistent with expected values, and for experimental data must compare favourably to 
results obtained by alternative quantification algorithms. Critically, it must not require 
extensive manual inspection of spectra to corroborate findings and must have acceptable 
performance in cases of lower than average signal-to-noise. While heretofore published 
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solutions provide broadly accurate results, the incidence of substandard quantification is 
difficult to gauge as publications typically present little benchmarking and either include 
no comparisons to earlier work or report only cherry-picked example peptides. This may 
also relate back to the first factor, in that even bioinformaticians working in the same field 
are not confident in setting up and configuring other published programs in a way that will 
allow fair benchmarking! 
The aims of this work were four-fold. Firstly, to develop and present a tool with an 
accessible interface front-end to a sound quantitative algorithm.  Secondly, to show that 
the design choices made in the algorithm structure and calculations support a claim of 
robust and accurate quantification, and to explore the limitations of the algorithm as data 
quality decreases. Thirdly, to show that the results produced compare favourably to 
existing modern approaches. Lastly, to argue that the tool, supported by this analysis, is 
justifiably an improvement on existing work, and a practical addition to analysis resources 
in the field of proteomics. 
In the chapters below, I present, a software tool, HeavyMetL for analysis of 15N MS data 
that addresses the issues above, namely usability/accessibility, accuracy of quantification 
and robust handling of suboptimal quality data without extensive manual supervision. I 
have compared the performance of several isotopologue distribution matching metrics in 
the context of this tool to assess spectral matching performance over a range of 
incorporation levels, and to vindicate the selected metric as the keystone of my 
algorithmic approach. Finally, I have benchmarked my tool by comparison against a 
recently published hybrid quantification algorithm (ProteinTurnover) that has used a 
degree of orthogonality in its approach (166), and have concluded with an argument for its 
utility. 
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Chapter 2: HeavyMetL: A Program to 
Analyse 15N-Labelled Proteomic MS Data 
2.1 Introduction 
This chapter describes the design and implementation of a software package for 
determination of relative abundance and label incorporation in 15N-labelled samples 
analysed by LC-MS/MS. The package, HeavyMetL, is written in JavaScript and runs on 
the latest versions of popular freely available web browsers (Mozilla Firefox and Google 
Chrome), enabling graphical analysis of 15N data without the necessity for command-line 
interaction. The quantification algorithm is an evolution of several approaches that have 
been previously described for 15N, with refinements to improve signal-to-noise and to 
handle sample-to-sample chromatographic differences, implemented in a multi-threaded 
system. Chapters 3 and 4 expand upon the work detailed herein, the former describing 
analysis of various possibilities for the spectral matching scoring system used in 
HeavyMetL, and the latter analysing a benchmark comparison of this software to a pre-
existing analysis tool. 
2.2 Proteomic Software Design Considerations 
Researchers working with proteomics data are drawn from a wide array of backgrounds 
and cannot be expected to be experts in either proteomic mass spectrometry or 
bioinformatics. A recurrent issue in all ‘big data’ -omics fields is a disconnect between the 
expectations of the bioinformaticians and computer scientists who build new tools for 
analysis and the experience of biological researchers who ultimately form the bulk of the 
software user base after release.  
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A recent report (188) on the experiences of end users of MS software highlighted this 
disconnect succinctly: 
“Interviewees commonly complained about the lack of user-friendly software. 
Parameter setting and manual interaction is a significant time consumption for 
mass spectrometry scientists. Twenty-seven interviewees specifically mentioned 
how manual intervention required a significant amount of their time, with 
percentages ranging 10−50%. Users also spend a significant amount of time in 
learning how to use software. User complaints about software included hard to 
learn interfaces, inefficient interfaces, and broken features.” 
‘Manual intervention’, in this case, refers to manually selecting parameters on a ‘dataset-
by-dataset’ basis (or even on individual elements within a dataset) because the default 
parameters (whether global defaults or automatically selected based on dataset 
characteristics) do not yield acceptable algorithmic decision making (with regard to peak 
selection, spectral matching etc.) for most elements within the dataset. 
Furthermore, the report goes on to observe that while developers (interviewees who spent 
a significant portion of their time coding) consider the majority (92%) of the remaining 
unsolved problems in computational MS analysis to be minor issues, among non-
developers the reverse was true; they considered the majority (86%) of the remaining 
unsolved problems to be major issues. While subjective, this report could be interpreted to 
suggest that although many problems have been addressed by theoretical algorithm 
development, the rate of translation of these solutions into broadly accessible ‘complete 
products’ (or at least, software that is seen by non-developers as complete products!) is 
low. 
Prior to the implementation of HeavyMetL as a software package, extensive consideration 
was given to the characteristics of the user base, and a number of design decisions were 
made with these characteristics in mind. My target user is a researcher looking to analyse 
data from a proteomic experiment. I assumed that the researcher would have sufficient 
involvement in the experiment to be familiar with the experimental design, sample 
processing and MS run configuration, but would not necessarily be the proteomic mass 
spectrometrist who performed the MS part of the analysis. They could also be a primary 
researcher who had entrusted the MS work to a colleague or service facility, or they could 
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be a bioinformatician, either working with the primary researcher or re-analysing a public 
dataset. The target user could therefore possess a range of skill levels with regard to the 
relevant steps in a proteomic experiment (Table 2-I), although for practicality a lower 
bound had to be assumed for most skills, including basic familiarity with proteomic 
techniques (digestion of sample to peptides, identification of peptides by MS2 and 
database or spectral library searches, and inference of protein parents) and mass 
spectrometry concepts (spectra of mass-to-charge ratios vs. intensities, and total/extracted 
ion chromatograms). From personal experience it also seemed reasonable to assume the 
user would have some prior experience with other graphical user interface (GUI)-based 
identification and quantification software (such as Mascot and MaxQuant) and spreadsheet 
programs such as Microsoft Excel, but may not be comfortable working on the command 
line (navigating the file system, performing file operations, installing/running command-
line based programs, installing dependencies via package managers or compiling code) or 
with dedicated statistical environments, whether command-line based (such as R) or GUI-
based (such as PRISM).
 
 
Table 2-I. Anticipated Minimum Proficiencies for End-User Demographics.  
Assumed proficiency is ranked as Acquaintance < Familiarity < Proficiency < Expertise.
Biologist / Biochemist Proteomic Mass Spectrometrist Bioinformatician
Sample Preparation
Biological Background Expertise Familiarity Acquaintance
Experimental Design Expertise Expertise Expertise
In-vivo labelling Proficiency Expertise Familiarity
Proteomic Sample Preparation
Protein Extraction Familiarity Expertise Familiarity
Sample Cleaning Familiarity Expertise Familiarity
Digestion Familiarity Expertise Familiarity
Bottom-up Proteomic MS Analysis
LC Separation Familiarity Expertise Familiarity
Data-Dependent MS Analysis Acquaintance Expertise Familiarity
Data Processing
Peptide-spectrum matching Acquaintance Expertise Proficiency
MS data types (peaklist, rawfile etc) and formats (mgf, mzML etc) Acquaintance Proficiency Proficiency
DDA data concepts (retention times, ion chromatograms, spectra etc) Familiarity Expertise Familiarity
Popular GUI quantitation software Acquaintance Expertise Proficiency
Command-line navigation Acquaintance Acquaintance Expertise
Statistical Analysis
Basic statistical concepts Familiarity Familiarity Expertise
MS Data-specific statistical concepts Acquaintance Proficiency Proficiency
Spreadsheet software Proficiency Proficiency Expertise
Dedicated statistical environments e.g R, MATLAB Acquaintance Acquaintance Expertise
Researcher Demographic
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In order for the software to be an attractive solution for an average such researcher, I 
considered the following themes to constrain design decisions for the software. 
1. System Requirements. The software must be usable on an average contemporary 
personal computer (broadly, purchased within the last 5 years, with major system 
updates having been applied and with sufficient hard disk space to hold the data to 
be analysed locally). Ideally, system requirements such as operating system and 
prerequisite libraries are to be minimised so that initial setup is as straightforward 
as possible. Experience has shown that the average non-bioinformatician user does 
not have limitless patience to play around installing software, particularly if it 
requires interaction via the command line. 
2. User interaction. Further to the above, general operation of the program must also 
be accessible to users. The number of parameters that must be manually 
configured should be minimised, but advanced options should be available to 
expert users to allow for optimisation. The program should have a graphical user 
interface to avoid command-line interaction. The results should be output in a 
simple text table format to maximise compatibility with statistical analysis and 
spreadsheet software. Furthermore, the results should also be displayed graphically 
(and at a quality suitable for publication) to allow easy evaluation of quantitative 
performance and assess the effect of configuration changes. Graphical views of 
spectra are offered in many existing MS quantification packages such as 
Progenesis, Proteome Discoverer, Skyline (189), Spectronaut and Mascot 
Distiller. MaxQuant originally lacked any such display, and the later introduction 
of this feature was (in my personal experience) well received in the field. 
3. Speed. It is acceptable, taking contemporary quantification software such as 
MaxQuant, Progenesis or Proteome Discoverer as examples, for a large analysis 
involving several raw data files to take several hours on a desktop computer. It is 
considered typical that quantification analyses may need to be run overnight, even 
for modestly-sized experiments (for example up to 5000 confident peptide IDs, 6 
raw data files). However, a single run should be analysable well within a working 
day (ideally no more than 1-2 hours). Quantification for a single PMC in a single 
run should therefore take no more than a few seconds to compute, given an 
expectation of thousands or even millions of quantifications to be performed when 
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accounting for a large dataset with many runs. ‘Lag’ or unresponsiveness of the 
interface should be avoided (a problem even in commercial software, particularly 
in Proteome Discoverer and Progenesis when navigating results) and 
quantification progress for time-consuming tasks should be updated frequently to 
avoid giving the impression that the interface has ‘frozen’.  
4. Memory usage. Analysis of MS data involves data file sizes ranging from a few 
hundred megabytes up to several gigabytes. A contemporary midrange personal 
computer may be assumed to have between 8 and 64 gigabytes of memory. 
Analysis will require the reading of large amounts of data from each file. It is more 
efficient to store this data in memory where possible but loading whole raw data 
files into memory will quickly use up all available space, resulting in the system 
swapping memory with disk storage (a very slow operation). Loading data only as 
required reduces memory load but introduces a throughput bottleneck of disk-
reading speed, therefore disk operations must be arranged such that reading from 
disk is performed before the data are required for quantification. A technique used 
by MaxQuant (among others) is pre-indexing of raw data files before 
quantification starts so that disk reads during quantification are limited to the exact 
place within the file where each spectrum is stored. 
5. Quantification quality. Robustness of quantification is critical. If manual analysis 
of the data consistently out-performs a quantification algorithm it will be seen as 
not reliable. This requirement sets a deceptively high bar, as experienced 
researchers are very good at evaluating spectral quality ‘by eye’ and setting 
integration limits so as to maximise signal-to-noise. The quality of manual 
quantification produced by an experienced researcher will typically be very high. 
The theoretical advantages of computational approaches (aside from the feasibility 
of analysing many PMCs) are granular quality evaluation (rather than pass/fail), 
allowing information from poor quality quantification to be used with minimal 
bias, and consistent quality independent of researcher expertise. In order for the 
output of such approaches to be useful, however, they must compare robustly to 
experienced manual quantification. 
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2.2.1 Language and Distribution 
Open source bioinformatics projects are usually implemented in one of several ways. They 
may be made available as a downloadable program which is compiled against a target 
operating system (OS) (e.g. Skyline). The major advantage of directly compiled code is 
speed, particularly in the case of extensive numerical calculations (which does apply to 
quantification tasks). As discussed above regarding memory usage, however, a second 
bottleneck is the speed at which data may be read into memory from raw data files stored 
on disk (since the size of such files precludes keeping the entire file set in memory in the 
case of many analyses). Even with appropriate indexing of raw data files to minimise the 
data read, and scheduling of disk reads to ensure no wasted disk-read time, disk read time 
still applies an effective minimum bound on quantification, thus the speed advantage of 
compiled code is limited. The disadvantage to compiled programs is that they induce 
additional testing workload on development as some bugs may be platform-specific 
(assuming that versions of the program are compiled for more than one OS). 
Alternatively, the program may be written in an interpreted language (e.g. Perl, Python), 
or compiled to virtual machine bytecode (e.g. Java), both of which result in a platform-
agnostic distribution. This approach is quite popular for proteomics tools, as it is 
somewhat easier to resolve bug issues, and the loss of speed vs. compiled code is, in most 
cases, minimal. Some operating system-related issues are quite common, often relating to 
differences in the interpretation of file paths and text file line endings, or use of non-OS 
agnostic code libraries, but these common pitfalls may be avoided. A trickier issue lies in 
installation. While an OS-agnostic distributed program may be run on any system with 
correct setup, it is common for non-bioinformaticians to run into problems during 
installation such as incorrect execution environment version (especially in the case of 
Java, where version updates are frequent and may not be backwards compatible without 
adjusting default security policies), mis-configured system variables or failure to install 
dependencies not bundled with the program download (for example, in scripting languages 
such as Perl, Python and R, users are often expected to be familiar with installation of 
modules from centralised repositories). Such foibles are minor annoyances for 
experienced computer users but are very off-putting for users expecting things to ‘just 
work’. Existing 
15
N quantification tools as described in Section 1.2.2 have a poor track 
record in this regard. The four most recently published approaches implemented as 
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distributable software (ProTurnyzer (180), Protein TurnStILE (160), Protover (181) and 
ProteinTurnover (166) are all command-line based approaches which run via an 
interpreting runtime (ProTurnyzer and Protover in Python, Protein TurnStILE in Perl and 
ProteinTurnover in R), a compatible version of which (not necessarily the latest!) must be 
installed and configured correctly to be callable from a command line console. Indeed, a 
prototype design of the HeavyMetL core quantification algorithm was initially written and 
tested in Perl. Ultimately, users reporting issues and deployment inconveniencies I 
experienced myself led me to discard this strategy before the final implementation. 
Thirdly, projects may be hosted on a remote server and accessed via a web interface. This 
approach is arguably the most operating system-agnostic; great efforts have been made to 
standardise behaviour of websites in browsers across operating systems. 
Usually, this approach places the onus of computation on the hosting server rather than on 
the local machine. The actual program may be written in a compiled or interpreted form, 
or even some combination thereof. This is invisible to the user and does not increase setup 
complexity, so may be engineered for optimal speed or maintenance. For quantification, 
this may on first glance seem ideal, as the servers are likely to be far more powerful than a 
personal computer. However, the server must be maintained (requiring a larger on-going 
commitment to the tool) and may become overloaded if usage is greatly increased. 
Furthermore, in the case of quantification, a large amount of data must be sent to the 
server, which, unless the server is on a local network, is time consuming and risks time-
out of the connection. This is likely to offset any speed benefits of computation server-side 
unless the quantification to be performed is extremely complex. Transferring data for 
remote processing also raises issues of privacy; many researchers are understandably 
reluctant to send large amounts of data to third parties for analysis. In some cases (e.g. 
medical data containing identifiable patient information) submitting data to a third party 
for processing presents ethical and legal difficulties. 
Another possibility, which is the route I have taken for HeavyMetL, is to provide a web-
based tool in which the processing is performed locally within the browser. This takes full 
advantage of the highly standardised behaviour of popular multiple operating system-
compatible browsers, particularly Mozilla Firefox and Google Chrome, and a ready-made 
GUI platform via the HTML document object model, while avoiding the need for server 
maintenance or long data transfer times. This option has only recently become feasible as 
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a possibility following large improvements in JavaScript speed in-browser (particularly 
driven by competition between Mozilla’s SpiderMonkey JavaScript engine and Google’s 
V8 JavaScript engine) and the adoption of several key JavaScript standard features 
including local file access and multi-threaded execution. Running in a browser still has 
limitations; the maximum usable memory is limited, and raw computation speed will 
never reach the limits of compiled, platform-optimised code. These limitations may be 
mitigated somewhat by careful program design. Memory footprint is to be minimised in 
any case - see Design Constraint 4, Section 2.2, and computation time is only one 
bottleneck on the overall analysis speed; disk access rates will also constrain the analysis 
of large files and, at a higher level, the ease with which the user can supply the necessary 
input data and evaluate results also contributes to the total time for the analysis. 
2.2.2 Program Requirements 
2.2.2.1 Input 
Extensive pre-processing of raw data is both time consuming and compares unfavourably 
to similar modern quantification platforms such as MaxQuant that are able to read raw 
data directly. The program must therefore be able to accept a set of raw data files with 
minimal pre-processing. Data files produced by MS instruments from different vendors 
are each in different, proprietary binary formats. While most vendors supply code libraries 
that allow third-party programs to read these formats, they are almost universally 
Windows-only, and thus would require the quantification software to also be limited to 
Windows if it is to directly read these proprietary formats. Conveniently, a conversion tool 
(msconvert from the ProteoWizard suite (190)) which reads the vast majority of MS data 
formats is available, and widely used within proteomics. This may be used to convert raw 
data files into open standards for raw MS data that are widely used in proteomics, namely 
the mzML format (191) and the older mzXML format (192). For maximum compatibility, 
it makes sense to target these open standards as raw data files from almost all instruments 
can be rapidly and easily converted to this format either directly from the acquisition 
software or with msconvert. Raw data in mzmL/mzXML format takes the form of the 
three-dimensional data space described in the Introduction (see Figure 1-XX. ), 
specifically, a series of spectra (m/z vs. intensity) stored in order of acquisition, and thus 
corresponding to an LC retention time. The information regarding each consecutive scan 
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is stored as a list of scan parameters (the ‘scan header’) followed by a record of the 
‘spectrum data’ in terms of m/z values and intensity pairs, in a space minimising structure 
(and possibly further compressed, depending on file format). Various items of additional 
metadata, such as instrument hardware and configuration information, are also stored at 
the start of the file, and at the end there may be (depending on the conversion process) a 
byte-indexed record of every scan entry. 
To accompany the raw data, information regarding the PMCs to be quantified is required. 
Peptide-spectrum matching and identification of PMCs for quantification is a significant 
computational challenge that is outside the scope of this work, and (at least for non-
15
N 
labelled peptides) a wide array of software solutions exist. It is assumed for the purposes 
herein that such analysis will be performed separately. Unfortunately, there is no standard 
peptide identification output format that is consistently supported across search engines; 
the closest example would be mzIdentML (193), but as an XML-based format this is not 
readily produced from the output of search engines that do not export it directly. It is 
therefore necessary that for inputting PMCs the program should accept a simple text-table 
file which can be generated from the tabular output of any search engine output requiring 
only minimal rearrangement of the data. Direct support for the outputs of popular search 
engines is something to consider as a secondary goal, but this would impose a large 
burden in terms of potential input bugs and would also add an ongoing requirement to 
maintain compatibility for these formats over time. 
Finally, the analysis of generalised 
15
N data from various experimental designs, with a 
wide variety of sample preparation approaches and analysis setups will entail some pre-
configuration of analytical parameters, at least if the algorithm is to yield optimal results. 
While it will be possible to estimate (or extract from raw data file metadata) many 
characteristics of the data during processing, it will likely speed processing and reduce 
anomalous results if certain parameters can be constrained beforehand. Examples of such 
constraints would include the expected range of 
15
N incorporations and the expected range 
of RT shifts for a PMC between runs. Other parameters must be set by the user, such as 
the definition of any expected post-translational modifications on the peptides. For 
simplicity, the default settings should be expected to produce reasonable quantification for 
common arrangements of experiment, sample preparation and analysis. 
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2.2.2.2 Output 
Given the input data, the program should calculate quantification information for each 
PMC. For 
15
N data this information consists of the incorporation level of the 
15
N labelled 
signal and the relative abundance of the labelled and unlabelled signals. Various further 
statistics for each quantitative result will also be of interest, including the RTs of the 
labelled and unlabelled peaks and a level of uncertainty for the quantification. The 
program should also calculate quantitative information at the protein level since this will 
be the most relevant output for many researchers. The requirement for both text-table and 
graphical type outputs are necessary for easy user interaction (see Design Constraint 2, 
Section 2.2). 
2.3 Program Implementation 
2.3.1 Overview 
HeavyMetL is a quantification tool for the analysis of 15N-labelled samples by mass 
spectrometry. Given a set of raw MS data files and a list of PMCs, spectra are extracted 
from raw data files and fitted to a range of potential 
15
N incorporations to generate values 
for both abundance ratio and incorporation level of peptides and proteins. User interaction 
is via a graphical interface that lists the files and peptides/proteins specified, allowing 
users to 'browse' the results of quantification graphically at both the peptide and protein 
levels, alter quantification settings from within the program and view the results of such 
changes. Once satisfied, the user can export both the peptide and protein level results to a 
text-table format for further analysis in a spreadsheet program (e.g. Microsoft Excel) or 
statistical analysis suites such as Perseus, R or MATLAB.  
Details of access to the program code and a web address for a live implementation of 
HeavyMetL are given in Appendix I. 
2.4 Program Operation 
HeavyMetL takes three types of input data and produces output in the form of text tables 
and graphics. A program schema is shown in Figure 2-I. The first type of input data 
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required is raw data, in one of the open standard formats (mzML or mzXML) as described 
above in Section 2.2.2.1. Secondly, a list of peptides to be quantified is supplied (in tab- or 
comma-separated format), listing each identified instance of PMC individually, as they 
represent different m/z and RT locations in specific raw data files. The columns required 
in this list are given in Table 2-II. These data are commonly available in standard exports 
from popular programs. For example, the “evidence.txt” result file in MaxQuant, the tab-
delimited export of the Peptide table in Proteome Discoverer, the spectrum report from the 
Scaffold data aggregation tool (http://www.proteomesoftware.com/products/scaffold/), and 
the mzTab export from supporting programs (including Mascot) all contain the necessary 
data without the need to splice together multiple search engine exported output files. 
Thirdly, various quantification configuration parameters may be set by the user, although 
the default settings are selected to give reliable quantification in most circumstances. An 
overview of these parameters is given in Table 2-III. 
After peptides have been quantified, results may be exported at the peptide or protein 
level. Protein level quantification is inferred from constituent peptides (according to 
protein grouping information supplied in the list of PMCs), with a filter applied to exclude 
a percentile of peptides with the worst labelled signal Similarity Scores in each run 
(default 5%). The labelled/unlabelled ratio and labelled signal incorporation are calculated 
separately as the corresponding median quantification result across all the remaining 
quantified peptides for the protein in that run. The columns included in the output are also 
listed in Table 2-II
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Figure 2-I. HeavyMetL Program Schema / Processing Workflow. Yellow and green boxes 
are input provided by and output provided to the user respectively. The grey box is the 
starting raw data file. The purple boxes indicate pre-processing performed prior to 
HeavyMetL analysis; the orange box indicates intermediate data typically generated 
during pre-processing. The blue boxes indicate user interaction with HeavyMetL via the 




Table 2-II. HeavyMetL Inputs and Outputs. 
Type Parameter Table Column Name Notes
Raw Data .mzML  - 
Raw Data .mzXML  - 
PMC List Protein Group  PROTEIN Used to group peptides for protein-level quantitation.
PMC List Protein Description  PROTEIN_DESCRIPTION For data pass-through and display only.
PMC List Protein ID Score/Likelihood  PROTEIN_SCORE For data pass-through and display only.
PMC List Peptide Sequence  PEPTIDE_SEQUENCE Given without preceeding/trailing cleavage site indicator or neighbouring residues.  Case is ignored.
PMC List Peptide ID Score/Likelihood  PEPTIDE_SCORE For data pass-through and display only.
PMC List
Peptide contributes to protein 
quantitation?  CONTRIBUTES_TO_PROTEIN
Whether peptide should be considered for when calulating protein-level quantitiation data (this will 
generally be true).  Accepts synonyms of yes/no and true/false and ignores case.
PMC List File Name where PMC was 
detected
 FILE_NAME For files where there a particular PMC was not detected, the RT is estimated using the mean RT from all 
files where it was detected.
PMC List Scan Number of PMC detection  SCAN_NUMBER
PMC List Retention Time of PMC detection  RETENTION_TIME
PMC List Modifications  MODIFICATIONS Scaffold -style modification format
i.e. [ResidueLetterCode][Position]: ModificationName
PMC List Charge State  CHARGE All values are assumed to be positive charge (sign is ignored).
Peptide Table Protein  PROTEIN
Peptide Table Peptide  PEPTIDE_SEQUENCE
Peptide Table Is Unique?  CONTRIBUTES_TO_PROTEIN
Peptide Table Charge  CHARGE
Peptide Table Modifications  MODIFICATIONS
Peptide Table Unlabelled Match Score [file]_SCORE_UNLABELLED
Peptide Table Unlabelled Intensity [file]_INTENSITY_UNLABELLED
Peptide Table Labelled Match Score [file]_SCORE_LABELLED
Peptide Table Labelled Intensity [file]_INTENSITY_LABELLED
Peptide Table Labelled Incorporation % [file]_INCORP_LABELLED
Protein Table Protein Accession  PROTEIN
Protein Table Protein Description  PROTEIN_DESCRIPTION
Protein Table Unlabelled/Labelled Ratio [file]_RATIO
Protein Table Label Incorporation % [file]_INCORP
Either may be supplied. Retention time is used by preference if both are present.No assumption is made 
regarding if the Scan/RT referrs to the MS1 event in which the precursor was observed or the MS2 event 
which gave rise to the PSM - both are calculated by reference to the corresponding raw file.








Pass-through from input PMC list.




Table 2-III. User Configurable Processing and Display Parameters. 
Parameter Description Default Value
Fixed Modifications
List of fixed modifications (comma or semicolon-separated). Format is 
"Modification Name (Residue Single Letter)"
Carbamidomethyl (C)
m/z  Error Tolerance (ppm) Window in m/z  units (Thompsons) around theoretical m/z  values from which 
intensity is to be retrieved.
10
Retention Time Window (min)
Retention time window about observed/estimated peptide identification time in 
which to retrieve spectra.
0.5 (i.e. 30 s)
Maximum Peak Apex Shift (min)
Maximum retention time shift to allow when searching for labelled signal apex 
relative to unlabelled signal apex (if one was found).
0.2 (i.e. 12 s)
Do Not Quantify Unlabelled Signal
Do not quantify unlabelled signal, or correct for unlabelled signal presence when 
quantifying labelled peptides.
FALSE
Minimum Label Incorporation % Minimum incorporation percentage tested when quantifying labelled signal. 10
Maximum Label Incorporation % Maximum incorporation percentage tested when quantifying labelled signal. 95
Peptide Match Score Threshold
Do not use peptides with Similarity Score below this value for protein-level 
quantitation.
0.85
Show XICs on Log10 Scale
Show extracted ion chromatogram (XIC) y- axis on log scale to accentuate 
chromatographic variation at peak boundaries. Affects displayed graphics only.
FALSE
Y -Axis Precision Number of decimal places to show.  Affects displayed graphics only. 2
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2.4.1 Interface 
HeavyMetL presents an empty table to the user on launch, with a series of buttons along a 
top menu bar, all of which are initially greyed out except “Raw Data” (Figure 2-II-A). 
Clicking on this button presents a standard file selection dialog (Figure 2-II-B) allowing 
the user to select the raw data to be processed. Submitting this dialog begins a process of 
raw data file pre-indexing (see Section 2.4.2) to optimise later data read rates. Indexing 
progress is shown for each file (Figure 2-II-C). During and after the pre-indexing process, 
the user may click on the “Identifications” button to select a list of PMCs for analysis via 
another file selection dialog. After pre-indexing, HeavyMetL iterates through the list of 
PMCs, where necessary predicting a suitable retention time for extraction if there is no 
direct MS2 evidence in that file (also see Section 2.4.2). Having predicted any missing 
retention times, a table of the proteins represented by the PMC list input is presented by 
the HeavyMetL interface (Figure 2-II-D). The “Settings” and both quantification 
processing buttons are now available. The “Settings” button presents users with a screen 
that allows various configuration parameters to be changed (see Table 2-III). The two 
quantification processing buttons, “Process All” and Process Selected” allow users to 
choose to analyse all defined PMCs at once, or alternatively select a specific PMC or 
protein and perform quantification only on the selected PMCs for a faster result. This 
latter option also graphically reports additional metadata regarding the quantification 
(relative ratio, the chromatographic profile of the extracted signal and final integrated 
spectra for the unlabelled and labelled signals) to allow the user to browse through and 
assess quantification performance visually (see Section 0). In either case, although most 
relevant for the Process All option, initiating quantification processing displays a 
processing overlay with a progress bar and (for advanced users) the current distribution of 
CPU effort between data extraction via the file worker threads and quantification via the 




Figure 2-II. User Interface Screenshots. A: Initially presented blank table. B: Raw file selection dialog. C: Raw file pre-indexing progress. D: 
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2.4.2 Loading Data and Pre-Processing 
Raw spectral data files are pre-indexed before quantification begins to improve spectrum 
retrieval speed during the quantification process. HeavyMetL loads the scan header data 
(see Section 2.2.2.1) into memory along with a byte reference to the within-file location of 
the spectral data so that information such as scan number, MS level (e.g. MS1) and RT are 
quickly accessible, while the much larger spectral data structure is only loaded if 
necessary. If there is no byte index at the end of the raw data file, one is constructed by 
mapping all scan headers within the file – while this delays indexing, it is necessary for 
efficient navigation of the file during quantification. HeavyMetL further cross-references 
MS1 headers as a linked list, such that each header records the index of the previous and 
next headers (raw data file indices, while consecutive, are not guaranteed to be continuous 
if, for example, intervening MS2 data were removed during conversion of the raw data file 
to an open format). This allows processing to quickly iterate through consecutive spectra 
within a RT window without having to advance scan number by scan number, checking to 
see if each is present, or having to unnecessarily load non-relevant MS2 (or MS level) 
data. 
After file indexing is complete, the list of PMCs is loaded from the user-supplied text 
table. This file is cross-referenced to the selected raw data files while loading to calculate 
a RT for each PMC in each file based on what on information (MS1 or MS2 Scan number 
or RT) is provided in the PMC list. HeavyMetL will attempt to quantify PMCs across all 
input raw data files; allowing for chromatographic RT shift within a window (default 30 
s); it is assumed that files will have comparable gradient conditions and chromatographic 
performance (necessary both for PMC matching between raw data files and to minimise 
differences in performance of the quantification algorithm). This assumption is not 
unreasonable; it is generally considered good practice to analyse runs from the same 
dataset sequentially and chromatographic differences in the hands of experienced 
operators are minimal. Even in the case of technical issues mid-sequence (e.g. replacement 
of part of the LC system between runs), if the chromatographic run parameters are 
unchanged then a shift of more than 5 minutes would be very unusual. 
If the samples are pre-fractionated, corresponding fractions across samples can be 
analysed together but analysis of multiple fractions across multiple samples is currently 
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unsupported, as there is no method for defining which runs correspond to each pre-fraction 
(and thus limiting RT-matching to within a fraction group). If the PMC list is based on 
identification runs separate from the main quantitative dataset, these raw data files must 
also be included in the input. 
For raw data files in which the PMC does not have a directly corresponding MS2 spectrum 
(and thus MS1 RT), the RT must be predicted. RT prediction has a wide range of possible 
approaches (Table 2-IV) but most quantification software uses some variant of cross-run 
matching with various levels of sophistication. In the case of HeavyMetL, a simple cross-
run matching approach is implemented using the average of RTs from raw data files in the 
analysis where RT data is known. 
 
Table 2-IV. Options for Matching PMCs Between MS Runs. 
2.4.3 Definition of Analysis Parameters 
Before processing, the user may also define parameters relevant to the quantification via 
the Settings dialog: any fixed modifications (by default, carbamidomethylation of 
cysteine), the windows for mass error (default 10 ppm) and RT (default 30 s), the 
maximum unlabelled/labelled apex RT difference (default 12 s), and the expected range of 
the label incorporation percentage (default 10%-95% 15N). HeavyMetL does not consider 
96%+ incorporation by default (although the user can change this if they anticipate a very 
high level of incorporation) in order to avoid confusion with unlabelled co-eluting 
Method Required prior knowledge Accuracy
In-run MS2 data None Exact
Cross-run comparison
(same LC setup)
MS2 data collected from previous 
runs of sample
Good (variance depends on 
sample and LC reproducibility)
Computational based on existing 
data / Machine Learning




(differences in LC setup)
Published data Moderate-Poor
De novo  prediction
Published RT constants, for 
example Meek, 1980
Poor
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peptides in the expected mass range of the fully labelled target peptide. The default 
settings are expected to give good performance in most scenarios, assuming relatively 
modern instrumentation (2005 onwards). 
2.4.4 Quantification Processing 
HeavyMetL breaks down the processing of each PMC in the supplied list (and 
corresponding RTs) into two stages. Firstly, a mini-dataset for the PMC in each raw data 
file is assembled, comprising a set of theoretical distributions across the range of potential 
15N incorporations, and a minimal set of MS1 data extracted from the raw data. Secondly, 
each mini-dataset is analysed to quantify the labelled and unlabelled 15N isotopologue 
envelopes. For the labelled distribution, the process of quantification also involves 
identification of the 15N incorporation whose corresponding distribution gives the best 
match to the data. This allows processing capability to be divided between the retrieval of 
spectra from the raw data files (which involves a lot of disk activity), and the calculation 
of quantification results (which is processor intensive). 
HeavyMetL is multi-threaded, in that multiple sequences of operations are executed 
simultaneously, to make optimal use of modern computer processor capabilities. Threads 
are implemented via the WebWorker HTML standard 
(https://html.spec.whatwg.org/multipage/workers.html), which is effectively a JavaScript 
in-browser implementation of multi-threading. Processing is split between a ‘main thread’ 
and two groups of processing threads, firstly a set of ‘file workers’, each assigned to 
handle disk access for a particular raw data file, and the second a pool of ‘quantification 
workers’ which handle the calculations to quantify individual PMCs within a set of 
spectra. 
The main thread is responsible for displaying the user interface, co-ordinating access to 
raw data files via file workers, loading the list of PMCs to be analysed and coordinating 
the exchange of data between the file workers and the quantification workers. After 
processing, the main thread also handles generation of graphics for display of results and 
synthesis of peptide/protein export tables. 
To begin processing, the main thread constructs a list of the PMCs to be analysed in each 
file. PMCs are sorted in order of ascending RT. Theoretical distributions are generated for 
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each PMC for both the unlabelled and possible labelled incorporation levels using the 
algorithm described by Kubinyi (see Figure 1-XXIV) (167). The input peptide sequence is 
parsed to gather information about the frequency of each amino acid, then the total 
number of carbon, hydrogen, nitrogen, oxygen and sulphur atoms are calculated. For each 
PMC, a set of ‘extractions’ is generated, where one extraction defines the theoretical m/z 
values (and associated expected proportionate intensities) for a particular 15N 
incorporation level (including the unlabelled case) and thus, in combination with the m/z 
Error Tolerance parameter, defines m/z windows from which signal intensity should be 
‘extracted’ from the observed spectral data. To save memory, the extraction data are only 
retained as long as is necessary to process the associated PMC in every file for which it is 
to be quantified. Each extraction has a corresponding uses counter which is initially set to 
the number of files in which the PMC is to be quantified and decrements by one every 
time the extraction is applied for a new file; when zero, the extraction data are deleted. 
The theoretical distribution code was tested for bugs by comparison with IDCalc, an 
existing implementation of the Kubinyi approach 
(http://proteome.gs.washington.edu/software/IDCalc/). 
A ‘quantification task’ dataset is created for each PMC to be quantified in each file. A 
quantification task comprises all the elements required to perform quantification on a 
single PMC in a single file. The main thread fills in the starting information which 
comprises the full PMC-to-be-quantified definition - the protein, peptide, charge, 
modifications, file name, closest RT, and RT extraction window (first and last scan 
number). While some of this information (such as protein name) is not necessary for 
quantification itself or is implied by the handling file worker (e.g. the raw data file name), 
it is required later to combine the results of individually processed tasks into peptide- and 
protein-level quantification across files. 
The set of tasks is then passed to the file workers which, for each PMC, pair this data with 
the set of extractions generated by the main thread, and then retrieve and add the spectral 
data (Figure 2-III). For each quantification task, the set of MS1 spectra falling within the 
RT window around the RT of the PMC must be retrieved, which involves both reading the 
data from the raw data file and then decoding the data into a set of m/z-intensity pairs. The 
complete spectra are cropped to a relevant mass range according to the extractions. By 
delegating access to each file to a separate thread, HeavyMetL ensures that disk access 
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(data can only be loaded from one disk location at a time) is not wasted while spectra are 
being decoded from the raw data. To avoid performing many time consuming short reads 
of the raw data file to extract individual spectra, the RT windows of multiple 
consecutively queued PMCs are combined to form a single large RT window 
corresponding to a large continuous block of raw data (since the PMCs are sorted by 
retention time), which can be loaded from disk in a single read and then accessed in 
memory as each PMC is processed in turn. 
These optimisations help to prevent file access becoming a bottleneck for quantification 
by minimising the time that the disk is idle (not loading data from a file). Furthermore, 
uncropped full spectra from previous quantification tasks are not discarded until the 
current quantification task RT window has moved past them (in order to avoid repeating 
the work of decoding the data to m/z-intensity pairs). Since the PMCs are sorted in order 
of ascending RT, once the extraction window has ‘moved on’, spectra outside the window 
can be safely discarded. 
Once the spectral data have been added, the quantification task is ready to be passed to a 
quantification worker for the calculation of a result. Due to the optimisations described 
above, the time taken by the file workers to retrieve all the spectra necessary for each 
quantification task is quite variable. If the file workers were to wait for each task to be 
passed to a free quantification worker before beginning the retrieval process for the 
spectra needed by the next task, a lot of disk access time would be wasted. If the file 
workers retrieve spectra and generate quantification tasks as quickly as possible, however, 
a different problem arises. When a series of tasks can be processed by the file workers 
very quickly (due to substantial RT overlap minimising the retrieval of new MS1 spectra 
from each raw data file), or the tasks currently being processed by the quantification pool 
are particularly time consuming, then a large number of quantification tasks may ‘pile up’ 
waiting for a free worker thread. Storing even the cropped spectra for many tasks can 
cause memory usage to rapidly balloon. 
This problem is resolved by a buffered scheduling system (Figure 2-IV). When a file 
worker completes preparation of a quantification task, if there is a free quantification 
worker, the scheduler in the main thread immediately assigns the task for processing. If all 
quantification workers are busy, the task is held in a first-in-first-out queue (of equal 
length to the quantification worker pool) allowing the file workers to proceed with 
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retrieval of the spectral data for the next PMC. The ‘ballooning memory’ issue is 
mitigated by applying a maximum length to this queue; file workers attempting to add to 
the task queue when it is already full are instead held in a second queue (also first-in-first-
out); the file worker does not proceed with further spectral retrieval until the quantification 
task can be moved to the queue proper.
 
 
Figure 2-III. HeavyMetL Pre-processing and Data Extraction. When quantification is started (rightwards from the double solid border after 
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Figure 2-IV. The Buffered Scheduling Queue. A: If there are remaining slots in the task queue, quantification tasks (blue hexagons) can wait for 
a worker in the quantification pool to become free while the file worker that created them is free to continue with further extraction work. B: if 
the task queue is full, both quantification task and file worker must wait for a free slot in the queue before the file worker can proceed with 
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The quantification workers, on receiving a task, perform a series of steps for each possible 
theoretical distribution, for each labelling state; first for the unlabelled signal (a single 
theoretical distribution), then for the labelled signal (a range of theoretical distributions). 
In each cropped MS1 spectrum the signal intensity is summed within a mass error window 
(default 10 ppm) around each isotopologue. If this is the labelled signal, it is possible that 
some of the unlabelled signal isotopologues may have m/z values very close to those of the 
theoretical labelled signal isotopologues for low 15N incorporation values. To prevent the 
matching algorithm accidentally matching the isotopologue ‘tail’ of the unlabelled 
distribution, the mass range of the matched unlabelled isotopologues (step 2) is excluded 
from further matching. This avoids a mis-matching of the labelled distribution to parts of 
the unlabelled signal. The search window for the labelled signal is also restricted to a 
smaller retention window around the recognized unlabelled apex (the maximum 
unlabelled/labelled apex RT difference, by default 12 s). 
Next, the extracted spectra are matched to the theoretical distributions. The first approach 
I tried at this point was to use every spectrum in the retention time window, and for each 
spectrum to try matching without one of the isotopologue masses (‘leave-one-out’) on the 
assumption that the other isotopologues were unaffected. This approach generated results 
with a number of problems. The algorithm frequently returned a match that was not part of 
the elution peak of the heavy signal but, instead, was a noise or interference mismatch at 
one or other extreme of the retention time window. Additionally, for lower 15N 
incorporation levels where there are many isotopologues to be monitored, an interfering 
co-incident peptide m/z will be part of an isotopologue distribution that will also interfere 
with many other isotopologues in the matched distribution. The leave-one-out approach 
scales poorly to leave-many-out since at this point one is discarding most of the 
isotopologue distribution and matching to theoretical spectra with only a few data points. 
I found that a better solution was to ignore the lowest theoretical intensity isotopologues, 
ranking highest to lowest intensity and discarding any past a certain percentage (default 
70%) of cumulative total intensity. I then generated a ‘scaled spectrum’ by finding the 
isotopologue with the smallest ratio between observed intensity and predicted proportion, 
and scaled up the theoretical distribution by this ratio. This produces a spectrum with the 
same proportions as the theoretical distribution where at least one isotopologue is the same 
intensity as in the observed spectrum, while the other isotopologues may be more intense 
Chapter 2: HeavyMetL: A Program to Analyse 15N-Labelled Proteomic MS Data 96 
but they can never be less intense (following the assumption that co-eluting interfering 
peaks may add to the intensity of some isotopologues but will never subtract; Figure 2-V). 
In essence, this is an estimate of the minimum possible intensity associated with the 
labelling state currently under consideration (assuming the current theoretical distribution 
is the right one) at all points over the retention time window. The total intensities of the 
scaled spectra are used to locate chromatographic intensity maxima within the retention 
time range, but not for actual matching to the theoretical spectra. Instead, having located 
maxima, the corresponding non-scaled spectrum at each local maximum, and one 
neighbouring spectrum on each side are summed (to enhance the signal-to-noise ratio) to 
give a ‘signal-enhanced’ maximum spectrum, and these ‘signal-enhanced’ spectra are 
matched against the current theoretical distribution. This ensures that matching is 
performed using all isotopologues, but only at the points during elution when the signal 
was highest. Under the assumption that the noise specific to single isotopologues will be 
primarily additive (i.e. overlap of co-eluting signals) rather than multiplicative (e.g. 
variable ionisation efficiency), then this strategy aims to minimise such noise by using the 
least affected isotopologue to locate the point at which the true signal is strongest. 
The actual difference between the ‘signal-enhanced’ maximum spectrum and the 
corresponding theoretical distribution is measured by a Similarity Score based on the 
Kullback–Leibler Divergence between the observed and theoretical isotopologue 
distributions (194). The choice of Similarity Score was a key element in the development 
of the HeavyMetL algorithm; the score used was selected from among a number of 
potential candidates based on experimental results; this work is discussed in detail in 
Chapter 3. 
Across all compared theoretical distributions at all local maxima, the highest scoring 
maximum-theoretical distribution pair is taken to be the elution peak apex for the current 
label state. The reported incorporation level and intensity for this unlabelled or labelled 
apex then defines the incorporation level of the matched theoretical distribution, and the 
total intensity of the scaled maximum spectrum (without neighbour summing) respectively 
(Figure 2-VI). The unlabelled and labelled peak apexes are located independently, which 
ensures the only assumption made regarding the degree of co-elution of labelled and 




Figure 2-V. Fitting a Scaled Theoretical Spectrum to Observed Data. The use of a scaled spectrum reduces the effects of co-eluting co-incident 
mass species.
Scaling isotopologue (black line 
and red line same height) – has 
lowest ratio to corresponding 
theoretical proportion
Observed intensity higher than 
expected for other isotopologues 
suggests co-eluting noise.
Isotopologues that do not 
contribute a substantial 
amount to total intensity 
(below shaded area) are 
not considered for the 
scaling isotopologue, so 
are not used to locate 
chromatographic maxima, 
or for fitting the final 
scaled spectrum (but are 




Figure 2-VI. HeavyMetL Quantification. The ‘Quantification’ section is handled by quantification workers, then the data are passed back to the 
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Protein-level results are calculated based on only those PMCs flagged as ‘contributing’ to 
their parent protein in the input file (see Table 2-II). In each file, all the PMCs contributing 
to each protein are collated.  For each protein, the ratio reported is the median ratio of 
contributing PMCs, and likewise the label incorporation level reported is the median label 
incorporation percentage of contributing PMCs. Taking the median values rather than the 
mean avoids skewed quantification in the case of severe mis-quantification of a single 
PMC. 
The total run time for quantification of all PMCs mainly depends on computer hardware 
configuration, dataset size, quantification parameters and processor and memory pressure 
from running processes during analysis (there will also be some differences in 
performance due to the choice of web browser). Since files are processed in parallel, 
analysis time does not grow linearly with the number of raw files, but in general an 
analysis of two conditions in triplicate (six raw data files) on relatively modern hardware 
will generally be completed in about an hour or less. For a ‘real world’ example, see 
Section 4.2.2 below. 
To further examine the relationship between dataset size and analysis time, I analysed an 
increasing number of clones of a single 1.5 GB raw file (the ‘unlabelled’ Ostreococcus 
tauri sample from Chapter 3; see Section 3.4) against a list of 1042 unique, high-
confidence PMCs (for details, again see Section 3.4), and timed how long quantification 
processing took with default settings (this does not include the time taken to pre-index the 
files, typically less than a minute).These runs were conducted on an Apple MacBook Pro 
running macOS 10.14.6; 2.7 GHz Intel Core i7 with 8 logical processors; 16 GB RAM, in 
Firefox v. 69.0.1. The results are shown in Figure 2-VII. The data highlight the 
effectiveness of the measures taken to avoid duplication of effort for multiple files; 
although calculation of many theoretical spectra for a number of PMCs is computationally 
expensive, the additional overhead from processing additional files is minimal. The 
processing time increases linearly with file number, taking approximately 2 extra minutes 
for each additional file.  Despite the MacBook having only 16 GB RAM, 30 raw files (~45 
GB data) were processed without issue. 
This analysis is admittedly somewhat artificial. The single raw file that was ‘cloned’ (to 
ensure differences in processing time were purely due to the number of files analysed) for 
this analysis comes from a genuine dataset. In truly ‘real’ datasets, however, the files will 
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be more diverse, and file-to-file differences may affect processing time. Such issues are 
not considered by this analysis. For an alternative example of timing on a ‘real’ dataset, 
see Section 4.2.2 below. 
 
Figure 2-VII. Processing Time versus Number of Files. Various numbers of clones of a 
raw EML MS data file (see text for details) were analysed by HeavyMetL (x-axis) and the 
time taken to complete processing was measured (y-axis; times in minutes). The number of 
files at each point is also shown above the point. 
2.4.5 Result Display 
Graphics are drawn dynamically using the canvas HTML element. A third-party 
JavaScript library (fabric.js; http://fabricjs.com/) was used to abstract much of the 
underlying complexity for ease of use. Overview figures are displayed for both single 
PMC level quantification and protein level quantification summary according to which 
row in the protein/PMC table is selected. The PMC level graphic shows (Figure 2-VIII L-
R top row) the relative quantified intensity of the unlabelled and labelled signals and the 
corresponding extracted intensity chromatograms and matched apex spectra (Figure 2-VIII 
bottom row). The protein level graphic shows a scatter plot for the incorporation level and 













0 5 10 15 20 25 30








































Chapter 2: HeavyMetL: A Program to Analyse 15N-Labelled Proteomic MS Data  101 
protein-level statistic is shown as a black diamond while the first few letters of the 
sequence of individual PMCs are shown in light grey to illustrate the distribution of results 
(Figure 2-IX). The design of both overview displays is to highlight when quantification 











Figure 2-VIII. Graphical display of Results at the PMC-Level (Next Page). The PMC 
identity (sequence, modification state, charge) is shown above the figures. Top Row: 
Relative label intensity (left, showing each sample as a bar on the x-axis vs. intensity on 
the y-axis) and extracted chromatogram (right, with retention time on the x-axis vs. 
intensity on the y-axis), showing the time of each label peak maximum finally selected by 
HeavyMetL. The red line indicates the time of the MS2 scan that led to PMC identification 
(when applicable). Bottom Row: The peak maximum spectrum used for quantification of 
the unlabelled (left) and labelled (right) signal, showing the m/z value on the x-axis vs. 
intensity on the y-axis. Red lines indicate the distribution of the scaled fitted theoretical 
distribution and where the observed intensity was greater or less than expected. The width 
of the red lines (ignoring the T-piece at the top, which just serves to highlight the end of 
the line) indicate the m/z extraction windows based on the user-configurable ppm error. 
Only isotopologues equal or greater in height than the grey shaded areas are used for 





Figure 2-IX. Graphical display of Results at the Protein-Level. Left side: Protein Log2 Ratio (Unlabelled/Labelled) indicated by black 
diamonds. Right side: Label Incorporation Level (%) indicated by black diamonds. In both figures, protein values are taken as the median of all 
contributing peptides - these are shown in light grey to illustrate the spread of the data.
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2.5 Conclusions 
The HeavyMetL quantification approach is similar to the strategy employed by other 
‘theoretical-distribution matching’ approaches, particularly Protein TurnStILE, but is 
substantially different from the ‘ratio-only’ approach (e.g. Protover) or the hybrid strategy 
employed in ProteinTurnover. As described throughout this chapter, in addition to 
interface usability and robust quantification, specific consideration was given to algorithm 
memory usage and speed 
While the choice of a browser platform resolved the question of installation difficulty and 
facilitated implementation of a ‘clean’ interface that is consistent across operating 
systems, this choice also applied limitations in terms of speed and, especially, memory. A 
number of careful optimisations such as the task-scheduling queue system were 
implemented to minimise memory usage, but as the number of raw data files in an analysis 
increases, memory pressure will inevitably grow. The memory optimisations ensure this is 
unlikely to be relevant for the analysis of a modestly sized dataset in the case of an 
average researcher. High-throughput proteomic specialists, however, who frequently 
analyse 200+ raw data files simultaneously, may run into browser-imposed limitations 
(either on memory space or number of concurrent WebWorker threads) when attempting 
to perform similarly scaled experiments in HeavyMetL. These limitations may usually be 
avoided by configuration of browser internal settings (typically accessed via the 
about:config address), but precisely how these limitations may be overridden is subject to 
frequent change in both Mozilla Firefox and Google Chrome. In some cases, it may be 
necessary to break down the analysis in order to limit the number of simultaneously 
analysed files. 
Nonetheless it is important to stress that this issue is not unique to HeavyMetL. Large scale 
analyses in proteomic software packages (and indeed analyses of very large data files in 
general) frequently require some re-configuration of the program to increase memory 
limits. Java-based programs, for example, often require that the memory space assigned to 
the Java runtime at program start (the ‘heap size’) is manually re-configured for large data 
sets. Ultimately, assigning a substantial proportion of system resources to any program 
will impact the performance of other programs and system responsiveness. Most datasets 
will be modestly sized, and it is reasonable that for general use, a quantification package 
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should be expected to ‘play nice’ with other programs. If the user wishes to analyse a very 
large dataset or improve processing speed at a cost to other running processes on the 
computer, a requirement for specific manual assignation of extra resources (e.g. memory, 
CPU time etc.) is a sensible precaution, ensuring that standard operation of the program 
does not degrade system performance. In this regard, HeavyMetL is no different to other 
proteomic analysis platforms. 
It is reasonable to conclude that HeavyMetL is a successful implementation of a solution to 
the issues described in Section 1.2.3 and further formalised as requirements in Section 
2.2.2. Analysis of a typical modestly-sized dataset is acceptably fast on modern 
computers, provides reasonable analysis times, and the in-browser nature of the interface 
makes access and use of the tool straightforward. 
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Chapter 3: A Comparison of Spectral 
Similarity Assessment Methods 
3.1 Introduction 
The HeavyMetL algorithm described in Chapter 2 relies on a measure of spectral similarity 
in order to identify the theoretical distribution that best matches the isotopologue pattern 
observed in the raw data, a process I will henceforth refer to as ‘incorporation assessment’. 
Spectral similarity comparison methods are often formulated in terms of a measure of 
‘distance’ between a target entity and one or more of comparison candidates– the most 
similar comparison is the one with the smallest distance. Alternatively, similarity may be 
formulated in terms of the likelihood that two entities are the same, in which case the goal 
is to find the comparison with the highest likelihood. Examples of both approaches are 
common in regression analysis (fitting a statistical model to a data set); common methods 
include ‘Least Squares’ (minimising the sum of squared differences) and ‘Maximum 
Likelihood’ (maximising a likelihood function). From a numerical optimisation view both 
comparisons are equivalent problems, for example maximum likelihood may be, and often 
is, computed by finding the lowest negative (log-)likelihood. As well as different 
‘optimum’ values in typical formulation, comparison methods may have different ranges 
(e.g. 0 to 1, 0 to infinity etc.). For consistency throughout this chapter I will discuss 
spectral comparison in terms of spectral Similarity Score (SS) with a range of 0 to 1, with 
1 being the optimum value achieved with perfect similarity. The various comparison 
methods discussed will be transformed to a corresponding Similarity Score when 
necessary. 
In the context of the HeavyMetL algorithm, incorporation assessment involves creating a 
series of theoretical isotopologue distributions representing the peptide molecule with a 
range of 15N incorporation percentages (henceforth the theoretical distribution, “T”, set). 
The predicted isotopologue m/z values of each T distribution are used to retrieve 
corresponding intensities from the observed data within an RT window. Specifically, m/z-
intensity data distributions at each local total intensity maximum form the observed 
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distribution, the “O”, set, for that maximum. Each theoretical distribution of T is thus 
compared against multiple corresponding O extractions. 
Spectral comparison may be symmetrical or one-way. To calculate a Similarity Score, one 
may compare the relative intensities of all m/z values observed in either spectrum 
(symmetrical), or just the intersection (symmetrical), or consider one spectrum to define 
the valid m/z values for comparison and ignore non-matching m/z values in the other 
spectrum. For symmetrical comparison, the ordering of the two spectra (T vs. O or O vs. T) 
is irrelevant. In the case of 15N distribution matching, a one-way comparison is more 
appropriate since additional m/z values detected in the observed spectrum should not 
detract from match quality as they may originate from a co-eluting species or background 
noise. Failure to observe intensity at m/z values in the observed spectrum that are 
predicted to be present in the theoretical distribution, however, is an indication of less than 
perfect similarity. Furthermore, in the case of HeavyMetL, the theoretical distribution m/z 
values are the reference used for extraction of the m/z-intensity pair data from the 
observed spectrum, so it is most appropriate that the theoretical spectrum defines which 
m/z values are to be compared using the chosen SS. 
A number of mass spectrometry spectral similarity scoring methods have been defined in 
the literature; most successfully applied previous methods were compared by Toprak et al 
(195), in the context of fragment ion spectral comparisons for quality assessment in PRM 
and SWATH-style DIA analyses. Any spectral similarity measure will have advantages 
and disadvantages in the context of a particular MS application as the sources and 
distribution of interference from background noise, overlapping signals and transformation 
artefacts will differ. While, prima facie, matching an observed fragment ion spectrum to a 
theoretical distribution T or previously acquired spectral library entry is similar to 
matching an observed precursor isotopologue distribution to a predicted isotopologue 
distribution (as herein), in practice there are many differences (Table 3-I). 
Spectral matching of MS2 fragment ion spectra heavily penalises large differences 
between O-T/L pairs, particularly with regard to absence of high intensity peaks or 
unexpectedly high intensity peaks predicted/previously observed at low intensity, as these 
are the best indications of an incorrect match. They are not assessed in the context of 
finding the ’best’ match from a number of very similar comparisons, all of which are 
derived from the ‘correct’ PMC definition but at incremental percentage steps (e.g. 48%, 
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49%, 50% etc.) of 15N around the optimum match. A ‘good’ SS in our case should ideally 
have a clear maximum at the correct 15N incorporation (Figure 3-I) so that minor effects of 




Figure 3-I. Idealised Behaviour of a Similarity Score. For accurate and sensitive assessment of incorporation level the score should be maximal 
when and only when the spectrum is compared to a theoretical spectrum at the correct incorporation level. The smaller the relative increase in 
score when matching correctly, the greater the opportunity for noisy spectra to be mis-assessed, and the greater likelihood that mis-assessed 
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Table 3-I. Considerations of Spectral Distance Functions in Proteomic MS Contexts. 
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For HeavyMetL, the SS must value the proportional differences between precursor 
isotopologue ions very highly, in order to be able to determine the subtle changes induced 
by fractional increases in 15N incorporation, and to reject cases where the isotopologue 
distribution is highly contaminated by interference. In practice, the approach will have to 
cope with varying levels of background noise, levels of co-eluting interference, mass 
accuracy, effective mass resolution and intensity measurement precision. It is impractical 
to model these various parameters to create a theoretical dataset with any confidence of 
real-world applicability. While various comparisons between spectral similarity 
calculations have previously been made in other proteomic MS contexts (195, 196), the 
criteria on which they are judged were primarily designed to assess match plausibility, 
rather than picking a ‘best’ match out of a series of theoretical spectra, with a substantial 
proportion of very similar candidates corresponding to 15N incorporation levels close to 
the true value. Using these previous approaches and earlier 15N quantification work as a 
guide, I selected several representative options that seemed likely to be appropriate for the 
HeavyMetL algorithm and compared them via an experimental approach. 
3.2 Spectral Similarity Scores 
Given a set of mass values from a theoretical distribution (assuming a particular 15N 
incorporation level) T, each SS described below compares an observed distribution of 
intensities across those m/z values in O, and the predicted intensities of those m/z values in 
T. These are all one-way comparisons, predicated on the m/z values in T. Ion intensity is 
considered as a fraction of the total intensity (or sometimes, the most intense ion) so as to 
standardise differences in signal strength. Let n be the number of isotopologues with a 
non-negligible fraction of total intensity in T. Let Ti be the fractional intensity of the ith-
isotopologue in T, and Oi the fractional intensity of the ith-isotopologue in O. 
Previous ‘theoretical-distribution-matching’ 15N quantification approaches (see 
Introduction, Section 1.2.2) have relied on various formulations of a ‘Least Squares’ 
approach, which in essence is the minimisation of a spectral distance value based on the 
Euclidean Distance (between the fractional intensities of each Ti <-> Oi ion pairing (see 
Equation 1, below). An obvious modification to this method to emphasise the role of high-
intensity ions is to weight the contribution of each squared difference by the intensity of 
the observed ion (Equation 2). 
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 SS"#$ = 1	 −	)∑ (,- − 	.-)01-23     (Equation 1) 
 SS4"#$ = 1	 −	)∑ ,-(,- − 	.-)01-23     (Equation 2) 
The work of Toprak et al. (195) in assessing distance calculations for use when comparing 
fragment ion spectra suggests that angle-based (dot-product type) approaches perform well 
for analysis of MS2 data, particularly a normalised version of the Spectral Contrast Angle 
(197). This is a measure specifically designed to be sensitive to differences in relative ion 
intensity and thus is an attractive option for this work. The formulation given in Toprak et 
al. (Equation 3) is already normalised to the (0,1) range. 





     (Equation 3) 
The hybrid 15N quantification approach of Fan et al., while not making use of a spectral 
distance calculation directly, suggests a further approach. Their algorithm matches the 
composite of the unlabelled and 15N labelled distributions simultaneously using a 
maximum likelihood approach to locate the optimum composite distribution. This could 
also be re-formulated as minimising the Kullback-Leibler Divergence (194, 198). This 
measure is frequently used in information theory to represent the relative entropy between 
two probability distributions. In this case, it could be thought of as the information lost 
when a particular observed distribution O is used to approximate the theoretical 
distribution T whose m/z values were used to extract the isotopologue intensities in O 
(199). If T was close to the actual incorporation level of the signal, then the resulting O 
should be a good approximation of T with a low amount of information lost. The 
Kullback-Leibler Divergence itself ranges from 0 to infinity, so it is necessary to use a 
logistic transformation to yield a score in the desired (0,1) range (Equation 4). 








     (Equation 4) 
Note that in Equation 4, where Oi is zero, the i-th term as a whole is also zero (the limit of 
x log(x) as x approaches zero is zero). Ti can never be zero as T only contains 
isotopologues with non-negligible fractional intensity. 
The candidates considered are representative of three general approaches for assessing 
similarity; scalar distance (SSEUC/SSWEUC), vector angle (SSSCA) and information entropy 
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(SSKL). A fourth category of correlation-based candidates were considered, such as 
Pearson’s correlation coefficient (r) or the alternative nonparametric Spearman’s 
correlation coefficient (rho). They were not considered in this case, based on Toprak et 
al.’s demonstration that measures of correlation performed poorly for spectral 
comparisons in general. 
While transformation of the various comparisons to a consistent range does not guarantee 
that the scaling will be consistent within those ranges (one SS might tend to report values 
in the range 0.9 to 1 unless spectra were wildly different, while another might value the 
same set of spectra in the range 0.1 to 1), transformation ensures that the maximum and 
minimum values are always consistent which makes implementation easier (so, for 
example, the HeavyMetL code does not have to allow for an SS to be a negative value, or 
have infinite magnitude). 
3.3 Comparison of Similarity Scores Using Real-World 
Data 
I wished to compare SS performance to determine which produced the ‘best’ incorporation 
assessment results when HeavyMetL was run using each SS algorithm in turn. Such 
optimisation might be done using theoretically generated data, in this case generating 
theoretical distributions for a range of peptides at different 15N incorporation levels then 
applying a noise function to simulate real-world interference. However, this would be 
biased by any assumptions of the noise function (e.g. maximum relative noise to signal, 
degree of interference across masses, degree of noise uniformity). The characteristics of 
spectral noise are not well defined (195), and this is particularly the case here, where the 
precursor isotopologue distribution to be matched is an isolated m/z range divorced from 
the context of the full MS1 spectrum, given that noise is variable across typical proteomic 
MS m/z ranges of 0-2000 Th. I reasoned that a robust comparison could only be performed 
with real-world acquired data. 
There is a downside to such an approach, when compared to theoretical data, in that in the 
latter case the exact ‘true’ incorporation is known. In a real-world context, even if cells are 
cultured to a target 15N incorporation level, there are a number of challenges. Firstly, 
100% pure 15N salts (for the growth media) are impractically expensive; the purity of 
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typically available salts is in the range of 98-99%. This means the true incorporation level 
of peptides will be slightly lower than the experimental target (even assuming the growth 
media has been mixed to a precise level of 15N incorporation without pipetting error). 
Secondly, peptides in incompletely labelled samples have been shown to display 
considerable variance even when efforts have been made to ensure that labelling time was 
sufficient to ensure a stable label incorporation level (200). It is likely that much of this 
variance is technical in nature (lower intensity peptides experiencing higher signal-to-
noise, higher mass peptides splitting their signal among more isotopologues giving more 
data points for incorporation estimation). The possibility of biological effects such as 
differences in parent protein synthesis rates resulting in different unlabelled/labelled 
elemental incorporation bias cannot be entirely discounted, however. It is therefore 
necessary to use a robust calculation of the calculated peptide incorporation distribution 
centroid as an estimator of the actual 15N incorporation level. All of these challenges apply 
equally to any genuine 15N labelling experiment; however, it is reasonable to assume that a 
SS which performs well under these conditions will (generally) perform well in real 
incorporation studies. 
In collaboration with Dr. Sarah Martin at the University of Edinburgh, an experiment was 
designed to assess the performances of each the four SS measures. Dr Martin performed 
the sample preparation and MS analysis work (see Section 3.4, below). The data 
processing, quantification with HeavyMetL and subsequent analysis of the results are my 
own work. 
Dr. Martin and I designed an experimental Ostreococcus tauri dataset consisting of an 
unlabelled sample and 3 labelled samples with different target levels of 15N labelling at 
40%, 50% and 60% 15N (Figure 3-II), henceforth known as Samples A, B and C 
respectively. O.tauri is a green algae and one of the smallest (in physical size) known 
eukaryotes (201). It is frequently studied as a model organism for metabolic cycles such as 
circadian rhythm. It is relatively easy to culture and label by EML. Furthermore, 
proteomic MS time-courses using 15N labelling have been extensively described (159, 
160, 202). 
The levels of labelling were selected such that the resulting precursor ion distributions 
would be maximally dissimilar to any unlabelled contaminating precursors that might 
originate from sample preparation (such as Human Keratins), providing the best 
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assessment of spectral distance measure performance. As incorporation approaches 
unlabelled (isotopologue distributions at <20% 15N) or fully labelled (isotopologue 
distributions at >80% 15N) the precursor distributions would be very similar to the 
distribution of (unlabelled) contaminant precursors with the same mass, which could be 
selected instead by the matching algorithm (see Figure 1-XXII-D). The apparent 
performance at those incorporation levels could thus be artificially inflated by matches to 
contaminant peptides. A step range of 40, 50, 60% was an acceptable compromise to 
minimise this risk while examining performance over an incorporation range. 
The PSM list for analysis was obtained by contemporaneously analysing an unlabelled 
O. tauri sample with the same sample preparation step and LC gradient conditions, so that 
features could be matched across runs by RT. There were three reasons for this approach. 
Firstly, this avoided differences in PSM identification from different samples, so that the 
same PMC list was analysed in each case. Secondly, incomplete EML labelling of 
peptides substantially increases the complexity of peptide-spectrum matching (even in 
cases where the actual incorporation level is known in advance, which is only possible in 
the case of complete labelling with very high purity 15N sources) and produces fewer 
identification results than searching unlabelled data. Thirdly, the expected usage scenarios 
for HeavyMetL involve either samples containing only labelled peptides (at unknown 
incorporation) with a contemporaneously analysed unlabelled PMC identity reference 
sample as is the case here, or the presence of fully unlabelled peptides in each of the 
samples to be analysed (a typical abundance-comparison design). The latter design would 
likely produce more easily quantified data; the unlabelled signal RT apex is easier to 
locate (there is only a single possible incorporation level to be tested), and the presence of 
an unlabelled signal RT apex in-run may be used to narrow the search window for the 
labelled signal apex. It is necessary, however, for the Similarity Score to perform well in 
both scenarios. I chose to refine my selection of Similarity Score on the more challenging 
experimental scenario to hopefully accentuate any performance differences between the 
candidates. 
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Figure 3-II. Experimental Design for Similarity Score Assessment. The unlabelled sample 
(in blue) was not used directly in the analysis of 15N incorporations but rather to generate 
the list of peptides for quantification (since direct identification of 15N labelled peptides is 
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3.4 Experimental Dataset Methods 
N.B. The Subsections 3.4.1 to 3.4.3 (inclusive) of this methods section are included for 
information but do not represent work undertaken by myself. They were performed by Dr. 
Sarah Martin, a collaborator at the University of Edinburgh. All data analysis subsequent 
to MS acquisition was performed by me, including post-processing (Subsection 3.4.4). 
3.4.1 Cell Culture 
Ostreococcus tauri OTTH059543 were cultured in 0.22 μm filter sterilized artificial sea 
water (Instant Ocean powder) at a salinity of 30 parts per thousand as described in Le 
Bihan et al., 2011 (159). Briefly, cultures were split weekly to 1 part in 50 to ensure 
continuous growth. In preparation for the experiment, cultures were passaged twice 1:50 
into media containing a mix of 14N sodium nitrate and 14N ammonium chloride (both from 
Sigma Aldrich, U.K.) and 15N sodium nitrate (98% pure) and 15N ammonium chloride 
(99% pure) (both from Cambridge Isotope Laboratories) mixed in appropriate ratios to 
give final combinations with 40, 50 and 60% 15N incorporation, and an additional 
unlabelled sample. Samples were cultured under a 12-hour daylight/ 12-hour darkness 
cycle at a constant 20 °C in a vertical environmental test chamber (MLR-350, Sanyo). A 
light intensity of 17.5 μEm2 s−1 was maintained using 724 Ocean Blue, Lee filter. Cells 
were grown for 8 days to an optical density of ~0.1 mm-1 at 600 nm in parallel with FACS 
(Fluorescence-Activated Cell Sorting) analysis (equivalent to approximately ~10 k cells 
per μL, or 700 μg protein per 100 mL). Whole cell lysate was sampled from each culture 
by centrifuging 30 mL culture (3200 g, 10 min) and washing pellets with 1 mL PBS 
before centrifuging again (12000 g, 5 min). Full pellet resuspension and cell lysis was 
achieved by pipetting up and down with 200 μL 2M urea. Samples were stored at 20 °C 
before digestion. 
3.4.2 Sample Preparation 
Samples were reduced with 12.5 μL each of 200 mM dithiothreithol and 1M ammonium 
bicarbonate for 30 min at room temperature. 12.5 μL of 500 mM iodoacetamide and 5 μg 
sequencing grade porcine trypsin (Roche, UK) were added for alkylation and digestion 
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overnight. 10 μL digest were diluted in 20 μL buffer A (97.5% HPLC grade water, 2.5% 
HPLC grade acetonitrile (both Fisher, U.K.), 0.1% formic acid (Suprapure Merck, 
Germany), cleaned on Stagetips, eluted in 10 μL buffer B (90% acetonitrile, 10% water, 
0.1% formic acid, 0.025% trifluoroacetic acid (sequencing grade, Sigma, U.K.)), vacuum-
dried (RC 10-10, Thermo Fisher, U.K.) and stored at -20 °C. 
3.4.3 MS Analysis 
Dried samples were re-suspended in 11 μL buffer A and analysed on a capillary-HPLC-
MS/MS system (1200 binary HPLC, Agilent, U.K., coupled to a hybrid LTQ-Orbitrap XL 
mass spectrometer, controlled by XCalibur v. 2.0.7, Thermo Fisher, U.K.) in 140 min. 
gradients. Capillary Picotip columns (10 cm x 360 μm o.d. x 75 μm i.d.) with a 15 mm tip 
opening and fitted with a borosilicate frit were purchased from New Objective (Presearch, 
UK). Fused-silica tubing was purchased from Composite Metal (UK). The reversed-phase 
bulk material used was 5mm Pursuit C18 obtained from Varian (UK). 
With buffer A as 97.5% water, 2.5% acetonitrile, 0.1% formic acid, and buffer B as 90% 
acetonitrile, 10% water, 0.025% trifluoroacetic acid, 0.1% formic acid, the solvent 
gradient program was as follows: 0% buffer B (0–12 min.), 0–5% buffer B (12–16 min.), 
5–15% buffer B (16–36 min.), 15–35% buffer B (36–80 min.), 35–100% buffer B (80–96 
min.), followed by 100% buffer B for 18 min. and back to 0% buffer B for 6 min. Prior to 
the analysis, a column/pre-column wash and conditioning step was performed consisting 
of a 1 h gradient of 0–100% buffer B over 20 min. followed by an isocratic conditioning 
step at 0% buffer B over 40 min. 
Data-dependent acquisition was performed with one profile-mode MS1 scan at 60 k 
resolution in the Orbitrap followed by five MS2 scans in the LTQ. 
3.4.4 Post-Processing 
The raw data were converted to mzXML format using the msconvert tool in the 
ProteoWizard suite (http://proteowizard.sourceforge.net/). MS2 peak-lists in MGF format 
were also generated from all samples using the same tool. The unlabelled sample peak-list 
was searched using Mascot Server (v. 2.5.1, Matrix Science) with the following 
parameters: fixed modifications = carbamidomethyl (C); variable modifications = 
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oxidation (M), acetyl (N-term); mass tolerance = 10 ppm; fragment mass tolerance = 0.1 
Da; max missed cleavages = 2; search database = Ostreococcus tauri UniProt reference 
proteome (retrieved 24/08/2016). The list of identified peptides was exported from Mascot 
in mzTab format and re-formatted for compatibility with HeavyMetL. Briefly, a new table 
was created based on the “PSM” rows in the mzTab file. The following columns were 
directly copied across (mzTab column names from the “PSH” row given first, HeavyMetL 
input names given second; see Table 2-II for details): “sequence” as 
“PEPTIDE_SEQUENCE”, “accession” as “PROTEIN”; “search_engine_score[1]” as 
“PEPTIDE_SCORE”; “charge” as “CHARGE”. The column “RETENTION_TIME” was 
added based on the mzTab “PSM” column “retention_time” divided by 60, the column 
“MODIFICATIONS” was added based on the mzTab PSM column “modifications” 
reformatted to Scaffold-style definitions, and the column “PROTEIN_DESCRIPTION” 
was added cross-referencing the protein accessions in “PROTEIN” to the “description” 
column in the mzTab “PRT” rows. Finally, the column FILE_NAME was added 
containing the file name of the unlabelled run, and the column 
“CONTRIBUTE_TO_PROTEIN” was added with a value set to TRUE for every row 
(irrelevant for analysis of this dataset as the data were considered at the peptide level 
only). Finally, the list was filtered to include only peptides with PEPTIDE_SCORE 
(Mascot Expect value) less than 0.001 to minimise the effects of mis-quantification due to 
incorrect sequences, yielding 1061 PMC entries, 1042 of which were unique. The list was 
analysed against all four raw data files (including the unlabelled sample for RT matching) 
four times with HeavyMetL, in which the SS was implemented as each of the four 
candidates shown in Equations 5-8 in turn. Default settings were used elsewhere, except 
for the ‘Maximum Peak Apex Shift’ parameter, which was set to the full extraction 
window of 30 s (samples A, B and C contained no unlabelled signals to be matched 
within-runs). This included the ‘Do Not Quantify Unlabelled Signal’ parameter being left 
as ‘false” despite there being no unlabelled signal in samples A, B and C; it is not 
necessary to change this parameter to true unless there is both no unlabelled signal and an 
extremely low level of 15N incorporation (<10%) is expected for the labelled signal. 
Quantifying any apparent unlabelled signal (e.g. from mis-matched co-eluting peptides) 
also prevents such signals being incorrectly matched as a labelled signal. 
Subsequent statistical analysis of results and generation of all figures was performed in R 
(v. 3.5.1). 
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3.5 Estimation of Average Sample Incorporation Levels 
While the labelled samples A, B and C were grown to fixed target incorporations, the 
‘true’ peptide incorporations were expected to be a distribution around an a priori 
unknown median, rather than a fixed point, due to 15N salt impurity, pipetting variance 
and, potentially, incorporation kinetics (see Section 3.3). Before analysing the data with 
HeavyMetL, I investigated a previously described method for estimating the average 
peptide 15N incorporation level in each sample without using cross-run matching of 
peptide identifications, based on a previously observed relationship between peptide mass 
and peptide Mass Decimal Residual (i.e. the fractional part of the mass value, henceforth 
MDR). This phenomenon was first described by Mann (203) and subsequently expanded 
into the Half Decimal Place Rule (HDPR) (204, 205). Informally, the HDPR observes that 
the first digit of the MDR is near the half of the first digit of mass values between 500 and 
999, near the half of the first two digits of mass values between 1000 and 1999, and near 
the half of the first digit of the mass values between 2000 to 3000, with various papers 
defining ‘mass’ as molar mass, molecular mass or (M+H)+; the relationship is observable 
on any scale and I use molecular mass in Da hereafter. When plotting MDR vs. mass , a 
characteristic series of diagonal bands are observed corresponding to a banded ‘wrapping’ 
of the linear relationship across the (0,1) MDR scale (see Figure 3-III-A for an example).  
HDPR has typically been used for quality control in MALDI-ToF analyses of peptide 
mass fingerprinting (identifying proteins based solely on peptide mass rather than using 
peptide fragmentation) studies (204, 205), although recently the approach has been applied 
to modern LC-MS/MS (206). Of particular interest to me was a 2010 study by Fetzer et al. 
in which the HDPR relationship was used to predict partial 13C incorporation in bacterial 
peptides (207). The Fetzer et al. approach first involves transformation of the banded 
MDR:Mass relationship to a linear Corrected MDR:mass relationship by identifying 
points associated with the ‘wrapped’ bands and correcting their MDR by adding a +1, +2, 
etc. correction factor across the bands. The data are transformed by a scalar rotation such 
that the bands are vertical in the y-axis. Specifically, peptide masses are rescaled as 
 Transformed	Mass = Mass − 1800 ∙ MDR 
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followed by k-means clustering to assign each point to a band. Using unlabelled and 
completely labelled standards, Fetzer et al. demonstrated that as the percentage of 13C 
incorporation increases from ~1% to 100%, the gradient of the Corrected MDR:mass 
relationship also increases. Using unlabelled and fully labelled standard samples for 
calibration, they were able to predict 13C incorporation based on the peptide masses of any 
similar sample. 
I applied a similar approach to two mass datasets. I first developed an analysis workflow 
on using a (partly) theoretical dataset based on 1042 unique, high-confidence (Mascot 
Expect value <0.001) PMCs identified in the unlabelled sample. Using the HeavyMetL 
isotopologue prediction algorithm, I calculated the expected masses of the most intense 
isotopologue for each PMC at natural 15N incorporation (~0.368%) and at 10-100% 15N 
incorporation in step sizes of 10. This resulted in 10 sets of mass values between 500 and 
3500 Da. There was one mass value greater than 3500 Da which would fall into a separate 
cluster, which was ignored to simplify analysis. I replicated the Fetzer analysis on these 
masses (and their corresponding MDRs), with some modifications. To avoid manually 
specifying a rotation scalar (chosen by Fezter et al. by eye) I instead transformed the data 
by Principal Component Analysis, which neatly separates the bands along one principal 
component (usually the first, although in the case of particularly noisy data it may be the 
second principal component) (Figure 3-III-B,C). Fetzer et al. then used k-means clustering 
to separate the rotated clusters. I found this approach to be insufficiently robust, frequently 
incorrectly splitting the clusters and that a more robust approach was to simply estimate a 
cluster separation threshold by density analysis of the principal component. I estimated the 
density along the axis with a cosine model to locate the density maxima, then took the 
half-way point between the maxima as a clustering cut-off (Figure 3-III-D,E,F). MDRs 
from the higher mass cluster were then corrected by adding +1 as in the Fetzer analysis 
(Figure 3-III-G) and I then calculated a gradient by linear fit for each 15N% step (Figure 
3-IV). As in the Fetzer work, I observed a strong linear relationship between 15N 
incorporation and the Corrected MDR:mass gradient, although in the case of 15N this 
correlation is negative while Fetzer et al. observed a positive correlation. On reflection, 
this is to be expected. The mass delta of 12C to 13C is ~1.0033 so increasing the percentage 
of 13C will, on average, raise the MDR. In contrast the mass delta of 14N to 15N is ~0.9970 
so increasing the percentage of 15N will decrease the MDR.  
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Figure 3-III. Transformation of Mass Decimal Residual Values. MDRs were transformed 
to allow linear analysis of their relationship with peptide mass. The data shown are the 
masses selected for MS2 in the unlabelled sample. A: Initial distribution of MDR vs. 
peptide mass for all masses less than 3500. B: Data centred and scaled (to unit variance) 
showing the calculated principal components. C: Data plotted on principal component 
axes. D: Density analysis of points along principal component 1. The red line indicates a 
cut-off point half-way between the two density maxima, partitioning the data by ‘band’ 
(orange and blue). E: Cluster assignment by density cut-off on principal component axes. 
F: Cluster assignment by density cut-off on original axes. G: Corrected MDR vs. mass 
(applying +1 to all MDR in orange cluster). 
Chapter 3: A Comparison of Spectral Similarity Assessment Methods 123 
 
Figure 3-IV. Mass to Corrected MDR Gradients across a Theoretical Dataset. Data 
shown are the masses of the highest intensity predicted isotopologue (at the percentage of 
15N incorporation shown above each panel) for the set of 1042 unique PMCs identified 
from the unlabelled sample. UL=Unlabelled sample, corresponding to a natural 
abundance of 15N (about 0.368%). A linear fit of gradient to incorporation was performed 
(lower right corner) demonstrating a linear relationship between the expected gradient 
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I then applied the same analysis to my experimental unlabelled and labelled data. I took 
the list of all precursor masses (i.e. those selected for MS2) reported in mgf peak-list files 
generated from each raw data file for the unlabelled sample and labelled samples A, B and 
C, transforming the mgf PEPMASS value for each spectral entry according to 
corresponding reported CHARGE. I made the assumption here that even in the case of 
partial 15N labelling, the vast majority of species selected for MS2 will still be sample-
derived peptides (as opposed to environmental protein contamination such as skin 
keratins, or non-peptide contaminant ions falsely recognised as peptides), even if the 
fragment ion spectra are not easily identifiable without knowing their incorporation. For 
consistency of analysis with the theoretical data above I also ignored mass values greater 







Figure 3-V. Corrected MDR to Mass Gradients using MS2 Precursor Masses. (Next Page) 
A: Precursor masses are shown for each sample: UL=Unlabelled sample, 
sA, sB, sC = labelled samples A,B and C. B: The Corrected MDR:mass gradients for 
unlabelled sample and samples A, B and C (labelled as above) are shown as blue dots on 
the same plot shown in the lower right hand corner of Figure 3-IV. While the gradients do 
apparently decrease linearly and (nearly) parallel the gradient predicted with theoretical 
data, the y-axis intercept is clearly different. C: Inferred relationship between UL and 
labelled samples A, B, and C, y-axis scaled for sample C. For example, if I estimate the 
true average 15N incorporation of sample A to be 20% (green vertical line), then as the 
incorporations values for B and C on the x-axis intersect their respective gradient lines at 
the same y-axis value (green horizontal line) this predicts samples B and C to be at ~28% 
and ~35% incorporation respectively (blue dotted lines). 
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The precursor mass data also showed an apparently linear decrease in Corrected 
MDR:mass gradient relative to the expected (i.e. target) incorporation in each sample 
(Figure 3-V-A). The ratios were not in the same range of those attained with the 
theoretical dataset (Figure 3-V-B), but plotting the Corrected MDR:mass gradients vs. 
Incorporation calculated from the theoretical prediction (based on only well-characterised 
PSMs from the unlabelled sample) showed that they appeared to be approximately parallel 
to the same gradient obtained using all precursor masses from the unlabelled sample and 
samples A, B, and C, the intercept of the  Corrected MDR:mass gradient axis intercept 
was clearly different, and it seemed unwise to assume that the gradient would nevertheless 
be the same. 
I felt it would therefore be inaccurate to attempt to directly predict the incorporation of 
labelled samples A, B and C assuming a linear relationship with the same parameters as 
that observed for the theoretical data, but it did not seem unreasonable to assume that the 
relationship was still linear, and therefore the inter-sample ratios of Corrected MDR:mass 
gradients between samples A, B and C should predict the corresponding inter-sample 
ratios of 15N incorporation. 
For example, the HDPR approach predicts ratios of 0.73 and 0.88:1 for A and B relative to 
C, thus in the case of sample C incorporation being 1% 15N, this predicts the 15N 
incorporation levels of samples A and B would be 0.73% and 0.88% respectively. This 
principle can be extended for any value of C (Figure 3-V-C). 
Since the original ‘target’ incorporation values would instead yield a ratio of 0.67:0.83:1 
for A:B:C, the HDPR-predicted pairwise ratios between all three incorporations 
(0.73:0.88:1) are larger than expected. Assuming that the true incorporation levels can be 
lower than or equal to the target, but not higher, then the model has to be constrained by 
sample C<=60 since taking sample A or B as the baseline for the ratio instead results in 
predicts incorporations for sample C that are greater than the target. Under this constraint, 
the HDPR estimation predicts that samples C and B will show a similar incorporation 
percentage point deficit while the percentage point deficit for sample A will be larger. 
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3.6 Similarity Score Evaluation 
I then analysed the list of 1042 unique, high-confidence (Mascot Expect value <0.001) 
PMCs identified from across Samples A, B and C using HeavyMetL. The analysis was 
repeated four times, using each of the candidate SS described above (Equations 5-8) in 
turn. 
The estimated peptide incorporations produced using each analysis are shown in Figure 
3-VI (top four rows). For comparison purposes, I also generated a random guessing 
baseline (SSRAND) consisting of an equal-length population of simulated incorporation 
quantification results. For each result I simulated the effect of the SS maximisation 
approach by generating a random number (between 5 and 20) of dummy chromatographic 
maxima each with a random SS uniformly distributed between 0 and 1, then taking the 
highest score value. This was then paired with a random incorporation estimate uniformly 
distributed between the minimum and maximum assignable incorporation levels (10% to 
95%) (Figure 3-VI, bottom row). 
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Figure 3-VI. Performance of Incorporation Level Estimators. Histograms of reported 
peptide incorporation levels are shown after calculation using four measures of spectral 
similarity (rows 1-4). For comparison purposes, a baseline result generated by random 
guessing (using a uniform distribution) is shown in row 5 (SSRAND). In each case the range 
of possible reported incorporations was 10-95%. Comparisons are shown for three 
different samples of O. tauri (A, B and C; left-to-right across grid columns) grown to 
target incorporation levels of 40%, 50% and 60% respectively. The actual attained 
incorporation levels were estimated by excluding the lowest quartile of reported 
incorporations by frequency (below the blue lines, these lines therefore also indicate the 
spread in terms of ‘full width at 25% maximum’) and taking the mean across all four 
Similarity Scores for each sample, shown as the red line overlaid through each column of 
the grid.  
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From the HDPR estimation I expected the true incorporation level for each sample to be 
several percentage points lower than the target due to impurities in labelled media, so in 
each sample I estimated a true rate as the mean of all measured labelled signal 
incorporations in the upper 75% of incorporations when ranked by relative frequency (to 
exclude the background of randomly distributed mis-quantifications, following a similar 
rationale to the FWHM estimation of peak width, see Figure 1-IV). To estimate the true 
mean, for each sample I took the mean of all four SS means, yielding estimates for 
labelled samples A, B and C of 34.4% 43.7% and 53.7% respectively. These estimates are 
shown for each sample as the red vertical lines in Figure 3-VI. The spread of reported 
incorporations around the estimated true incorporations was not substantially different 
between SS candidates when taking the corresponding standard deviations of the upper 
75% of peptide incorporations (as for the mean above), leaving little to choose between 
the candidates in terms of incorporation accuracy, although SSKL consistently gave the 
tightest spread (Figure 3-VII). 
 
Figure 3-VII. Standard Deviations of Reported 15N Percentage Incorporations. The 
coloured bars show standard deviations for the upper 75% of incorporation results when 
ranked by relative frequency.  
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Assuming the estimates for samples B and C were accurate, the incorporation estimate for 
sample A was several percentage points higher than the relationship between A,B and C 
predicted by the HDPR approach described in Section 3.5 (Figure 3-VIII); but closer to 
what would be expected with a constant deficit across all 3 samples of approximately 6 
percentage points. The simplest interpretation would be that this was indeed the case, in 
which case the HDPR-based estimation for sample A was not particularly robust given the 
sizeable error. 
 
Figure 3-VIII. Comparison of Incorporation Estimates by HeavyMetL and HDPR. The 
black line for each sample (UL=Unlabelled sample, sA, sB, sC = labelled samples A, B 
and C) indicates the relationship inferred by the HDPR approach. The y axis is scaled for 
labelled sample C (although the data could also be plotted scaled to sample A or B), such 
that if sample C takes a particular incorporation value, the x-axis value corresponding to 
that value on the y-axis indicates (for each sample) what the expected incorporation of 
that sample will be (thus the sample C line lies on y=x). The estimates obtained by 
HeavyMetL quantification are shown as vertical red lines, illustrating that assuming the 
sample C incorporation to be 53.7% as measured by HeavyMetL (green line), the HDPR 
approach (blue dotted lines) predicts that the sample B incorporation to be ~44% (in close 
agreement with the HeavyMetL result) but the sample A incorporation to be ~31% rather 
than closer to ~34-35% as predicted by HeavyMetL.  
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3.7 Standardisation of Incorporation Quantification 
Errors 
In order to evaluate the quality of results produced by each SS candidate, it is necessary to 
define a framework for comparison. The outcome of interest is the accuracy of the 
incorporation assessment reported by HeavyMetL when using each SS candidate, 
comparing each quantification result to the ‘true’ sample mean to get an error in 
percentage points. The size of the error is of interest, while the sign (positive/negative) is 
not; a positive error is no better or worse than a negative one. Since the ‘true’ 
incorporation values are not known (see discussion in Sections 3.3 and 3.5 above), the 
approximation I will use is the robust mean based on the upper 75% of the distribution of 
incorporation levels across all four SS (see Figure 3-VI). 
In order to compare errors between samples with different 15N incorporation levels, a 
method of error standardisation is necessary. Consider an incorporation range Xmin to Xmax 
and an incorporation quantification result x for a particular peptide. If x is produced by 
random draw between Xmin to Xmax with equal probability, the population X of x will be 
uniformly distributed. However, the incorporation percentage point error of x compared to 
the true (or estimated true) incorporation T is not necessary uniform because T may not be 
equidistant from both Xmin and Xmax. Furthermore, in other samples where T is different but 
Xmin and Xmax remain the same, the range of possibly quantification results either side of T 
is different. A standardised score allows combination of the results from labelled samples 
A, B, and C to compare SS candidate performance across all samples in aggregate (Figure 
3-IX). This requires that the percentage point errors from comparing the HeavyMetL 
quantification incorporation values to the estimated ‘true’ incorporations are transformed 
to a Standardised Incorporation Quantification Error (SIQE). 
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Figure 3-IX. A Standardised Incorporation Quantification Error. Such a score is required 
to directly compare incorporation percentage point errors between Samples A, B and C. 
Let [ be defined as the absolute (i.e. unsigned) percentage point error between the true 
incorporation and an observed incorporation, i.e. [ =|T – x|. Let a be the smaller of the two 
distances from true incorporation T to the limits of the incorporation range (Equation 5). 
Let b be the difference between a and the larger of the two distances from the true 
incorporation to the limits of the incorporation range (Equation 6). 
\ = min	^(.	 −	_`-1), (_`bc 	− 	.)d   (Equation5) 
e = max^(.	 −	_`-1), (_`bc 	− 	.)d − \   (Equation 6) 
When T is equidistant from Xmin and Xmax, b = 0 and a uniformly distributed population of 
random incorporations X will yield a corresponding distribution of absolute percentage 
point errors g that is uniformly distributed between 0 and a (Figure 3-X-A). When T is 
equal to Xmin or Xmax, a = 0 and a uniformly distributed population of random 
incorporations X will yield a distribution of [ (g) that is uniformly distributed between 0 
and b (Figure 3-X-B). In every other case T will be closer to either Xmin or Xmax, therefore a 
uniformly distributed population of random incorporations X will yield a distribution of 
signed errors uniformly distributed between either -a and a+b, or -(a+b) and a. Because [ 
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is an absolute error, a random x yielding 0 ≤ [ ≤ a is thus twice as likely as a < [ ≤ a+b 
and the distribution of g is therefore not uniform (Figure 3-X-C). 
 
Figure 3-X. Distribution of Errors from a Random Estimator. Let [ be the absolute 
difference between the true incorporation T and an estimate of the incorporation x, i.e. [ 
=|T – x| If a population of random estimates X has uniform distribution, then the 
corresponding distribution of the absolute error g, depends on the position of T within the 
range of possible estimations Xmin to Xmax. Let a be the smallest difference between T and 
Xmin to Xmax. Let b be the difference between a and the largest difference between T and 
Xmin to Xmax (See equations 9 and 10, main text). A & B: If T is equidistant from Xmin and 
Xmax or equal to one or the other, then the range of absolute deviations is also uniform. C: 
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   (Equation 7) 
To obtain a SIQE I calculate the probability of achieving an error less than or equal in 
magnitude to that observed if one were to randomly select an incorporation estimate. This 
is the cumulative distribution function for g, which for a given error [ is the integral of the 
probability distribution function f([) (Equation 7) from 0 to [: 
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 (Equation 8) 
3.8 Comparison of SIQEs Between Similarity Scores 
To further differentiate the performance of the four SS candidates, I compared the ability 
of the methods to consistently assign a higher score to matches with low-error compared 
to matches with high-error. I combined the data from samples A, B and C, and removed 
zero-scored PMCs, for a total of 3108 score-estimate pairs for each of the four SS 
candidates (and a corresponding dataset of 3108 random score-estimate pairs in SSRAND). 
I first compared SS–SIQE relationships directly (Figure 3-XI-A). Regardless of SIQE, 
most score values were generally close to 1. This is a result of the scoring process 
selecting the ‘best’ (highest) score and is also reflected in the distribution of SSRAND. A 
mathematical explanation for this is given in Appendix III. The relationship between score 
validity and score, while monotonic for all four SS, would not necessarily have the same 
gradient shape. To enable a fair comparison, I transformed each score to a score rank 
(assigning rank 1 as the highest score) (Figure 3-XI-B,C). Comparing SIQE across score 
ranks, all four methods clearly outperformed random guessing, with a greater weighting of 
high scores towards low SIQE. Many apparent differences (such as higher general scores 
for SSWEUC) were removed by rank normalisation, showing that both Euclidean distance 
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Figure 3-XI. Comparison of Relationship between Similarity Score and SIQE. (Previous 
Page) A: Similarity Score (y-axis) vs. SIQE (x-axis). B: Similarity Score Rank (y-axis) vs. 
SIQE (x-axis). C: The distribution of SIQEs (shown via horizontal boxplots) of SS ordered 
by rank in bins of 25. The ‘boxes’ cover the 25th-75th percentile range (i.e. the 
interquartile range) in each case, and the whiskers extend 1.5 times the interquartile 
range in either direction, bounded by the plot limits. Each column of the figure 
corresponds to results for a particular SS candidate (or the simulated random baseline 
score) as indicated. 
I also examined the data for peptide composition-related differences in SIQE. The 
peptides analysed were drawn from a list of peptide-spectrum matches and therefore their 
characteristics are heavily biased towards features that favour identification by standard 
proteomics MS and are further constrained by the processing prior to MS analysis. For 
example, the peptides were produced by tryptic digest, so the vast majority will end in 
either arginine or lysine. I reasoned that any significant composition-related difference in 
SIQE would affect the relationship between SIQE and peptide length and/or the number of 
nitrogens the peptide contained, regardless of sequence. I did not observe any such 
patterns (Figure 3-XII), which suggested that (as expected) all the Similarity Score 
candidate scores were unaffected by peptide composition. 
Looking at the whole dataset it was difficult to tease out any further differences, but closer 
inspection of the binned data revealed both Euclidean distance methods showed a spike in 
mean SIQE at the highest score, suggesting that in some circumstances SSEUC and SSWEUC 
assign scores very close to maximum to mis-fitted data (Figure 3-XIII). 
Ultimately, I felt that the poor mean SIQE of both Euclidean distance measures at very 
high score rank weighed against their use in HeavyMetL, as applying increasingly 
conservative score thresholds should (ideally) always yield better quality data. Although 
the observed difference in performance was small, I selected the Kullback-Leibler 
Divergence-based score SSKL, as the better-performing of the remaining two SS 
candidates for use in the incorporation assessment part of the HeavyMetL algorithm 
 
 
Figure 3-XII. Comparison of Relationship between Peptide Characteristics and SIQE. A: Peptide length (y-axis) vs. SIQE (x-axis). B: Number 
of nitrogen atoms in the peptide (y-axis) vs SIQE (x-axis). Each column of the figure corresponds to results for a particular SS candidate (or the 
simulated random baseline score) as indicated.
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Figure 3-XIII. SIQE as a Function of Score Rank. The SIQE is shown as the mean SIQE 
value over bins of 100 scores in ascending order. Note in particular the ‘spike’ in mean 
SIQE at very high score rank for the Euclidean based methods. 
3.9 Incorporation Assessment Performance at High 
Spectral Noise 
Having observed how HeavyMetL incorporation assessment (using the selected Similarity 
Score, SSKL) performed on a ‘real-world’ dataset. I was also interested as to how the 
incorporation assessment performance would hold up as the data quality decreased. To 
explore this, I created a dataset of 10000 random peptides by concatenating several 
random protein sequences (generated using the ExPASy random protein sequence 
generator at https://web.expasy.org/randseq/ - the generator has a maximum residue length 
per protein) then applying standard tryptic digestion rules. Using R with the v8 package to 
call HeavyMetL code where appropriate, for each peptide, I assigned a random 
incorporation level between 0 and 100 (restricted to multiples of 2 in order to halve 
processing time) and used the HeavyMetL isotopologue prediction algorithm to generate a 
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theoretical spectrum at the assigned incorporation level (thus yielding approximately 200 
peptides at each incorporation level). From the true theoretical spectrum, I then generated 
‘simulated observations’ with increasing amounts of log-normal noise applied to each 
isotopologue intensity. To generate a ‘simulated observation’ spectrum with a given noise 
level, I modelled the intensity of each isotopologue as a log-normal distribution with log 
mean equal to the log theoretical intensity of that isotopologue and log standard deviation 
equal to the noise level, then drew a replacement ‘noisy’ intensity value from this 
distribution. For example, for a noise level (in log standard deviation units) of 0, each 
isotopologue ‘noisy’ intensity is drawn from a log normal distribution with log mean = log 
theoretical intensity and log standard deviation = 0, i.e. the ‘simulated observation’ 
spectrum for noise level 0 is identical to the theoretical distribution. I generated 101 
‘simulated observation’ spectra for noise levels (in log standard deviation units) from 0 to 
1 in increments of 0.01. 
For each simulated observation I then calculated the best matching theoretical distribution 
(again for incorporation values between 0 and 100 in multiples of 2) and the associated 
SIQE. Note that in this analysis (due to the parameterisation of the log-normal distribution 
in R), ‘log’ means the natural log. A log standard deviation of 1 corresponds to a fold 
change of approximately 2.7, which would be well above what is generally considered to 
be the lower bound of detectable genuine fold changes using EML (208) and therefore 
considerably ‘noisier’ than typical real-world data. 
As Figure 3-XIV shows, the performance of the incorporation assessment decreases as 
spectral noise (in log standard deviation units) increases. The relationship between 
Similarity Score and noise appears to have an inverse nonlinear component, as both the 
median value and the lower limit of spread (1.5 times the interquartile range) decrease 
more rapidly as the log standard deviation increases (Figure 3-XIV-A).  However, the 
relationship between inaccuracy of incorporation assessment (as measured by SIQE) and 
noise is closer to a positive linear one, judging by the 90% density threshold in  Figure 
3-XIV-B (90% of the density for each level of log standard deviation noise is below the 
red line). It is possible to still correctly assign the incorporation level even with a low 
Similarity Score, so long as it is still the highest among all tested incorporation levels, so it 
follows that decreasing Similarity Score does not necessarily mean a proportionate 
increase in SIQE. 
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The results suggest that the optimum Similarity Score threshold for any given dataset 
would ideally be derived empirically. However, this is contrary to the stated goal of setting 
default parameters that are robust in most scenarios. Following the same logic as above, 
since a 1.5-fold change has traditionally been the minimum threshold to observe a genuine 
change (208), estimate of a standard deviation of 1.5 as an upper noise limit in typical data 
seems appropriately conservative; this corresponds to a log standard deviation of 
approximately 0.4  (see purple vertical lines in Figure 3-XIV) which, from the simulated 
dataset, suggests a possible Similarity Score threshold of 0.85 as this would encompass 
nearly all genuine matches (i.e. when there is measurable signal present) and yield 90% of 
incorporation assessments with a SIQE less than 0.1.
 
 
Figure 3-XIV. Incorporation Assessment Performance Versus Simulated Noise. A: Peptide length (y-axis) vs. Noise (in log standard deviation 
units; x-axis), shown as box plots for each simulated log standard deviation value. The ‘boxes’ cover the 25th-75th percentile range (i.e. the 
interquartile range) in each case, and the whiskers extend 1.5 times the interquartile range in either direction, bounded by the plot limits. B: 
SIQE (y-axis) vs Noise (in log standard deviation units; x-axis), plotted as a density estimate (where darker blue = greater density). The red line 
indicates a cut-off underneath which 90% of the density lies. The purple line indicates a (conservative) estimate of the typical upper bound for 
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3.10 Conclusions 
HeavyMetL is dependent upon spectral similarity in order to identify the theoretical 
distribution that optimally matches the isotopologue pattern observed in the raw data. I 
thus considered several Similarity Score candidates, described above (Equations 1-4), each 
transformed for consistency into a result between 0 (no similarity) and 1 (perfect 
similarity). All four SS candidates were tested against three different labelled O. tauri 
samples (A, B and C) generated with ‘target’ incorporations of 40, 50 and 60% 15N to see 
which provided the most robust assessment of incorporation. 
To estimate the ‘true’ mean peptide 15N incorporation for each sample A, B and C, I first 
tried a HDPR estimation approach, with mixed success. It was clear that the HDPR 
analysis yielded a linear relationship between the Corrected MDR:mass gradients 
sampled, but my attempt to interpret these relationships in terms of 15N incorporation by 
comparison of the resulting gradients with a set of standard gradients derived from 
predicted masses for various levels of 15N incorporation proved unsuccessful, as the 
theoretical results clearly covered a different range of gradient values. A combination of 
three factors may explain the discrepancy; first, the theoretical mass lists were all inferred 
from a limited subset of the unlabelled precursor masses with an inherent bias for 
identifiability (no co-eluting peptide resulting in a chimeric MS2 spectrum, higher 
intensity precursor); secondly, for the theoretical data this subset of precursors was the 
same across all incorporation levels, whereas for the experimental data the same peptide 
species would not always have been selected; thirdly, the theoretical data assumed that the 
most intense isotopologue of the peptide species would always be the selected mass, 
which may not always be the case in the complete data. 
I was, however, able to infer an expected ratio between the 15N incorporation levels of 
samples A, B and C, which was approximately consistent with the expected ratios between 
the 15N incorporation values for samples B and C, but predicted a lower incorporation for 
sample A relative to B and C. 
I then analysed the data with HeavyMetL using all four SS candidates. All four measures 
outperformed random guessing and, overall, showed very similar performance. Taking the 
mean incorporation across the four SS candidates for each sample yielded estimated 
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sample incorporation levels of 34.4% 43.7% and 53.7% for sample A, B and C 
respectively. This result was much closer to the consistent 15N incorporation percentage 
point drop initially expected, rather than the lower sample A incorporation relative to A 
and B predicted by HDPR, suggesting that the HDPR analysis was not particularly 
accurate. 
Comparing the performance of the four SS candidates, the Kullback-Leibler Divergence 
based score SSKL yielded the lowest standard deviations in 15N incorporation across the 
three samples (when background mis-quantification was removed). After transformation 
of the absolute 15N incorporation error (deviation from the predicted mean) to a SIQE, I 
compared SS candidate SIQEs against SS ranks, and against peptide characteristics which 
might affect incorporation assessment. These comparisons revealed no marked differences 
between any of the Similarity Scores. However, closer examination of mean SIQE showed 
some evidence of inconsistency of performance in SSEUC and SSWEUC at very high score 
ranking, suggesting there may be spectral characteristics that they overvalue. This last 
observation was also consistent with manual evaluation of results, in that the Euclidean 
based methods assigned more ‘obviously’ (i.e. by eye) incorrect incorporation estimates. 
When taken as a whole, there was much less difference in performance between the 
Similarity Scores than I had expected based on ad hoc manual evaluation of the SS while 
testing the algorithm code, demonstrating the danger of bias in a manual evaluation 
approach. On the other hand, making ‘obviously’ incorrect incorporation estimates (even 
if a particular score performs similarly in the aggregate) contributes to a user perception of 
poor quantification, so there could be an argument to admit (effectively anecdotal) manual 
evaluation into the overall consideration. 
A further observation was that, when comparing across SS rankings, the SIQE increased 
with decreasing score as expected but the average SIQE for each of the 4 SS at low score 
was still much lower than the baseline ‘random guessing’ SIQE (compare Figure 3-XI-C 
across columns). The fact that lower ranked scores are still generally associated with an 
SIQE lower than obtained by random matching suggests that the majority of the time in 
this dataset, these may be genuine low-intensity labelled signals with an associated greater 
uncertainty around the incorporation estimate, rather than a complete mismatch, which 
speaks to the robustness of the algorithm using any of the four SS candidates. One 
explanation could be that even if there is only a weak signal with 1 or two isotopologues, 
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if a particular incorporation value is the only one that yields intensity when its m/z 
extraction windows are applied, that will be the best matching distribution even if the SS 
is low. If this were the case, a re-analysis of the sample on an older instrument with poorer 
resolution and mass accuracy, or a different dataset composition with a more complex 
sample might be expected to result in a substantial increase in SIQE at low SS rank. 
Alternatively, in a sample with a wide spread of expected peptide incorporation values, 
even the increase in SIQE observed in this analysis at low score rank might be 
unacceptable. In all of these cases, it would be advisable to apply a conservative SS 
threshold to ensure only good matches are considered further. 
There was very little to differentiate the remaining two scores, but SSKL had consistently 
(if by a very small margin) outperformed SSSCA in terms of a smaller spread of 
incorporation assessments, so I chose the Kullback-Leibler Divergence based Similarity 
Score for further use in HeavyMetL. Finally, I examined the performance of incorporation 
assessment (using the chosen Similarity Score) as data quality decreased, using a 
simulated dataset to which I introduced increasing amounts of log-normal noise.  The 
incorporation assessment showed robust performance even when noise was increased 
substantially beyond what is typically encountered in EML, with more than 90% of results 
having SIQE < 0.1 even when the added noise (in log standard deviation) corresponded to 
an average of 1.5-fold change in intensity. This analysis also suggested that a default 
Similarity Score threshold of 0.85 could be used to separate incorporation assessments 
based on true-but-noisy signal from those based on false signals (such as incorporation 
assessments based on ‘signal’ that is just background noise). 
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Chapter 4: Benchmark of HeavyMetL 
Performance vs. an Orthogonal Approach 
4.1 Introduction 
To assess quantification performance, HeavyMetL was benchmarked against an existing 
public dataset. The recent publication of the ProteinTurnover algorithm (166) describes a 
cohort of Arabidopsis seedling samples with increasing 15N incorporation over a series of 
time points (4, 8, 24, 32, 40, 48 h). The dataset also includes a 0 h time point which 
effectively contains no labelled sample. The authors have evaluated the MS2 spectra 
manually to further filter the list of peptide identifications. These data provide a useful 
public benchmark across a range of 15N incorporation percentages in which the number of 
mis-sequenced peptide-spectrum matches may be assumed to be relatively low. 
In contrast to the dataset used in Chapter 3, this dataset is a ‘SILAC-style’ dual labelling 
containing both unlabelled peptides and labelled peptides at a range of 15N incorporations. 
ProteinTurnover is an ideal candidate for a benchmarking comparison since the 
approaches of HeavyMetL and ProteinTurnover are partially orthogonal, with respect to 
the actual quantification of the unlabelled and labelled peak. HeavyMetL locates the 
unlabelled and labelled peak apexes within the RT window independently. The process of 
fitting a range of labelled distributions simultaneously determines both labelled peak apex 
RT and incorporation percentage for the distribution with the best fit. The 
unlabelled/labelled ratio is then calculated from the ratio intensity at each label apex. In 
contrast, ProteinTurnover does not attempt to define the limits or apex of either label 
elution peak directly, but instead measures the extracted ion chromatogram of a series of 
m/z windows corresponding to the approximate location of possible isotopologues. The 
gradients of the linear correlations between the highest intensity isotopologue and the 
other isotopologues over all observations within an RT window are used to determine a 
combined unlabelled and labelled spectrum. The unlabelled and labelled distributions are 
modelled by fitting a mixture of two beta-binomial distributions using maximum 
likelihood estimation; the ratio of unlabelled to labelled is then derived from the area 
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under the curve of the two fitted distributions, and the labelled incorporation percentage 
from the parameters of the rightmost fitted beta-binomial curve. The use of a beta-
binomial distribution is interesting; essentially the authors propose that since incorporation 
into different amino acids may not proceed at the same rate, for a given peptide there is 
not an equal probability of every nitrogen in the peptide being labelled (this probability 
would also be the overall incorporation level). To account for this, rather than fitting a 
binomial distribution (which would assume equal probability), they fit a beta-binomial 
distribution where the probability for each nitrogen atom being labelled follows a beta 
distribution, which varies between 0 and 1 with mean π equal to the overall incorporation 
level. 
The effect of this adjustment is to slightly broaden the distribution shape from a standard 
binomial distribution. HeavyMetL, by comparison, assumes an equal probability of every 
nitrogen in the peptide being labelled (as per the standard binomial distribution). However, 
since the Kullback-Leibler Divergence based Similarity Score used in HeavyMetL weights 
in favour of high intensity isotopologues which will typically not be substantially affected 
by this broadening, there may be very little practical difference. One effect of the peak 
broadening however is that taking into account more, low intensity isotopologue masses 
during matching may increase susceptibility of the matching to background noise, 
increasing variance when quantifying low intensity spectra. 
Since the extraction of ion intensity data is performed before the determination of label 
incorporation, there are higher practical limits on the mass error tolerance for extraction in 
ProteinTurnover. However, by calculating relative isotopologue proportions from the 
gradients of their correlations across the full RT extraction window rather than just using 
just the spectra closest to the peak apex, ProteinTurnover is potentially more robust in 
scenarios where the apex signal for a label state is heavily contaminated by noise while the 
rest of the elution is unaffected. For the best comparison, therefore, I assessed the 
performance of both algorithms over the time course as a whole, which includes scenarios 
of low signal-to-noise for the labelled signal in the earlier time points (where 15N 
incorporation is low), as well as stronger signal-to-noise in the later time points where 
incorporation is higher. 
Through the graphical user interface, HeavyMetL allows quantification parameters to be 
easily optimised for a particular dataset, as the result of changing settings can be quickly 
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re-calculated for individual proteins and peptides and assessed visually. For the 
comparison to ProteinTurnover, I applied no manual optimisation to this dataset, relying 
on default parameters, to avoid any optimisation bias. In addition, to ensure the best 
comparison, the same isotopic mass and abundance constants used in the ProteinTurnover 
algorithm were used in HeavyMetL (copied directly from the ProteinTurnover source 
code). 
4.2 Benchmark Dataset Materials and Methods 
N.B. This chapter describes a re-analysis of publicly available data. Sample preparation, 
mass spectrometry analysis and processing of the dataset using ProteinTurnover were 
performed by Fan et al. (the authors of the ProteinTurnover paper) and details on these 
steps are included here for information purposes only. The re-analysis of the data using 
HeavyMetL, the comparison of the results to the ProteinTurnover quantification data, and 
the evaluation of the benchmark conclusions are my own work. 
4.2.1 Dataset Details 
The ProteinTurnover paper describes a number of datasets in which they investigate both 
label incorporation and label dilution (166). This analysis used the label incorporation 
time-course dataset, for which both raw data and quantification values obtained by the 
authors are publicly available on MassIVE via the accession number MSV000079223). 
The files relevant to this analysis were: 
1. The MS data in mzXML format (raw/hr_2/4/8/24/32/40/48.mzXML). At the time of 
writing, the 16 h time point file (hr_16.mzXML) hosted on MassIVE was truncated and 
thus excluded from the analysis. 
2. The list of identified peptides in Spectrum report file format (other/soluble-FDR-
Scaffold spectrum report.csv). 
3. ProteinTurnover quantification values (other/ Root-soluble_Turnover-many.rar/ fits-
many_soluble.csv). The labelled signal incorporation percentage and relative abundance 
used in this analysis are derived from the π and alpha columns for each time point in the 
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spreadsheet: labelled signal incorporation percentage = 100 π; relative abundance = 
alpha/(1-alpha). 
4.2.1.1 Dataset Method Summary 
A full description of this dataset is given in the paper of Fan et al. (166). Pertinent details 
on the generation of this dataset are given here for information purposes (and do not 
represent my own work). 
Arabidopsis seedling root tissue samples were homogenized by grinding in an ice-cold 
grinding buffer consisting of 290 mM sucrose, 250 mM Tris-HCl (pH 7.6), 25 mM EDTA, 
5 mM DTT, 1 mM PMSF, 0.5 × protease inhibitor cocktail (Roche, Indianapolis, IN), 
filtered through Miracloth, and the soluble protein fraction separated by centrifugation. 
Soluble proteins were recovered by acetone precipitation, pelleted by centrifugation and 
resuspended at a concentration of 8 μg/μL in 1 M urea/1 mM DTT which was then diluted 
to 1 μg/μL with 1 M urea/1 mM DTT/50 mM ammonium bicarbonate before digestion 
with trypsin (Promega, Madison, WI). The peptides were analysed using a Q-Exactive MS 
(Thermo Fisher Scientific, San Jose CA) with an ACQUITY UPLC BEH C18 column (1.0 
mm × 150 mm, 1.7 μm particle size, Waters, Milford, MA). With buffer A as 99.9% 
water, 0.1% formic acid and buffer B as 99.9% acetonitrile, 0.1% formic acid, the solvent 
gradient program was as follows: 2%–10% buffer B (0–2 min.), 10–40% buffer B (2-62 
min.), 40%–85% buffer B (62-63 min, then maintained for 10 min.). The column was 
equilibrated for 15 min. with 2% B prior to the next run. Data were acquired in DDA 
mode with MS1 scans (range 350−1800 m/z) acquired at 70 k resolution and a target value 
based on predictive automatic gain control of 1×106 with 20 ms of maximum injection 
time. Based on an ion selection threshold of 1×104 counts, the 12 most intense precursor 
ions (z ≥ 2) were isolated (2.0 m/z isolation width) and sequentially fragmented in the 
HCD collision cell with normalized collision energy of 30%. MS2 scans were acquired 
with 35k resolution and a target value of 2×105 with 120 ms of maximum injection time. 
Selected precursor ion m/z values were dynamically excluded from further selection for 15 
s. 
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4.2.2 Analysis of Dataset with HeavyMetL 
Since the sample was not alkylated before digestion, the validity of the few cysteine-
containing hits that were reported was difficult to evaluate. For simplicity, the list of 
identified peptides list was filtered to remove the 16 cysteine-containing entries and any 
peptides identified solely in the 16 h time point for which data were not available. This left 
a total of 1903 PMCs to be analysed across 6 time points - 0, 4, 8, 24, 32, 40 and 48 h. The 
list of peptides was re-formatted for compatibility with HeavyMetL input in accordance 
with the required column headers. Briefly, a new table was created based on the Scaffold 
report (item 2 in the list above). The following columns were directly copied across 
(Scaffold report column names given first, HeavyMetL input names given second; see 
Table 2-II for details): “Peptide sequence” as “PEPTIDE_SEQUENCE”, “Protein 
accession” as “PROTEIN”; “Protein name” as “PROTEIN_DESCRIPTION”; “Peptide 
identification probability” as “PEPTIDE_SCORE”; “Protein identification probability” as 
“PROTEIN_SCORE”; “Variable modifications” as ”MODIFICATIONS”; “Spectrum 
charge” as “CHARGE”; “Exclusive” as “CONTRIBUTE_TO_PROTEIN”. The columns 
“FILE_NAME” and “RETENTION_TIME” were added based on the data extracted from 
the Scaffold report column “Spectrum name”. 
The data were then analysed with HeavyMetL using the default settings (see Table 2-III). 
Analysis of the 1903 PMCs across 6 files (8GB in mzXML format) took 16 minutes for 
complete processing (Apple MacBook Pro running macOS 10.13.6; 2.7 GHz Intel Core i7 
with 8 logical processors; 16 GB RAM; Firefox v. 62.0). 
Subsequent statistical analysis of results and generation of all figures was performed in R 
(v. 3.5.1). 
4.3 Benchmark Results 
4.3.1 Overview 
HeavyMetL reports both the label incorporation level and the apex intensity of the 
unlabelled and labelled peaks for each peptide and associated protein, using the protein 
grouping information provided in the input peptide list. Depending on the experimental 
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design, either label incorporation or relative abundance or both may be used to infer 
protein turnover. I evaluated both measures at both peptide and protein level, comparing to 
the published quantification results from ProteinTurnover as a benchmark, taken from the 
output files published alongside the raw data. 
Quantification results were filtered to a single result per unique peptide sequence to allow 
straightforward comparison against the ProteinTurnover results. In cases with multiple 
PMC instances sharing the same sequence (but different modification/charge states), the 
PMC with the highest mean intensity across all unlabelled and labelled signals was used. 
The final dataset used for comparison thus contained no duplicate peptide sequences, 
consisting of 1284 peptides with at least one successfully quantified time point. Although, 
in Section 3.9, I established that a Similarity Score threshold of 0.85 would likely be an 
effective way to further filter HeavyMetL results to improve dataset quality, I did not have 
a corresponding way to filter the ProteinTurnover dataset. For the fairest comparison, 
therefore, no Similarity Score filter was applied. 
4.3.2 Peptide-Level Quantification Comparison 
Since the data represent a biological system in flux, it cannot be assumed that all proteins 
in a time point sample will necessarily have the same level of incorporation. Assuming a 
similar level of incorporation estimation accuracy, the resulting distributions of labelled 
signal incorporations reported by different quantification algorithms should have similar 
properties. Comparing the peptide incorporation results reported by HeavyMetL to the 
ProteinTurnover benchmark, at timepoints after 8 h, there was good agreement, especially 
using only the top 75th percentile of data by frequency (in both datasets) in order to 
exclude the most obvious mis-quantifications (Pearson’s r = 0.57, 0.68, 0.76, 0.72 for  24 
h, 32 h, 40 h, 48 h respectively; Figure 4-I). In contrast, at 4 h and 8 h the data were not 
well correlated (Pearson’s r = 0.43 and -0.11 for 4 h, 8h respectively), with both datasets 
showing clear evidence of a large amount of mis-quantification based on the wide spread 
of incorporations reported. Since the incorporation level of 15N is expected to rise over 
time, these time points have the lowest 15N incorporation and consequently the weakest 
labelled signal (and highest signal-to-noise); later time points have higher 15N 
incorporation and thus stronger labelled signal and larger signal-to-noise ratio. Agreement 
between programs is therefore correlated with the expected signal-to-noise ratio, which is 
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a logical outcome. Since the SSKL method used by HeavyMetL to assess spectral matching 
is mathematically equivalent to distribution fitting using maximum likelihood estimation 
as performed by ProteinTurnover, then the algorithms may be expected to have similar 
weaknesses when confronted with low intensity or noisy data. 
Nevertheless, there are still significant differences between the two algorithms, so it does 
not necessarily follow that peptides with a poorly assigned incorporation level in one 
method will also have a poorly assigned rate in the other. I therefore compared the 
distribution of incorporation levels and the unlabelled/labelled intensity ratios between the 
two methods (Figure 4-II). The distribution of incorporation (Figure 4-II-A,B) in the 4 h 
and 8 h time points indicate a greater degree of agreement between the two than suggested 
by the individual value comparisons in Figure 4-I, with a similar trend across median 
values despite the much greater spread of data. 
Since an accurate determination of the incorporation is necessary for accurate 
determination of the labelled peak intensity, the unlabelled/labelled ratio quantification 
measures are, to an extent, dependent on the quality of the labelled incorporation level 
result. This is reflected in the distributions of reported unlabelled/labelled ratios across 
time points (Figure 4-II-C,D), which follow the same trend observed in the incorporation 
levels (Figure 4-II-A,B), and the median labelled signal intensity, as an approximation of 
signal-to-noise (Figure 4-II-E). 
 
 
Figure 4-I. Correlation of Labelled Signal Incorporation Values. Dotted lines indicate where perfect correlated data would lie. Pearson’s r 
values given in plot titles. Solid red lines indicate a linear fit to values in the top 75% of data by frequency in both HeavyMetL and 
ProteinTurnover.
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Figure 4-II. Comparison of Peptide-Level Quantification Result Distributions. A & B: 
The distributions of labelled signal incorporation reported by HeavyMetL and 
ProteinTurnover respectively. C & D: The distributions of unlabelled/labelled signal 
ratios reported by HeavyMetL and ProteinTurnover respectively. E: Relative median 
intensity of labelled signal (as reported by HeavyMetL) in each time point. 
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Figure 4-III. Comparison of Protein-Level Quantification Result Distributions. A & B: 
The distributions of protein-level labelled signal incorporation reported by HeavyMetL 
and ProteinTurnover respectively. C & D: The distributions of protein-level 
unlabelled/labelled signal ratios reported by HeavyMetL and ProteinTurnover 
respectively.  
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4.3.3 Protein-Level Quantification Comparison 
Finally, the datasets were compared at the protein level. Protein level quantification was 
derived by taking the median peptide-level value for both metrics independently. As well 
as the median being a widely used summary statistic, this allowed the fairest comparison 
to the ProteinTurnover results, since ProteinTurnover reports only the relative proportion 
of unlabelled to labelled signal as the alpha parameter which precludes any intensity-
weighted approaches. As might be expected, the results closely mirrored the peptide-level 
comparison, with some reduction in spread (which is to be expected, as taking the median 
peptide-level values naturally disfavours outlying mis-quantification). While performance 
of both algorithms was very similar, the incorporation values reported by HeavyMetL 
show a more sustained trend towards zero at low time points (Figure 4-III-A,B), which is 
consistent with the only a priori known data point, that 15N Incorporation at 0 h must 
equal natural abundance, 0.37%. This suggests that (at least using a median inference 
method) the values reported by HeavyMetL may, as a whole, be more accurate (although 
clearly subject to similar levels of variance). The tighter spread of unlabelled/labelled 
ratios reported by HeavyMetL in these time points (Figure 4-III-C,D) is consistent with 
this conclusion, as accurate determination of ratio relies on accurate determination of the 
incorporation level. 
4.4 Conclusions 
Notwithstanding the limitations of no manual optimisation, HeavyMetL produced 
comparable results to ProteinTurnover. The lack of correlation between reported labelled 
signal incorporation values with the benchmark results at low signal-to-noise (despite both 
approaches producing similar overall distributions) suggests that there is a proportion of 
these low-intensity peptides whose quantification could be further improved, since they 
are reported with lower error by ProteinTurnover (likewise, there is a similar proportion of 
peptides whose quantification by HeavyMetL has lower error than the corresponding 
ProteinTurnover result). It is interesting that while reported quantification at the low 
signal-to-noise timepoints (4 h and 8 h) had similarly high levels of variance for both 
algorithms, extrapolation to protein level results by the median did favour HeavyMetL, 
although there is clearly room for further optimisation of the algorithm to improve 
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discrimination performance and eliminate unreliable peptide quantification at low signal-
to-noise. It is possible that the combined labelled and unlabelled distribution matched by 
the ProteinTurnover algorithm tends to overvalue the contribution of the unlabelled 
isotopologues (whose incorporation and thus distribution is known a priori) resulting in an 
overestimation of the incorporation and intensity of the labelled signal at very low 
incorporations. The combined distribution matching may allow high intensity, easily 
quantified unlabelled signal to lend authenticity to what is essentially noise mis-identified 
as labelled signal. 
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Chapter 5: Concluding Discussion 
In proteomic MS1-based quantification, there are two methods of introducing a sample 
label in vivo. Labelling in vivo allows the earliest possible mixing of samples in a 
processing pathway and thus minimises the steps where two samples (or a sample and a 
standard) are processed independently and thus subject to differential technical variance). 
Labelling can be applied to specific amino acids (SILAC) or to all atoms of a particular 
element (EML, particularly 15N labelling). SILAC is currently used far more widely; and I 
propose that this is due to two perceived advantages over 15N:  
1. Ease of data processing. Several mature, user-friendly software options exist for 
SILAC quantification, whereas the 15N existing options are limited in capability, 
produce varied quality of quantification (especially for low intensity signals) and 
are not very easy to use by non-bioinformaticians. Computationally, EML 
quantification is more difficult. Since the distribution of isotopologues for the 
unlabelled and labelled SILAC peptides are nearly identical, the same parameters, 
mass-shifted, can be used to calculate a chromatographic maximum intensity or 
integral for both signals However, in EML the total signal in the labelled peptide is 
spread over a different number of isotopologues than in the unlabelled peptide, 
thus complicating quantification (as described in the Introduction) and increasing 
the potential for differential effects due to noise. 
2. A more easily achieved minimum ‘quantifiable’ incorporation level. For 15N, it 
is often suggested that partial labelling results in datasets that are intractable to 
analysis (particularly when there is differential partial labelling between proteins), 
and therefore that 15N is only a viable labelling technique when a label 
incorporation level close to 100% can be achieved. It is technically difficult to 
achieve near 100% labelling given reagent purity, particularly when under further 
experimental constraints such as labelling time. This perception has the effect of 
(apparently) disqualifying 15N labelling from consideration in many experiments. 
As a consequence, 15N is relegated to areas where SILAC has important limitations, most 
prominently in plant proteomics, where partial labelling of other amino acids occurs due to 
conversion pathways. 
Chapter 5: Concluding Discussion 158 
I further propose that a robust, easy to use quantification solution that can handle partial, 
non-uniform 15N incorporation across proteins actually negates not only the first but also 
the second of the SILAC advantages described above. Although it is more challenging to 
quantify computationally, if this challenge can be addressed then complete separation of 
the unlabelled and labelled signal in EML requires only a sufficient incorporation such 
that the two isotopologue distributions do not substantially overlap for the majority of 
peptides. This is the case for most peptides at much less than 100% incorporation. Take as 
an example the set of theoretical peptides nAK, i.e. AK, AAK, AAAK and so on, with 
each increase in n adding one more alanine (and thus one more nitrogen atom). Impose a 
strict separation requirement that less than 1% of the labelled signal overlaps less than 1% 
of the total unlabelled signal. At n=3 (AAAK), 97% 15N incorporation is needed to meet 
the requirement. However, at n=4, only 91% incorporation of 15N is needed, while at n=5 
(a peptide of 6 total residues, typically the smallest reliably observable by bottom-up 
proteomic MS), only 85% 15N incorporation is sufficient. If 15N incorporation need only 
be above 90% to ensure practically no overlap of signal for the majority of peptides, this is 
a substantially more achievable level of incorporation. 
Accordingly, the barrier to wider 15N usage might be argued to be the availability of 
software with robust performance and usability comparable to that of MaxQuant and 
commercial alternatives. Although there are no mature, user friendly software packages 
available that offer the ability to reliably quantify 15N data with inconsistent, partial label 
incorporation, various approaches have been described in the literature (see Section 1.2.2) 
which suggest that, with further refinement, a robust quantification approach is achievable. 
The task then would be to implement this as a software package accessible to non-
bioinformaticians and capable of performing such quantification at a rate that the users of 
quantification packages such as MaxQuant have come to expect. 
At the beginning of Chapter 2, I set out a list of requirements that I considered necessary 
for such a software package and went on to describe HeavyMetL, a browser-based 
quantification tool which provides robust quantification in a user interface that fulfils the 
requirement list. It has a fully graphical user interface, allows in-tool visualisation of the 
matched spectra and chromatograms associated with quantitative results, and on a modern 
personal computer can process moderately sized MS datasets in the ‘minutes to hours’ 
timeframe typical of SILAC quantification tools. Unlike existing 15N solutions, 
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HeavyMetL is easy to set up (by simply visiting a web page in a supported browser), 
works across operating systems, has an accessible user interface that does not require use 
of the command line, and provides graphical output for quantification allowing rapid 
optimisation of quantification parameters such as m/z Error Tolerance. 
While the implementation of HeavyMetL described in this thesis fulfils the usage 
requirements as originally set out, there are a number of technical and design aspects 
which are obvious candidates for future improvement. These fall into three areas: 
1. Improvements and extensions to the quantification algorithm. Most obviously, 
the algorithm could be extended to support other types of EML, since the 
quantification approach is compatible with any elemental isotopic label (in the 
same way that SILAC-style quantification approaches can support Dimethyl 
labelling). Since the consideration of non-simultaneous unlabelled/labelled 
retention times is already supported by HeavyMetL, the only change required 
would be modification of the input to the theoretical distribution prediction 
algorithm to allow isotopic changes to elements other than nitrogen (the actual 
algorithm itself is sufficiently generalised to allow this already), and the associated 
changes to the user interface to allow the type of EML to be specified. A further 
adaptation would be to follow the proposal advanced by Fan et al. in 
ProteinTurnover that incorporation levels may differ between amino acids. Fan et 
al. modelled this process by allowing some variance in the probability of each 
nitrogen atom being labelled via a beta distribution (see Section 4.1), but a more 
representative way to model this (following the hypothesis to its conclusion) would 
be to generate the isotope distribution for each population of amino acids in the 
peptide separately (rather than combining them to a single pool of atoms). A range 
of theoretical distributions corresponding to different incorporations for each 
amino acid could be generated, then cross combined to yield peptide-level 
distributions. This would require generation of a huge number of possible 
distributions – the number of incorporation levels to be tested, raised to the power 
of the number of different amino acids in the peptide! Rather than generating all 
possible combinations, some form of multiple regression would have to be 
implemented. It would also likely be necessary to apply this optimised fitting only 
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to the final ‘best fit’ chromatographic maximum determined by the existing 
method, to avoid very extensive calculations. 
2. Code restructuring to take advantage of new language capabilities. The 
JavaScript language standard is frequently updated, and some of these changes lift 
previous design constraints that necessitated performance concessions. The choice 
of JavaScript + browser as a platform will always limit the maximum 
quantification speed (although in many cases disk access speed will still be the 
bottleneck). Recently, a web standard for a binary instruction format that allows 
near-native execution speeds in browsers (WebAssembly) was announced. Porting 
calculation-heavy aspects of HeavyMetL into WebAssembly would likely allow 
further substantial speed improvements (or alternatively facilitate more nuanced 
quantification as described above without a reduction in performance). 
3. Improvements to management of multiple data files as a single dataset. From a 
proteomics perspective, there are also some areas where the ‘gold standard’ in how 
multiple MS raw data files are managed as a single dataset has substantially 
advanced since HeavyMetL was designed. The approach of matching PMCs 
between MS raw data files via mean sample RT used in HeavyMetL is more 
sophisticated than previous 15N approaches that require the time to be specified 
explicitly for all files. Even so, this is a relatively unsophisticated approach 
compared to the algorithms used in prominent label-free/SILAC quantification 
software such as MaxQuant and Progenesis QIP (see Section 1.1.2.11.3) and these 
are also now being outclassed by cutting-edge approaches such as machine 
learning. The difficulty in the case of 15N is that retention time matching 
algorithms typically work on the assumption that peptides are represented by a 
limited range of isotopologue patterns such as found in LFQ and in SILAC, as 
these techniques do not affect the isotopologue distribution shape, but rather apply 
a constant mass shift. Thus, potential features can be identified by comparison to a 
small range of generalised isotopologue distributions representing peptides of 
increasing mass. In contrast, 15N labelled peptides will not only frequently have a 
substantially different isotopologue distribution to that of a typical ‘unlabelled’ 
peptide, but the distribution will potentially differ from run-to-run with changes in 
15N incorporation. This makes run-to-run feature matching more difficult without 
knowing the incorporation level for each peptide in each run prior to quantification 
(which is what HeavyMetL is attempting to calculate; a chicken-and-egg problem). 
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Using machine learning to identify possible peptides regardless of incorporation 
and align them between runs may be a plausible solution to this, although would 
represent considerable development effort to achieve. Any retention time solution 
should also involve a more comprehensive solution for pre-fractionated 
experimental designs, as these are now the standard experimental approach for 
most proteomic investigations. The current necessity to analyse fraction groups 
individually in HeavyMetL is not up to par with, for example the experimental 
design options in MaxQuant. 
4. Improvements to the user interface. The current interface is functional but there 
are quality-of-life improvements that could be made. Firstly, the input of the PMC 
list could be expanded to accept unmodified exports from major search engines (to 
avoid the currently necessary step of partially re-formatting the various different 
peptide-level identification tables produced by different search engines to the input 
format required by HeavyMetL. Alternatively, the program could allow the 
relevant columns in a text table file to be manually defined by the user (or perhaps 
selected from a list of templates) during import into HeavyMetL (rather than 
explicitly renaming columns according to the HeavyMetL specification shown in 
Table 2-II). This is an approach used by the Spectronaut and SpectroDive DIA 
analysis packages available from Biognosys. Secondly, the user configurable 
settings could be stored as a persistent browser object (a ‘cookie’, or the newer 
‘LocalStorage’ specification) thus ensuring that settings were not lost when the 
browser window was closed. 
In Chapter 3, I explored a specific technical aspect of the HeavyMetL quantification, 
namely the choice of Similarity Score used to compare the observed data with the set 
theoretical distributions I calculated for each PMC. Using an experimental dataset of an 
unlabelled sample of O. tauri and three labelled samples with target incorporations 40%, 
50% and 60% 15N, I first explored an orthogonal technique to estimate a global peptide 
average incorporation for each sample based on the relationship between peptide mass and 
its MDR, known as the half decimal place rule (HDPR). This method yielded an 
approximate estimate of the incorporation ratio between the three labelled samples but the 
results from HeavyMetL followed the expected ratio (given the original target values) 
much more closely. I concluded that the HDPR estimation was likely too sensitive to 
uncontrollable sources of bias (such as the stochastic selection of precursors in DDA) to 
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provide accurate estimation of global incorporation values. Ultimately, the incorporation 
estimations were based on very small differences in the gradient of linear fits between 
mass and MDR, so even small differences due to noise or differential precursor selection 
could have large effects on the estimate. However, it might be possible to improve HDPR 
estimation with further data filters (e.g. precursor intensity). The HDPR method still has 
merit as an unbiased, non-search-result driven estimation of global incorporation in a 
sample, especially if combined with a peak-picking algorithm to identify probable 
peptides in MS1 without the use of MS2 scans to yield identities. Since peptide 
identifications are not required, the samples could be analysed on short gradients with MS1 
scans only, reducing MS analysis cost. A scenario where this might be applicable would 
be estimation of 15N incorporation in cultures being labelled to stability, to monitor 
whether the incorporation level has stabilised; then at that point a full DDA analysis with 
identifications could then be performed and analysed with HeavyMetL (or another 
quantification solution).  
I then compared four candidate Similarity Scores to see how my quantification workflow 
from Chapter 2 performed using each in turn as the spectral comparison score. The 
performances of the four Similarity Scores were very similar, which was not the result I 
had expected. On further consideration, however, this result was the most likely outcome. 
Given that the Similarity Scores are only applied for matching purposes to data that has 
already been extracted using predicted m/z values within a very narrow m/z window, the 
chances of extracting intensity associated with another co-eluting PMC are not high. 
Furthermore, the Similarity Score reported is that of the ‘best’ matching extraction, so for 
‘off-target’ intensity (e.g. background noise or a co-eluting PMC) to be the bulk of the 
reported match spectrum, such a ‘mostly noise’ spectrum would have to yield a higher 
Similarity Score than the actual labelled target. Completely random matches are therefore 
relatively unlikely. The m/z extraction windows are themselves defined by theoretical 
prediction for a particular 15N incorporation, so only incorporation values close to the 
‘true’ incorporation will tend to yield substantial extracted intensity and a potentially 
viable match, regardless of Similarity Score.  
With this in mind, it was important that the data from all three levels of target 
incorporation (samples A, B and C) be compared together, to maximise the sensitivity of 
the analysis and highlight subtle differences across score rank. The conversion of the 
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incorporation percentage point errors to a Standardised Incorporation Quantification Error 
(SIQE) was therefore a useful tool to allow the results from all 3 incorporation levels to be 
directly compared. An experiment with more replicates (or more target incorporations) 
could have improved the robustness of the Similarity Score comparison by increasing the 
number of incorporation-score pair data points. Early builds of the HeavyMetL algorithm 
lacked a number of optimisations for speed, and when the experiment was designed it was 
not clear how many samples it would be practical to analyse, given that the analysis would 
have to be repeated four times with each of the four different candidate scores. A greater 
number of samples, with multiple technical replicates and more target incorporation points 
would in retrospect have been perfectly viable, with the overriding practical limitation 
being sample preparation time and cost of MS analysis rather than the feasibility of data 
analysis. 
An alternative improvement would be a change of the experimental design. In the 
Similarity Score comparison, label incorporation was assumed to have stabilised at each 
target value (less a small amount to account for salt impurity), and thus be distributed 
tightly (and unimodally) around a mean value in each sample. This was not unreasonable, 
given previously observed incorporation behaviour over the same labelling period using 
the same labelling methods (160). Differences in turnover and amino acid composition, 
however, combined with potential kinetic imbalance between 14N and 15N incorporation in 
different amino acids, could potentially result in genuine differences in incorporation 
between peptides. The assumption made here was that this effect would be minor 
compared to the distribution of errors in the 15N incorporation estimation, but this 
assumption is difficult to validate. One experimental approach to explore this might be to 
label until assumed incorporation stability, as above, and then sample across a time course 
where a pulse of an unlabelled, low-frequency amino acid such as tryptophan (Trp) was 
briefly introduced. PMCs containing Trp would then exhibit an increase in the variance of 
15N incorporation as the unlabelled Trp was incorporated, followed by a decrease as the 
unlabelled Trp was diluted out. The changes in Trp-containing peptide 15N incorporation 
variance relative to the variance of incorporation of 15N into peptides that do not contain 
Trp over the course of incorporation and dilution would yield useful information on the 
inherent (non-quantification error) incorporation background variance. 
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At the end of Chapter 3 I concluded that a score based on the Kullback-Leibler 
Divergence (SSKL) was the optimum choice for the isotopologue distribution matching, in 
the context of the HeavyMetL algorithm. It is worth noting there that while SSKL had the 
strongest overall performance, the slightly lower cumulative mean SIQE for the Euclidean 
distance-based scores at lower score ranks (despite their dire performance at high score 
ranks) suggests a possibility for further optimisation of the Similarity Score by combining 
both SSKL and SSEUC. 
Finally, in Chapter 4, I benchmarked the quantification from HeavyMetL (using SSKL for 
spectral comparison) against a recently published 15N quantification method, 
ProteinTurnover, using the same incorporation time-course study in Arabidopsis reported 
in the ProteinTurnover publication. Overall, both methods gave similar results, with good 
agreement and similar distribution of data points in both peptide and protein-level 
comparisons in the later stages of the time course (where incorporation levels were 
higher). In the early stages of the time course (where incorporation levels were low), the 
performance was notably worse for both approaches, although HeavyMetL appeared to 
have an edge. I concluded that HeavyMetL has quantification performance clearly 
equivalent to or better than ProteinTurnover, which is the most recent and sophisticated 
15N quantification approach so far proposed. 
Given the above-par quantification performance, combined with its advantages in terms of 
user accessibility and interaction, it does not seem unreasonable to advance the statement 
that HeavyMetL is a general improvement on the existing 15N quantification solutions in 
the field. While it is not yet as mature as some extensively developed software packages 
such as MaxQuant, a non-bioinformatician could now analyse 15N -labelled data using 
HeavyMetL and expect to generate usable, robust quantitative results, interacting solely 
via a relatively straightforward GUI. They can rely on seeing the same interface and 
having access to the same functionality whether they are on Windows, macOS or Linux, 
and can analyse any raw data that can be converted to (or exported as) mzML or mzXML, 
identifying the PMCs to be quantified by any method of their choice (so long as the result 
can be coerced into a text-table format with the necessary columns defined in Table 2-II). I 
therefore submit that HeavyMetL is not only a viable analysis tool, but that it potentially 
enables the usage of 15N labelling outside of speciality niche areas, in more direct 
competition with SILAC and similar techniques.
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Appendix I: Details of Code Availability 
A live version of the HeavyMetL program is hosted at  
https://pdcharles.github.io/HeavyMetL/HeavyMetL.htm 
 
The source code is released publicly under an MIT license, and is split into two 
repositories. 
HeavyMetL-specific program code can be found at: 
https://github.com/pdcharles/HeavyMetL 
 
A generalised library for interaction with MS data, which defines code for handling 
chromatograms, spectra and scans as JavaScript objects, alongside further object 
definitions for common proteomic MS file formats (including mzML and mzXML), the 
isotopologue distribution prediction algorithm, and miscellaneous program flow, thread 
control and mathematical calculation functions is located separately at: 
https://github.com/pdcharles/MSLIB 
 
The following external code projects are also used in HeavyMetL code: 
Pako (https://github.com/nodeca/pako) is a library for decompression of data compressed 
in ‘zlib’ format, which is a compression technique used in some mzML/mzXML files. 
Fabric.js (http://fabricjs.com/) is an HTML5 Canvas element abstraction library used in 
HeavyMetL to generate PMC and protein-level graphical output.  
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Appendix II: Annotated HeavyMetL 
Screenshots 
The following seven pages consist of sequential full-screen screenshots from the 
HeavyMetL interface over the course of setting up and initiating processing on the 
benchmark dataset presented in Chapter 4. 
Page 187 - Initial view of main screen 
Page 188 - Selection of raw data files 
Page 189 - Loading scan headers from raw data files 
Page 190 - Selection of PMC List in text-table format 
Page 191 - Main screen with dataset loaded and ready for processing 
Page 192 - Settings configuration screen 
Page 193 - Processing underway 
Annotations are shown in blue text. 
Screenshots of the graphical results are already included in Chapter 2; see Figure 2-VIII 
and Figure 2-IX.  
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Appendix III: Explanation of Score 
Distribution in Random Simulation 
In Chapter 3, to compare the results of analysis with each of the four candidate Similarity 
Scores to a baseline (SSRAND), I simulated a dataset where there was no association 
between Standardised Incorporation Quantification Errors of individual quantification 
results and their corresponding score assigned to that result (see Section 3.6). 
The simulated dataset scores were generated by taking the maximum of a random number 
n (between 5 and 20) of draws from a uniform distribution between 0 and 1. 
Let Xn be the maximum of the set of n uniformly distributed independent variables in the 
range (0,1). Xn may be shown to follow a Beta(n,1) distribution (209) (Figure AIII-I). 
 
Figure AIII-I. Densities of the Beta distribution for Beta(n,1) where n=5...20 
The values of SSRAND will be drawn (approximately) equally from each distribution shown 
in Figure AIII-I, so it is unsurprising that the SSRAND scales in Error! Reference source n
ot found.-A are seen to skew heavily towards the upper end of the score range. 
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Furthermore, the expected value (mean) of SSRAND can also be calculated. The expected 
value for each Xn is: 
 E(#$) = $$'( 
By the law of total expectation, the expected value for the dataset score is therefore 
 E(SS*+,-) = E(#.)P(n = 5) + 	E(#4)P(n = 6) + ⋯+ E(#78)P(n = 20) 













15 ≈ 0.91 
A mean value of 0.91 is also consistent with Figure 3-XI-A. 
